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TLE proteins are a closely related family of vertebrate corepressors. They have no 
intrinsic DNA binding ability, but are recruited as transcriptional repressors by other 
sequence specific proteins. TLE proteins and their homologues in other species have 
been implicated in many developmental processes including neurogenesis, 
haematopoiesis and the formation of major organs. They have also been implicated in 
early lineage specification in vertebrates but a direct role in this has not been found in 
mammals. The aim of my PhD is therefore to analyse the function of TLE proteins in 
early lineage specification and cell fate decisions using mouse embryonic stem cells 
(ESCs) as a model.  
The investigation of this has previously been complicated, firstly by the large array of 
transcription factors that TLEs interact with and secondly by redundancy between 
similar TLE proteins hindering loss of function approaches. To circumvent these 
problems, I have used two complementary experimental strategies. The first was 
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1.1 Outline of vertebrate axis formation 
At the core of developmental biology is the question of how complex multicellular 
organisms develop from a single cell. This process involves tightly controlled growth, 
differentiation, patterning and morphogenesis. An unpatterned group of dividing cells 
first gains asymmetry, setting up the primary axes on which all further development is 
consequential. These are Anterior-Posterior (A-P) or “head to tail” which runs parallel 
to the notochord in vertebrates and the perpendicular Dorsal-Ventral or “front to back”. 
Specification of the position of axes may be maternally induced or decided after several 
cell divisions depending on species. In Xenopus for example, axis specification is 
induced by maternal determinants concentrated asymmetrically opposite the sperm 
entry point, specifying a signalling centre known as the Nieuwkoop centre (Harland et 
al. 1997). However, the frog zygotic genome does not become transcriptionally active 
until after initial axis specification during Mid Blastula Transition, and therefore 
maternal transcripts are essential determinants. Contrastingly, in the mouse, zygotic 
transcription starts at the 2-cell stage, suggesting the effect of any maternal RNA would 
be rapidly diluted out. No mammalian Nieuwkoop centre has been identified. While 
there have been a number of studies devoted to establishing a deterministic model for 
early mammalian development, their findings are controversial and cell identity does 
not appear to begin become fixed until compaction of the morula (Antczak and 
Blerkom. 1997; Zernicka-Goetz 1998; Piotrowska and Zernicka-Goetz. 2001). Whether 
maternally specified or self-regulative however, axis specification depends on distinct 
groups of cells organizing surrounding cell movement and gene expression. Pioneering 
work by Spemann and Mangold in 1924 led to the identification of one such group of 
cells in the amphibian dorsal blastopore lip that became known as the Spemann 
Organizer (Spemann et al. 1924). Transplantation of this can induce a complete 
secondary axis in a second embryo. The Organizer is itself induced by the Nieuwkoop 
centre. Based on related gene expression and morphology, Organizer equivalents have 
been found in other species such as the Early Gastrula Organizer and the later node in 
mouse, Hensen’s node in chick and the embryonic shield in teleosts. Further studies 
have shown that different parts of the organizer or different stages differed in their 
ability to produce a complete axis. For example, late gastrula Spemann Organizers do 
not induce a secondary axis with head, and in the mouse neither the node nor EGO can 
2
induce a complete axis on its own (Tam and Steiner. 1999). These findings highlight the 
physical and temporal separation of different organizing activities. The organizer also 
initiates the initial lineage separations and cell movements that are the first 
morphological signs of embryonic axes and are known as gastrulation.  
At gastrulation the establishment of the three embryonic germ layers first becomes 
apparent. All animal tissues and organs can be traced back to one of three separate 
lineages known as germ layers. The innermost endoderm gives rise to the digestive and 
respiratory tracts at the organism’s core and associated organs such as liver, lungs and 
pancreas. Ectoderm forms the nervous system and surface epidermis. Mesoderm forms 
all other cell types including blood, muscle, circulatory and skeletal systems and other 
organs.  The separation of the three germ layers occurs during the process of 
gastrulation. In amphibians, this starts with invagination of superficial dorsal cells 
towards the blastocoel cavity. This blastopore contains the organizer, which initiates the 
differentiation of involuting cells into separate germ layers with the first emerging cells 
destined to become dorsal mesoderm (Harland et al. 1997). In birds and mammals it 
starts with a movement of cells in the disc shaped embryo through a feature called the 
primitive streak, which runs along the AP axis with the organizer at its anterior end 
(Mikawa et al. 2004). Gastrulation in the model species the mouse will be discussed in 
more detail below. Rodent gastrulation (reviewed in detail below, with references) looks 
somewhat different, as the cells appear to move from the inside to the outside of the cup 
shaped embryo although this is more of a morphological than functional distinction. 
Although the initial topological arrangements and subsequent movements of these 
layers relative to each other vary between species, the basic function of gastrulation is 
similar across all vertebrates, from Xenopus to mouse.   
 
1.2 Mouse early embryonic development 
As with all multicellular organisms, mammalian development commences with the 
proliferation of a uniform group of equivalent cells with no apparent morphological 
distinctions.  As the mammalian embryo is unique in having to generate both embryonic 
and extra-embryonic lineages, early development begins with an expansion phase 
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during which the progenitors of these lineages proliferate. After fertilization, the zygote 
begins to divide, taking around 3 days to produce the 16 cell morula. Up to the morula 
stage, cells from different embryos can be combined with no apparent defects in 
development. This demonstrates that the mammalian embryo is highly regulative 
compared to other vertebrates and suggests the absence of any maternal patterning 
system. At this stage, in a process known as compaction, the cells on the inside become 
specified as inner cell mass (ICM) and the outside, the extra-embryonic trophectoderm. 
Immediately following compaction, the first overt morphological asymmetry becomes 
apparent with the formation of the blastocoel cavity dividing the embryo along its future 
proximal distal axis. The trophectoderm will contribute to trophoblast and 
extraembryonic ectoderm, future components of the placenta. At 4.5dpc a second extra-
embryonic lineage resolves itself from the inner cell mass, as the primitive endoderm 
(PrEn) segregates from the ICM.  The PrEn will give rise to two distinct extra-
embryonic lineages, the visceral and parietal endoderm and the remaining ICM will 
differentiate into a central epithelial structure, the epiblast. The visceral endoderm 
surrounds the epiblast and cells in this layer will contribute to the visceral yolk sac, 
while the parietal endoderm forms a second outer extra-embryonic layer known as 
Reichart’s membrane. The cells in the epiblast will contribute to extraembryonic 
mesoderm and the three germ layers that will eventually form the embryo proper. Up till 
around 6.5dpc epiblast cells can mix extensively and the embryo appears bilaterally 
symmetric.  This symmetry is broken at a morphological level by the process of 
gastrulation. As gastrulation begins, cells converge towards one side of the proximal 
epiblast and form the primitive streak, a structure through and in which, the 
morphogenetic movements of gastrulation proceed. Cells delaminate from the epiblast 
and ingress through the streak to generate the mesoderm, endoderm and posterior neural 
tube. As early primitive streak gene expression first appears in the epiblast, the distal 
most cells in this region have organizer activity and have been referred to as the Early 
Gastrula Organizer (EGO) (Tam and Steiner. 1999). Later the distal region of the 
primitive streak forms a morphologically recognizable structure known as the node, 
which has historically been associated with the organizer in other vertebrates although 
this was not shown until the early 1990s (Beddington 1994).   
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As in other vertebrates, the organizer region of the mouse embryo will have a major role 
in patterning the A-P axis in the neural tube. Formation of the streak at the future 
posterior side is the first morphological sign of the anterior-posterior axis. Epiblast cells 
ingress through the primitive streak and exit to form the three germ layers. Cells exiting 
along the midline will form axial mesoderm, definitive endoderm and floor plate of the 
neural tube. The axial mesendoderm will form the notochord, prechordal plate and 
anterior endoderm; all three structures alongside the floor plate will produce signals 
patterning the dorsal-ventral axis.  Streak derivatives migrating laterally, will generate 
the paraxial (somites) and lateral (blood) mesoderm. The left-right axis is not specified 
until gastrulation and arises from an asymmetry in the lateral plate mesoderm. This first 
7.5 days of murine development is summarized in Fig 1.1 (Beddington and Robertson 
1999; Rossant and Tam. 2004; Arnold and Robertson. 2009).   
While streak formation is the first morphological sign of asymmetry, at least a day prior 
to gastrulation, anterior-posterior polarity can be detected at the level of gene 
expression. Canonical anterior organizer markers such as Hex, Cerberus and VE-1 are 
detected at the future anterior side of the egg cylinder (Rosenquist and Martin. 1995; 
Belo et al. 1997; Thomas and Beddington. 1998). The expression of these and other 
anterior organizer or mesendoderm markers such as Dickopf, Lefty and FoxA2 begins in 
the primitive endoderm and then their expression becomes restricted to the distal region 
of the visceral endoderm (DVE). The DVE starts to migrate anteriorwards at around 
6.0dpc, just before gastrulation (then becomes referred to as anterior visceral endoderm 
- AVE). 
The molecular basis for the establishment of the DVE and the resulting future axes from 
the highly regulative beginning of mammalian development is still not fully understood. 
However, there is evidence for the involvement of TGFß signalling including BMP4 
and Nodal, and Wnt signalling in the establishment and maintenance of proximal-distal 
polarity. The NODAL ligand is initially expressed throughout the epiblast but becomes 
localized to the proximal region around 5dpc. Its downstream effector SMAD2 is 
expressed in overlying VE that receives the Nodal signal and activates the transcription 
of anterior mesoderm markers such as such as Cerberus and Lefty. Interestingly, a large 
proportion of these DVE/AVE markers are also Nodal and Wnt antagonists. The role of 
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Fig 1.1 Early mouse development
Embryonic development of the mouse from from fertilization until 7.5dpc. Top panel 
shows developmental stages before implantation into the uterus, bottom panel shows 
stages after implantation. Taken from Beddington and Robertson,1999
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these molecules appears to be the attenuation of Nodal signalling in the underlying 
epiblast so that it is able to differentiate into anterior neural plate (Brennan et al. 2001). 
Meanwhile Nodal signalling at the proximal end of the epiblast autoinduces its own 
activity by activating Nodal pro-protein processing enzymes FURIN and PACE4 and by 
an auturegulatory Nodal/Bmp4/Wnt loop to promote more Nodal transcript (Ben-Haim 
et al. 2006). The combination of these activities reinforces a proximal-distal signalling 
gradient, which will be converted to anterior-posterior. Antagonists secreted by the 
DVE also stop the formation of ectopic primitive streak. Visualization of DVE-AVE 
migration has been achieved through cell labelling experiments and the use of reporter 
moue lines such as Hex-GFP.  Time lapse imaging of embryos derived from the Hex-
GFP mice show that Hex expressing cells are observed to actively migrate in this 
direction (Srinivas et al. 2004) The attractive or repulsive signals controlling direction 
are not well understood however a Wnt gradient may be important. OTX2 activates the 
Wnt inhibitor Dickopf and loss of OTX2 prevents AVE migration. This can be rescued 
by Dickopf transcribed from the Otx2 locus suggesting Wnt repression through Dickopf 
is the necessary signal (Perea-Gomez et al. 2001; Kimura-Yoshida et al. 2005). The 
importance of Wnt signalling in axis formation will be discussed in more detail below. 
The Nodal antagonists Cerberus and Lefty can also influence AVE migration. Ectopic 
expression of either/both on one side of the embryo causes AVE to move preferentially 
towards that side (Yamamoto et al. 2004).  
The AVE is responsible for patterning the future anterior side of the embryo although 
does not significantly contribute to it. Many signalling molecules expressed later in the 
Anterior Definitive Endoderm (ADE) that emerges from the primitive streak are also 
produced here. AVE expresses Hesx1 and also induces this gene’s expression in 
underlying anterior ectoderm. This population corresponds to future forebrain 
precursors (Thomas and Beddington. 1996). Interestingly, the gastrulation defect in the 
Nodal mutants is caused by loss of Nodal signalling in extraembryonic lineages. It can 
be rescued by wild type ES cell contribution to the epiblast but still results in anterior 
axis truncations (Varlet et al. 1997). OTX2 expressed from AVE is also necessary for 
head induction although loss of OTX2 leads to a much further caudal truncation 
(Acampora et al. 1997). Somewhat surprisingly, loss of AVE by mechanical ablation 
does not disrupt patterning of the entire anterior region but still causes forebrain 
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truncation. In addition, explants of AVE do not ectopically induce anterior markers like 
Otx2 or Engrailed1 in epiblast. Interestingly, axis duplication experiments with both the 
node and the EGO, fail to generate a complete axis with anterior structures.  However 
when the AVE and the EGO are used in combination they induce anterior neural tissue 
in naïve epiblast (Tam and Steiner. 1999). These studies indicate AVE is necessary, but 
not sufficient to correctly pattern the early head region. As development proceeds the 
AVE is replaced by axial mesendoderm derived from the node.  The anterior most 
population of these cells, the anterior definitive endoderm expresses an overlapping set 
of markers to that of the AVE.  It is thought that the AVE induces anterior identity and 
that when the AVE is displaced proximally as a result of the forwarded movement of 
the ADE, the ADE will take over its role helping to sustain the anterior neural identity 
initiated by the AVE. 
An important function of AVE is local suppression of Wnt, Nodal and BMP 
posteriorizing signals from the extraembryonic region and posterior proximal epiblast in 
the head region. OTX2 is a transcription factor important for induction of some of these 
antagonists (Perea-Gomez et al. 2001). The multifunctional antagonist CERBERUS has 
been shown in Xenopus to antagonize Wnt/Nodal/BMP signals and block the induction 
of Brachyury by a Nodal signal specifically (Piccolo et al. 1999). However in mice, 
Cerberus (Cerl1) mutants develop normally. Mouse CERL1 does not repress Wnt 
signals suggesting that additional factors are involved (Belo et al. 2000; Shawlot et al. 
2000). Double null mutations in both Lefty and Cerberus however, cause ectopic 
expression of primitive streak markers in the anterior region. Interestingly this defect 
can be rescued or suppressed by a Nodal loss of function allele (Perea-Gomez et al. 
2002). In addition, mouse embryos null for the Nodal coreceptor Cripto fail to rotate 
AVE and distally express neural markers, but lack trunk mesoderm (Ding et al. 1998). 
These studies suggest that antagonism of posteriorizing signals by AVE, especially 
NODAL, is needed for head induction in the correct place.   
The Wnt pathway is also important in anterior-posterior axis specification. Wnt3a is one 
of the first markers of primitive streak formation in the posterior epiblast and loss of 
Wnt pathway components affects this polarity. Proximal-distal patterning and 
specification of DVE is also perturbed by loss of Wnt regulation throughout the 
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epiblast. In Xenopus, Wnt signalling is classically thought of as a dorsal determinant of 
cell fate. To further understand early embryonic development, this pathway needs to be 
examined in more detail. 
 
 
1.2 Wnt Signalling 
The Wnt pathway is one of the most important signalling pathways in animals 
(schematic in Fig 1.2a,b). It was first identified in Drosophila as a mutation in a gene 
(wingless) that causes a defect in denticle belt segmentation. A mouse oncogene was 
later identified as a homolog (int1), leading to the general name, Wnt. Wnts are secreted 
glycoproteins that are able to bind to the FRIZZLED cell surface receptor family in 
conjunction with LRP coreceptors. In the absence of Wnt, the protein ß CATENIN can 
be found at the membrane complexed with ECADHERIN to mediate cell adhesion. Free 
cytoplasmic ß catenin is phosphorylated and rapidly degraded. A complex with the 
protein Adenomatous Polyposis Coli (APC) at its core and the active kinase, GSK3, 
mediates this. When Wnt is bound to receptors however, GSK3 becomes inactivated. ß 
CATENIN is then free to translocate to the nucleus where it can interact with DNA 
binding proteins of the TCF/LEF family. TCF/LEF binds to specific sequences in Wnt 
responsive promoters and when it is bound by ß CATENIN it activates downstream 
target genes (Reya and Clevers. 2005). TCF does not have any activating or repressive 
ability of its own. It relies on ß catenin to activate, and cofactors such as Groucho 
proteins to repress transcription. Binding of ß catenin and GROUCHO occur in the 
same physical space on TCF proteins and the two complexes have been shown to be 
mutually exclusive (Daniels and Weis. 2005). This helps to tightly regulate Wnt target 
genes. TCF can also interact with the closely related proteins CBP and p300. In 
Drosophila, these can repress transcription by acetylating TCF, and lowering its affinity 
for ß CATENIN (Waltzer and Bienz. 1998). However they also have histone acetyl 
transferase activity and can help activate transcription by opening the chromatin 
structure. This appears to be dependent on the cellular context or regulation by other 
factors (Li et al. 2007).  
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Fig 1.2 Involvement of TLEs in major signaling pathways
The Wnt pathway.  In the absence of wnt ligand, ß catenin is phosphorylated and 
targeted for degradation by the proteosome. TCF is bound by corepressors such as 
Groucho/TLEs and wnt targets are repressed (a). When wnt ligand is bound by the 
receptor, Gsk3 is inactivated and ß catenin is free to translocated to the nucleus. It 
can bind TCF and activate transcription of wnt targets (b) (Figure taken from Flier 
and Clevers, 2009). 
(c) The Notch pathway. Notch ligands such as Delta and Jagged on signaling cells 
bind the notch receptor and cause cleavage of its intracellular domain. This 
translocates to the nucleus and binds CSL/RBPJ with cofactors to activate target 
genes. In the developing nervous system, these include bHLH Hes proteins which 
use Groucho/TLEs as corepressors to repress proneural genes (Figure adapted 
from High and Epstein, 2008)
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Wnt signalling is involved in many different processes including embryonic 
development and embryonic and adult stem cell regulation. Misregulation of the 
developmental processes associated with the pathway can lead to cancer. Indeed around 
60% of colorectal cancer cases have a mutation in the APC gene (Powell et al. 1992). 
One of the first and best known roles for Wnt signalling in development is axis 
specification as studied in the in the amphibian and zebrafish embryo. In Xenopus, the 
organizer is induced by an early signalling centre known as the Nieuwkoop centre. 
Because the organizers descendents mostly populate the Dorsal axis, in Xenopus this 
initial axis has interchangeably been referred to as Dorsal and anterior – dorso-anterior. 
The location of this group of cells is determined maternally and provides the first 
symmetry breaking event to establish anterior-posterior axis polarity (Heasman 2006). 
Organisms that develop with yolky eggs (such as fish and amphibians but not 
mammals) also have an early animal-vegetal axis that affects later development. 
Fertilization and polar body extrusion happens at the animal pole while the yolk tends to 
concentrate at the vegetal axis. In Xenopus after fertilization, the egg undergoes a major 
cytoplasmic rearrangement known as cortical rotation. Maternal determinants are 
concentrated by cortical rotation, to a vegetal part of the fertilized oocyte opposite the 
sperm entry site. The concentration of these elements is a result of mRNA transport by 
cytoskeletal motor proteins. Blocking this, for example using low temperature, stops 
axis formation and causes a ventralized embryo to develop instead (Gerhart et al. 1989). 
It was later found that depleting ß CATENIN in Xenopus embryos using antisense 
deoxyoligonucliotides had a similar effect. Embryos develop ventralized and this can be 
rescued by ß catenin mRNA injection (Heasman et al. 1994). Lithium chloride acts as a 
GSK inhibitor. Treating Xenopus embryos with LiCl has the opposite effect as ß 
CATENIN depletion, eliciting a dorsalized phenotype. This is due to stabilized ß 
CATENIN and increased Wnt signalling through the entire embryo (Klein and Melton. 
1996) causing an expansion of dorsal (dorso-anterior) and loss of ventral fate. LiCl has 
a similar effect on sea urchin embryos. The sea urchin embryo also develops with 
animal-vegetal polarity, where the animal macromeres are fated towards ectoderm and 
the vegetal micromeres become mesoderm and endoderm. These vegetal micromeres 
are also the site of initiation of gastrulation and contribute to the primitive gut 
(archenteron) and skeleton. Micromeres can induce a secondary axis with archenteron 
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in the animal poles of earlier embryos if transplanted. Treating embryos with LiCl 
causes an expansion of vegetal cell identity. Depleting ß CATENIN also had the 
opposite effect and transplantation of the organizer equivalent cells from ß CATENIN 
deficient embryos failed to induce a secondary axis (Logan et al. 1999).  
What Wnt targets lying downstream of TCF are the effectors of these processes? In the 
animal pole of Xenopus embryos where it is not normally expressed, Siamois is induced 
by injection of Wnt8 mRNA. Several TCF/LEF binding sites were also found in the 
Siamois promoter (Brannon et al. 1997). Siamois is a homeobox transcription factor that 
can induce a secondary axis, including Spemann’s organizer. Organizer genes such as 
Goosecoid and Cerberus are transcriptionally activated by SIAMOIS suggesting that 
this protein mediates Nieuwkoop centre activity (Carnac et al. 1996; Kessler 1997). A 
gene product with similar expression and function, Dharma, has also been discovered in 
zebrafish and is essential for axis formation. Dharma mutants have severe anterior 
truncations and lack a proper organizer, the embryonic shield. This protein can also 
ectopically induce organizer gene expression such as Goosecoid. Interestingly, Dharma 
mRNA expression in the yolk syncytial layer (YSL), which has been proposed to be the 
teleost equivalent of the mammalian visceral endoderm, is sufficient to at least partially 
rescue Dharma mutants (Yamanaka et al. 1998; Fekany et al. 1999). The TGFß nodal 
family is important in both the Xenopus organizer and its mouse equivalent, the node. 
Xenopus Nodal Related 3 (Xnr3) is one of the Xenopus homologues of Nodal. Its 
expression is regulated in part by TCF/LEF, which have been shown to bind and 
positively regulate the promoter. Both XNR3 and SIAMOIS directly induce Goosecoid 
expression which acts to repress ventral gene expression in the dorsal region of the 
embryo (McKendry et al. 1997). 
While no Nieuwkoop Centre has been discovered in mammals and neither Siamois nor 
Dharma appear conserved, later Wnt responses appear the same as in lower vertebrates. 
Thus ß catenin appears essential for early axis specification. ß catenin null embryos 
express only some DVE markers (Cerl1, but not Hex) and never initiate rotation of 
DVE. There is also a complete failure of primitive streak formation and no evidence of 
mesoderm induction (Huelsken et al. 2000).  Wnt3a is first expressed in the proximal 
posterior epiblast and later in the primitive streak and is one of the earliest predictors of 
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primitive streak formation. Wnt3a null embryos fail to form a primitive streak, node or 
mesoderm. They subsequently die before reaching 10.5dpc (Liu et al. 1999). Mutations 
in the APC complex have also been shown to have reciprocal phenotypes. APCmin mice 
have a mutation in APC that decreases the activity of the GSK3 containing complex.  
Heterozygous mice have a predisposition to intestinal tumours but APCmin/min mice do 
not form a normal axis and die by 5.5dpc. In fact, the primitive streak marker Brachyury 
becomes expressed throughout the epiblast creating a proximalized embryo and 
eventually leading to the ubiquitous expression of posterior mesodermal markers. 
Embryos also lost their ability to specify DVE. This study also found some evidence of 
asymmetrically expressed nuclear ß CATENIN in the trophoblast of wild type 4.5dpc 
embryos. Moreover chimeras show evidence of distalization of the primitive endoderm 
suggestive a role in early AP specification (Chazaud and Rossant. 2006). MESD is a 
chaperone protein involved in the biosynthesis of the Wnt coreceptors LRP5/LRP6. 
Mesd mutant embryos have a milder but still significant defect in axis specification. 
They begin to express Brachyury and Wnt3a in proximal epiblast but fail to form a later 
primitive streak (Hsieh et al. 2003).  
ß catenin has been shown to be involved in aspects of endoderm specification. It can 
bind Sox17 and in doing so promote endoderm formation. Sox17 target genes can be 
upregulated by ß CATENIN in Xenopus although this requires overexpression of Sox17 
too, suggesting that both proteins are required for synergistic stimulation of 
transcription (Sinner et al. 2004). One Sox17 target shown to be upregulated by ß 
CATENIN was Foxa2, which is a key regulator of endoderm formation. Loss of Foxa2 
in mice prevents definitive endoderm maintenance (Ang et al. 1993). When ß catenin is 
deleted conditionally in cells normally fated to become endoderm, these cells in mutant 
embryos instead become precardiac mesoderm and fail to express endoderm markers 
(Lickert et al. 2002).  
Another Wnt related factor to play a role in development is the TCF corepressor TLE4. 
This is a mammalian homologue of Drosophila Groucho, which keeps Wnt target 
genes, repressed in the absence of Wnt ligand. TLE4 was found to be a repressed target 
of the homeobox transcription factor Hex. This repression was found to play an 
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important role in the regulation of anterior-posterior patterning in both Xenopus and 
mouse. 
 
1.3 Hex and TLE4 
The proline-rich homeodomain containing protein Hex was first identified as a marker 
of haematopoietic precursors. While it is expressed in the developing blood during 
embryogenesis, it is also expressed in the endoderm and its derivatives, like the liver 
and thyroid. Hex is first expressed during mouse development at 4.5dpc throughout the 
primitive endoderm as it first forms beneath the ICM. By 5.5dpc Hex expression 
becomes restricted to the distal tip visceral endoderm. As discussed above, these cells 
have anterior inducing capacity. Embryos in which Hex has been removed genetically 
exhibit evidence of an anterior truncation and loss of rostral forebrain markers. 
Chimeras of wild type embryonic cells contributing to the epiblast and Hex null 
extraembryonic tissues also show this phenotype, indicating this is a result of loss of 
HEX in the ADE specifically (Thomas and Beddington. 1998; Martinez Barbera et al. 
2000). HEX has been shown to act as a transcriptional repressor and experiments in 
Xenopus suggest its role in anterior patterning is related to its capacity to suppress 
mesoderm induction. However, ectopic Hex expression in non-anterior cells also 
appeared to induce a non-autonomous activity that promotes Dorso-anterior identity in 
nearby cells, indicating that repression by HEX is important for the induction of 
anteriorizing signals.  Fusion of HEX to reiterated modules of the VP16 activation 
domain (λVP2) converts it to an activator of Hex target gene expression and injection of 
Hex λVP2 in Xenopus embryos resulted in embryos with ectopic mesoderm and 
anterior truncations. Ectopic expression of wild type Hex repressed dorsal mesoderm 
gene expression, acting on genes such as Goosecoid, and Chordin. Hex therefore 
promotes anterior identity in the head region by suppressing dorsal mesodermal 
organizer identity (Brickman et al. 2000) promoting the establishment of an anterior 
endoderm domain that expresses Cerberus and helps to insulate the anterior neural plate 
from posteriorizing influences.  
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Recent experiments in our lab have also tied the inductive role for Hex to Wnt 
signalling. Ventral vegetal misexpression of modest levels of ß CATENIN can induce a 
posterior secondary axis in Xenopus embryos. However coinjection of ß catenin mRNA 
alongside Hex produced ectopic heads (Zamparini et al. 2006). Moreover, as previously 
shown, misexpression of ß catenin or Wnts can dorsalize the ventral marginal zone of 
frog embryos (Glinka et al. 1996). This activity appears somewhat context independent 
as HEX can also promote ß catenin activity in Ventral marginal zone explants, where 
the combination of the two RNAs mimics the phenotypes observed in response to high 
ß CATENIN levels, the induction of heads in these explants (Zamparini et al. 2006). 
Taken together, these lines of evidence suggest that Hex is cooperating with ß catenin to 
specify anterior identity in Xenopus embryos. The ability of Hex to potentiate Wnt 
activity was also observed in transient cell culture assays and found to be dependent on 
TCF. Moreover, a genome wide screen for Hex targets in mouse ES cells lead to the 
identification of TLE4 as a Wnt repressor directly repressed by Hex, and experiments in 
Xenopus also support the notion that TLE4 is a direct target. Taken together, these data 
suggest that the amplification of Wnt signalling by Hex is at least in part due to the 
regulation of TLE4 expression and that this activity maybe be important for the 
specification of the anterior axis (Zamparini et al. 2006). 
While, TLE4 maybe an important component involved in regulating early Wnt 
signalling, the suppression of Wnt and Nodal signalling is necessary for anterior 
specification (see above). CERBERUS has Wnt antagonistic activity and is expressed in 
the same anterior domain as Hex (Brickman et al. 2000). The secreted Wnt repressor 
Dickopf is expressed in frog foregut endoderm underlying the head and in mouse 
headfold mesoderm and AVE. This gene also has head inducing ability and loss of 
Dickopf leads to anterior truncations, a phenotype similar to Hex mutants or AVE 
ablation (Glinka et al. 1998; Mukhopadhyay et al. 2001). FRITZ, FRZD8 AND 
FRZDB-1 are all soluble extracellular antagonists of Wnt ligand binding. These too are 
expressed in the anterior head region of the mouse embryo (Leyns et al. 1997; Mayr et 
al. 1997; Lu et al. 2004) and have homologues expressed in the anterior endodermal 
domain in frog. Clearly Wnt modulation in the anterior prospective head region and 
underlying cells is important. In Zamparini et al, Hex was shown to regulate two sets of 
targets, the first, including TLE4, were involved in the initial specification of the 
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anterior axis and involved the amplification of Wnt signalling.  The second were a class 
of genes suppressed by Hex once the anterior territory in the endoderm was already 
induced and these include factors that suppress wnt signalling. This two-stage model is 
summarized in Fig 1.3. In addition, the zebrafish YSL also expresses Hex and this has 
been shown to suppress Wnt8 and other axial mesoderm markers such as Chordin, 
which suggests a similar role in insulating the anterior region from posterior signals 
during gastrulation (Ho et al. 1999).  
TLE4 is a member of a larger family of highly related proteins with overlapping 
functions and expression patterns. These may also play a role in patterning processes 
and indeed TLE3 was also identified as a Hex target in our microarray screen. Their 
expression patterns in early embryos of any species have not been well characterized 
but TLE3 and TLE4 are expressed in the anterior regions of mouse and chick embryos 
at mid gastrulation and in the primitive streak. Mouse TLE3 at least seems excluded 
from the headfold region and restricted to underlying gut endoderm emerging from the 
PS (Leon and Lobe. 1997; Vanhateren et al. 2005). The suppression of TLEs may be 
involved in initial anterior specification but as transcripts are seen later in the anterior 
region and overlap with regions Hex is known to be expressed, TLEs may also play 
additional roles.  Further investigation of the TLE4 Wnt antagonist and related members 
of its family is therefore an important part of understanding anterior patterning. 
 
1.4.1 Groucho/TLE corepressors 
TLE proteins are a family of vertebrate corepressors that do not bind DNA on their 
own, but are recruited to DNA by sequence specific DNA binding proteins. They are all 
related structurally and evolutionarily to the Drosophila Groucho. Groucho was first 
identified in flies as a spontaneous mutation that caused defects including extra bristles 
above the eyes, giving the impression of the famous bushy eyebrows of Groucho Marx 
(Lindsley and Grell. 1968). This phenotype and genetic evidence linked it to the 
Enhancer of Split (ESpl) group of mutants, leading to its alternative name, Transducin 
Like Enhancer of split (TLE). ESpl mutants are typically linked to ectopic neural 
induction. Human and mouse homologues of the fly gene Groucho, were later cloned 
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Fig 1.3 Schematic representation of Hex interactions with the Wnt and Nodal-
related pathways
At blastula stage, Hex amplifies Wnt signaling through the repression of the Wnt 
antagonist Tle4. The Nieuwkoop centre genes Siamois and Xnr3 are markers of this 
process and this signaling centre is responsible for the induction of both anterior 
endoderm and axial mesoderm. Following mesendoderm induction, Hex is 
expressed in the anterior endoderm where it antagonizes the propagation of the 
Nodal signal to prevent mesoderm formation in the head field. Broken lines indicate 
the induction of defined domains in the mesendoderm.
(Figure and legend taken from Zamparini et al, 2006)
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and termed Grg (Mallo et al. 1993; Miyasaka et al. 1993). However for consistency in 
the literature, TLE has become standard nomenclature for all vertebrate Groucho 
homologues. The sequence and domain structure of full length TLEs is highly similar to 
Groucho. However the yeast Tup1 repressor is also highly structurally and functionally 
similar and perhaps represents evidence of an even earlier evolutionary ancestor 
(Flores-Saaib and Courey. 2000). TLE proteins do not have specific DNA binding 
ability or much innate repressive ability and rely on interactions with other proteins to 
carry out their role as corepressors. Their domain structure and biochemistry give some 
information about their mechanism of action.  
 
1.4.2 Biochemistry of TLE proteins 
There are six known TLE genes in mammals. Four are full length; similar to Drosophila 
Groucho in structure, and two are short truncated versions with different activity and 
roles (Gasperowicz and Otto. 2005; Buscarlet and Stifani. 2007; Jennings et al. 2008). 
Full length TLEs (TLE1-4) are purely repressive. TLE5, also known as AES is a separate 
gene that resembles a truncated, N-terminal only TLE. TLE6/Grg6 resembles a C-
terminal only truncation. TLE6 is unique to mammals while orthologs of the others are 
found in all vertebrate lineages. To understand the functional differences between the 
family members and their mechanism of action, we must look at the domain structure. 
This is summarized in Fig 1.4. 
The N terminal Q domain interacts with other TLEs using two leucine zipper-like 
motifs and mediates tetramerization. Tetramerization has been shown to be important 
for the mechanism of action of TLEs. Overexpression of a tetramerization deficient 
mutant Groucho construct in Drosophila does not lead to the wing disk abnormalities 
that overexpression of wild type Groucho does (Song et al. 2004). Deleting the Q 
domain of Groucho negates the ability of the protein to repress transcription in a 
reporter assay. However, this domain does not seem to play a direct role in repression. 
Replacement by the tetramerization domain of p53 restores most of the repressive 
ability lost by deletion. This leads to a model where TLE proteins can mediate long-
range repression from DNA recruitment sites by polymerizing via their Q domains and 
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Fig 1.4 Structure of Groucho/TLE proteins
Schematic of the general structure of drosophila Groucho (top) and the vertebrate 
TLE homologues. General domain functions are indicated above. LZ marks coiled-
coil leucine zipper like structural features used for tetramerization. P indicates CK2 
phosphorylation sites in the CcN domain and MAPK phosphorylation site in the SP 
domain. These features are conserved in vertebrates.  TLE5 has an altered GP 
domain that does not bind HDACS. TLE6 only has a WD40 domain with significant 
sequence homology to other TLEs but has a novel N terminal region with LZ-like 
and CcN-like features. QD is a splice variant consisting of only the N terminal half 
of the TLE4 Q domain. 
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spreading along the chromatin fibre (Chen et al. 1998; Flores-Saaib and Courey. 2000). 
However more recent evidence has contradicted this. Both wild type TLE3 and 
TLE3∆QD were able to condense synthetic chromatin arrays, suggesting single separate 
TLE molecules could interact with two histones. Chromatin condensation is one way 
TLEs have been proposed to mediate transcriptional repression. The QD was necessary 
to aggregate separate chromatin arrays however, suggesting it could play a part in 
mediating long range repression or higher order chromatin compaction (Sekiya and 
Zaret. 2007). The Q domain also interacts with transcription factors including the 
TCF/LEF family and binds these as native tetramers (Brantjes et al. 2001; Daniels and 
Weis. 2005). In summary, the Q domain has multiple functions and different 
requirements for tetramerization suggest more than one mechanism of action for TLEs. 
Moreover, while this data suggests aggregation along DNA is a component of Groucho 
mediated repression it is not the entire story. 
Adjacent to the Q domain lies the glycine/proline rich GP domain. This has been shown 
to interact with histone deacetylases (HDACs) such as Drosophila Rpd3. Yeast TUP1 
also interacts with the class III HDAC protein, SIR2. HDAC inhibitors such as TSA 
inhibit TLE mediated repression suggesting HDAC mediated chromatin silencing is 
also utilized by TLE family members to repress gene transcription (Chen et al. 1999; 
Flores-Saaib and Courey. 2000).  
The central CcN domain has been implicated in the regulation of TLEs. It contains a 
nuclear localisation sequence and two serine residues, which can be phosphorylated by 
CK2 kinase. This phosphorylation is necessary for TLEs to be retained in the nucleus 
(Nuthall et al. 2004). Also involved in regulation is the adjacent SP domain. This was 
thought mainly to be a spacer region but contains phosphorylation sites, for example for 
MAPK. MAPK phosphorylation has been shown to reduce the repressive activity of 
GROUCHO. This may be to allow the derepression of genes that are targets of both 
GROUCHO and the receptor tyrosine kinase signalling (RTK) pathway, for example by 
EGFR (Hasson et al. 2004; Cinnamon et al. 2008). In Xenopus, RTK signalling through 
FGF4 also inhibits TLE mediated repression of Wnt targets. These include mesodermal 
markers such as MyoD, in agreement with the role of Wnt signalling in dorsal 
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mesoderm specification. This mechanism is an interesting example of crosstalk between 
signalling pathways through TLEs (Burks et al. 2008).  
At the N terminus of full length TLEs lies the WD40 domain, which is the only part of a 
TLE protein to have its structure solved by x-ray crystallography. This has a seven 
bladed ß propeller structure similar to the G protein receptor ß subunit. The central pore 
of the propeller is the site of many interactions with DNA binding proteins. Two motifs 
know to interact with this region are found in a wide array of DNA binding proteins.  
These motifs, WRPW and eh1 (FxIxxIL) are found in a variety of transcription factors 
(Jennings et al. 2006). WRPW motif containing proteins include HES1 and the 
somitogenesis factor RIPPLY2 (Fisher and Caudy. 1998; Morimoto et al. 2007). 
Moreover the eh1 family is extremely large and includes at least three factors known to 
pattern anterior endoderm: HEX, GOOSECOID and HESX1.  There are also many 
other homeodomain and Fox proteins in this family (Swingler et al. 2004; Yaklichkin et 
al. 2007). The full list of Eh1 and WRPW containing proteins found to interact with 
TLEs is extensive and ever growing (Buscarlet and Stifani. 2007).  The C terminal of 
yeast TUP1 also has ß propeller structure, with residues exposed around the central pore 
that are vital for its repressive ability (Green and Johnson. 2005). A mutation in the TLE 
like gene of C.elegans, unc-37, also maps to this region and causes an effective null 
phenotype (Pflugrad et al. 1997). These studies show functional conservation and 
emphasize the importance of the WD40 domain for TLE function, specifically for 
protein interactions. 
Although the TLEs are dynamically regulated throughout gastrulation (Koop et al. 
1996; Vanhateren et al. 2005) at the RNA level, surprisingly little is know about 
transcriptional regulation of TLEs. Regulation by HEX is one of the only instances of 
direct control by a known transcription factor found so far. Stat3 and the oncoprotein 
E2A-HLF have also been shown to directly regulate TLE5 and TLE6 respectively 





1.4.3 Non full-length TLE proteins 
The vertebrate TLE family probably arose through tandem duplications of a single TLE 
ancestral gene. Based on phylogenetic analysis of different species TLEs, several 
independent duplications occurred to give the four full length TLEs we see in 
vertebrates today. Teleost fish underwent specific genome duplication in evolutionary 
history, creating extra copies of both TLE2 and TLE3. Retention of these duplications 
and sequence and expression pattern divergence suggests adaption to different roles. 
This would allow for greater control over TLE dependant transcriptional regulation than 
that provided by a single TLE like Groucho (Aghaallaei et al. 2005; Bajoghli 2007). 
TLE2 also underwent a duplication event creating a new TLE without the exons after 
the GP domain, TLE5. In mammals, the remaining C-terminal encoding exons from the 
duplication event appear retained as part of an independently expressed gene, TLE6. 
TLE2, 5 and 6 cluster together on chromosome 10 in mouse. 
C-terminal truncated forms of TLE such as TLE5 also have a GP domain. However 
these proteins do not appear to bind HDACs, possibly due to sequence differences 
(Brantjes et al. 2001; Yu et al. 2001). They often also act as positive regulators of genes 
normally repressed by full length TLEs (Wang et al. 2000; Swingler et al. 2004) 
Because of this, they are often considered as dominant negative TLEs. Thus they are 
thought to bind full length TLEs via their intact Q domain and sequester them into 
inactive complexes, a form of anti-repression like squelching. Dominant negative 
proteins also appear to be generated by alternative splicing. A naturally occurring splice 
variant of TLE4 in B cells, QD, contains just the first section of the Q domain with a 
single LzL motif. This was shown to block the interaction between TLE4 and PAX5 
(Milili et al. 2002). Another C-terminal truncated TLE1 splice variant with an intact GP 
domain has some repressive activity with respect to TCF, but would be predicted to 
function as a dominant negative with respect to co-factors (Lepourcelet 2002).  
It is becoming increasingly apparent that the regulation of transcription by TLE is 
becoming more complex. Short TLEs can behave as repressors or activators in a context 
dependant manner.  Much of the evidence pointing towards short forms as dominant 
negatives relies on strong, non-physiological overexpression or use of the GAL4 DNA 
binding domain to bring TLE5 binding partners to DNA reporter constructs. In sea 
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urchins, endomesoderm specification downstream of TCF is suppressed by injection of 
the TLE homologue LvGro through the inhibition of wnt signalling in the vegetal pole 
producing a severely animalized phenotype. However, a truncated LvGro consisting of 
just the Q domain had the same effect, suggesting that in this context it too could 
behave as a repressor. Further molecular analysis confirmed this repression, although 
differences in the range of genes affected by long and short LvGro were observed 
(Range et al. 2005). TLE4 is able to bind PAX5 and repress the target gene CD19. 
However TLE5 was unable to interfere with this repression, even at high levels 
(Eberhard et al. 2000). TLE5 was also shown to be a corepressor of the androgen 
receptor. Here it could repress transcription when recruited to naked chromatin free 
DNA by the receptor. The HDAC inhibitor TSA also had no effect on this repression. It 
could be mediated by interactions with the basal transcription machinery, such as 
TFIIE, which AES associates with specifically (Yu et al. 2001). In a similar way, the 
C.elegans TLE1 homologue unc-37 can interact with members of the mediator complex 
(Zhang and Emmons. 2002). These studies also highlight the fact the HDAC 
recruitment is not the only way that TLE proteins can mediate repression. 
The mammalian specific TLE6 has been discovered fairly recently and remains 
relatively uncharacterized. Roles have been identified for it in mouse morula 
development, cancer progression and neurogenesis (Dang et al. 2001; Marçal et al. 
2005; Li et al. 2008). TLE6 consists of the WD40 domain and a separate divergent N 
terminal half with a CcN like domain and coiled-coil like structures similar to the LzL 
tetramerization sequence in TLEs. TLE6 does not behave as an inherent transcriptional 
repressor as it does not repress when recruited to DNA by the GAL4 domain. This is 
consistent with its lack of repression domains. However it does antagonize repression 
by FOXG1 and TLE1, possibly competing with TLE1 for the FOXG1 eh1 motif. 
Interestingly, TLE6 does not bind HES1, which contains a WRPW motif, suggesting 
structural differences in the WD40 domains. TLE6 could be acting as a modulator of 




1.4.4 TLEs in development 
Because of their role as corepressors with a wide range of important transcription 
factors, TLEs are involved in many developmental processes. They were first identified 
in Drosophila as mutations in the Groucho locus which enhanced the phenotype of 
other Enhancer of split mutants, some leading to the lethal commitment of most 
ectodermal cells to the neural lineage (Ziemer et al. 1988). ESpl mutants tend to be 
homozygous lethal due to the loss of epidermal tissue caused by the increased 
ectodermal to neural conversion. This was later found to be due to be due to their 
involvement in the Notch signalling pathway (this pathway is summarized in Fig 1.2c). 
Notch signalling is a major pathway involved in cell – cell signalling and was initially 
described based on its regulation of neurogenesis. The induction of ligands such as 
JAGGED AND DELTA-LIKE activates NOTCH receptors in neighbouring cells. This 
causes lateral inhibition of downstream targets, a process by which the 
DELTA/JAGGED expressing cell blocks the cells around them from adopting their fate. 
In neural induction, the stimulation of Notch signalling shuts down neurogenesis in the 
neighbouring cells. The activation of the pathway proceeds as activated cell surface 
NOTCH receptors undergo cleavage and the intracellular domain (ICD) internalizes and 
enters the nucleus and binds the sequence specific DNA binding protein, CSL to 
activate transcription target gene transcription. The complex of CSL and NOTCH ICD 
is known to induce an assortment of bHLH proteins including key negative regulators of 
neural transcription, the Hes family. bHLH proteins control neural commitment and can 
either be positive, such as NEUROD proteins, or negative such as HES (Hairy enhancer 
of Split) related proteins. HES1, one of the mammalian HES homologues can repress 
neural fate as has been shown by its overexpression. Mutation of these genes allows 
ectopic activation of this fate (Knust et al. 1987; Lai 2004). Interestingly, Notch 
signalling also appears to have a positive role early in neural specification. Thus, 
constitutive expression of the NOTCH ICD in ES cells leads to increased specification 
of neural progenitors during neural differentiation (Lowell et al. 2006). NOTCH 
activation also had differing effects in the chick inner ear where it could both repress 
sensory hair cell formation as expected but also promote ectopic hair cells (Daudet and 
Lewis. 2005). 
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Further genetic evidence explaining Grouchos role in neurogenesis came from the 
interaction found between GROUCHO and HAIRY related basic helix-loop-helix 
(bHLH) proteins. These bind CSL with GROUCHO in the absence of pro-neural 
signals, leading to the repression of target genes such as the neural marker Hunchback 
(Paroush and Finley. 1994). The capacity of TLE to suppress neurogenesis in mammals 
has also been demonstrated. Early evidence of this came from the identification of an 
interaction between TLE1 and the mammalian bHLH protein (Grbavec and Stifani. 
1996). In the developing nervous system, both Hes1 and TLE1 RNA are expressed in 
similar domains supporting the notion that they act in concert to suppress neurogenesis. 
Moreover, mutations of either gene gave a similar phenotype in which mutants display 
an over proliferation of neurons. Postmitotic neuronal specific expression of TLE1 is 
also tied to the loss of neurons, especially in the dorsal and ventral telencephelon. This 
was probably due to apoptosis caused by blockage of terminal neural differentiation 
(Yao et al. 2000). Forced expression of TLE1 in primary cultures of neural progenitors 
led to decreased terminal differentiation and an expansion of mitotic progenitors. The 
WRPW motif found in HES1, but not the eh1 motif was found to be essential for this 
(Nuthall et al. 2004; Buscarlet et al. 2008). These studies lead to the model that NOTCH 
induced lateral inhibition causes TLE mediated repression by HES1, and allows a pool 
of undifferentiated neural progenitors to survive in the developing nervous system to 
give rise to later neural lineages. While TLE appears the primary regulator of Hes1, 
HES1 also regulates the phosphorylation of TLE1 by the kinase CK2 leading to its 
increased nuclear localisation. 
In addition to neural development, TLEs are also involved in many other developmental 
processes. TLE3 and TLE4 are expressed in the primitive streak in both mouse and 
chick, along with other structures undergoing epithelial to mesenchymal transition. This 
suggests they may play a role in mesoderm and endoderm specification (Koop et al. 
1996; Leon and Lobe. 1997; Vanhateren et al. 2005). Mesoderm can be ectopically 
specified in Xenopus animal caps by the injection of FoxD3 mRNA. This was found to 
be dependant on an eh1 motif in FOXD3, which is required to recruit TLE4 as a 
corepressor. Mutation of the eh1 motif destroyed both the binding and mesoderm 
specifying ability (Yaklichkin et al. 2007). FoxD3 null mouse ES cells have an 
increased propensity to differentiate, especially towards mesoderm and endoderm. 
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Markers such as Brachyury and Goosecoid are increased, although increases in 
trophoblast markers are also seen (Liu and Labosky. 2008). TLEs are predicted to bind 
many other Fox genes in various species including the FoxA family, which is vital for 
endoderm specification (Friedman and Kaestner. 2006; Yaklichkin et al. 2007). FOXH1 
may also recruit a TLE via Goosecoid to regulate axial mesendoderm development. 
FOXH1, which is normally a transcriptional activator, was shown to bind GOOSECOID 
as a corepressor and repress Mixl1 in mouse embryos (Izzi et al. 2007). Repression of 
Mixl1 was HDAC dependant and GROUCHO has been previously shown to bind 
GOOSECOID to mediate its repressive ability (Jiménez et al. 1999).  
TLE is also involved in somitogenesis. Presomitic mesoderm (PSM) segments into 
individual units and these must transition from mesenchyme into epithelial somites. 
Termination of PSM specific genes in zebrafish is dependant on a protein RIPPLY1, 
which contains a WRPW motif and bound TLE2. RIPPLY1 without WRPW failed to 
downregulate PSM genes such as Mesp-b suggesting a TLE is the effector of RIPPLY1 
action (Kawamura et al. 2005).  A similar gene in mice, Ripply2 also downregulates the 
Mesp-b homologue Mesp2, suggesting conservation of TLE involvement. The down 
regulation of Mesps is necessary for generating rostral-caudal polarity in somites 
(Morimoto et al. 2007). In Xenopus, TLE4 interacts with a protein, BOWLINE, which 
is part of a Ripply family. The Ripply family antagonizes the activator ability of Tbx 
genes in frog and zebrafish in conjunction with TLEs, which are vital for both paraxial 
mesoderm specification and somite segmentation. Interestingly, RIPPLY1 can repress 
transcription of the zebrafish Brachyury homologue No Tail, although it is not known if 
this is mediated by TLEs (Kondow et al. 2007; Kawamura et al. 2008).  
 
TLEs also play a role in organogenesis. TLE3 is expressed in foregut endoderm at the 
6-7 somite stage. However it is downregulated rapidly at the time of liver gene 
induction. In addition, forced lentiviral expression of TLE3 in foregut explants blocked 
the induction of liver markers such as Alb and Ttr (Santisteban et al. 2010).  Full length 
and short TLEs are also found in the developing pancreas with TLE2 and TLE3 
strongest in endocrine tissue. The transcription factor Arx can convert α cells into ß 
cells and repression of insulin promoter activity in a ß cell line could be improved by 
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interaction of TLE2 with Arx mRNA (Hoffman et al. 2008). These studies suggest TLEs 
are involved in the regulation of genetic programs controlling both pancreatic and liver 
differentiation. 
The effects of loss of TLE activity on embryonic development have not been well 
studied. Making a cell or mouse line with complete loss of TLE activity is complicated 
by redundancy between family members, although individual TLEs have been mutated. 
TLE5 homozygous null mice are viable and fertile although a growth defect is observed 
shortly after birth in all embryos. This becomes severe in about 20% of animals leading 
to a ~40% reduction in weight (Mallo et al. 1995). TLE3 null mice die in utero around 
13.5dpc. Death is apparently due to a placental insufficiency because of incomplete 
trophoblast giant cell differentiation caused by lack of TLE3 (Morrish et al. 2007). No 
early embryonic phenotype for loss of a TLE has been described to date. In this thesis, I 
explore the roles of TLEs in lineage specification through the generation of a set of both 




1.5 Embryonic stem cells 
Embryonic stem cells (ESCs) are generally defined as cells that are derived from the 
ICM of a blastocyst and have the potential to contribute to every somatic lineage of an 
animal. They can also be maintained and propagated in an undifferentiated state in in 
vitro culture with appropriate conditions. Whether they represent a true biological cell 
type or simply a functional state of being able to be maintained in these artificial 
conditions is unclear. However they are useful both as a model for developmental 
processes on a cellular level, and potentially as a source of cells for clinical 
applications. ES cells from mice were first isolated by Evans and Kaufman (Evans and 
Kaufman. 1981). These cells could contribute to chimaeric mice and also, as was 
subsequently shown, to the germline. Germline contribution still remains the most 
stringent test of the functionality of ES cells.  
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An important feature of ESCs is their ability to divide and grow while remaining in an 
undifferentiated pluripotent state. This is facilitated by a complex network of 
transcription and regulation and a number of key extrinsic cues. At the centre of this 
network are three master regulators: Oct4, Sox2 and Nanog (Chambers and Tomlinson. 
2009). OCT4 and SOX2 bind cooperatively to DNA on the promoters of many 
pluripotency genes such as Fgf4 to activate transcription (Ambrosetti et al. 2000). A 
specific level of OCT4 is necessary for ES cells to maintain pluripotency. Reduction to 
50% levels causes differentiation towards trophectoderm, while doubling the levels 
causes ES cells to differentiate towards primitive endoderm and mesoderm (Niwa et al. 
2000; Morrison and Brickman. 2006). Part of this function seems to be evolutionarily 
conserved as a Xenopus Oct4 homologue PouV can compensate for loss of Oct4 in 
mouse ES cells. Although amphibians do not have stem cells in the classical sense, 
POUV can repress commitment markers such as Goosecoid and Cerberus in frog 
embryos suggesting an earlier evolutionary role (Morrison and Brickman. 2006). In 
addition, Oct4 null mouse embryos fail to develop beyond the blastocyst stage. Null 
embryos fail to develop ICM cells, instead upregulating trophoblast markers in all cells 
(Nichols et al. 1998). Sox2 null ES cells also differentiate towards trophoblast although 
the phenotype is not as severe as loss of Oct4. Forced expression of OCT4 can in fact 
compensate for loss of Sox2 to some extent, suggesting SOX2 may help stabilize Oct4 
transcriptional complexes (Masui et al. 2007). Nanog is a homeodomain protein that 
increases ES cells capacity for self-renewal, even in the absence of LIF (Chambers et al. 
2003; Mitsui et al. 2003). Nanog null ES cells can still self renew indefinitely, although 
they have an increased propensity to differentiate (Chambers et al. 2007). In fact, levels 
of NANOG fluctuate naturally in normal culture conditions from low to high. High 
NANOG correlates with low levels of the primitive endoderm marker Gata6 (Takahashi 
and Yamanaka. 2006; Chambers et al. 2007; Singh et al. 2007). HEX is also expressed 
at low, fluctuating levels in ES cells and its expression is mutually exclusive with 
NANOG. Based on gene expression including increased Gata6, these HEX positive 
cells appear to be a primitive endoderm intermediate precursor. In chimaeras they also 
show a bias towards extraembryonic endoderm (Canham et al. 2010). These studies 
suggest NANOG is marking a sub population of ICM like ES cells at the furthest point 
away from commitment, on a scale of pluripotent self renewal to differentiation.  
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Recently, it was discovered that terminally differentiated adult cells could be induced to 
revert to an ES cell like state, termed induced pluripotent stem cells (iPS). This was 
achieved by transgenically expressing four factors in adult fibroblasts: OCT4, SOX2, C-
MYC and KLF4 (Takahashi and Yamanaka. 2006). It was later found that this list could 
be varied or factors omitted (Nakagawa et al. 2007; Yu et al. 2007). Constitutive 
activation of reprogramming factors was found not to be necessary either as the 
transgenes could be removed or recombinant membrane-penetrating proteins used 
instead (Kaji et al. 2009; Zhou et al. 2009). Although NANOG was not needed for iPS 
induction, selection of NANOG expressing colonies improved reprogramming 
efficiency and predicted germline competency (Okita et al. 2007). These findings 
suggest the self-renewal/pluripotency program is itself self-stabilising once established, 
given the correct exogenous factors. 
These extrinsic factors are vital for maintaining ESCs, which were first grown in vitro 
on mitogenically inactivated fibroblasts. They appeared to provide both a substrate that 
was amenable for ES cell attachment and secreted factors that regulated the intrinsic 
pluripotency network and kept ES cells in an undifferentiated state. It was subsequently 
discovered that the factor responsible for this was a protein, DIA or Leukaemia 
Inhibitory Factor (LIF). ES cells could be maintained without feeders on gelatin coated 
plastic in media supplemented with LIF and fetal calf serum (Smith et al. 1988). LIF 
binds the gp130 receptor and causes it to dimerize. This activates the downstream 
transcription factor STAT3, which inputs into the pluripotency network (Niwa et al. 
1998; Nichols et al. 2001). It was later found that BMP4 could replace fetal calf serum 
in media. BMP4 activates Id proteins, which act to inhibit neural differentiation (Ying et 
al. 2003). Although mouse ES cells can be maintained using the simple combination of 
LIF and BMP4, a wide range of signalling pathways including TGFß, Wnt and Map 
kinase/ERK have been shown to feed into the pluripotency network (Pera and Tam. 
2010).  Moreover, the ability of LIF and BMP4 to support ES cells maybe unique to the 
mouse system. 
Primate ES cells do not respond to LIF induced Stat3 induction and require TGFß 
activation by ACTIVIN plus BMP4 and FGF2 to maintain pluripotency (Thomson et al. 
1998). This may be because they are derived from a later developmental equivalent 
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stage to mouse ESCs. Interestingly, a later multipotent cell type known as epiblast stem 
cells (EpiSCs) can be derived from 5.5dpc mouse embryos. These share some of the 
characteristics of human ESCs both in their gene expression patterns and their 
requirement for ACTIVIN, BMP4 and FGF2 rather than LIF (Tesar et al. 2007). 
Interestingly, gp130 null embryos can survive and develop normally. However if 
implantation is delayed, gp130 null embryos show increased apoptosis in the ICM and 
fail to resume development (Nichols et al. 2001). Thus the in vitro culture environment 
used to culture mouse embryos may be similar to diapause-delayed implantation, in that 
they are slowed through normal development so both contexts require this additional 
signal to maintain pluripotency.  
Another pathway feeding into the pluripotency network is Map kinase/ERK. FGF 
factors bind cell surface receptors and activate the downstream Ras-Erk signalling 
cascade. This in turn activates differentiation related genes and allows cells to transit to 
lineage commitment (Burdon et al. 1999). Mutation of Fgf4 in cells or treatment with an 
FGF receptor inhibitor blocks differentiation to neural or mesodermal lineages (Kunath 
et al. 2007). ESCs naturally secrete FGF4, which would be expected to induce 
differentiation (Rathjen et al. 1999). This is an example of the delicate balance between 
signals to maintain self-renewal and those to allow differentiation that exist together in 
ESCs. Interestingly, inhibition of MAPK activity appears to enhance mouse ES cell 
culture, while its activation appears required for human cells.  
The Wnt pathway has also been suggested to contribute to self-renewal. Overexpression 
of WNT5A and WNT6 in fibroblast feeders increases their ability to support ESC self-
renewal (Hao et al. 2006). This appears due to the secreted Wnts as conditioned media 
has the same effect without feeders. Stat3 transcript levels are increased following Wnt 
induction suggesting Wnt signalling synergises with LIF. However not all Wnt proteins 
are able to maintain self-renewal. Media conditioned by NIH3T3 cells expressing 
WNT3A supports self-renewal while WNT11 conditioned media does not (Singla et al. 
2006). GSK3 inhibition also affects cells in a similar manner. GSK3 degrades ß catenin 
so inhibition of this protein leads to more transcriptionally active ß catenin-TCF 
complexes. The inhibitor 6-bromoindirubin-3'-oxime (BIO) is able to maintain human 
ESCs in an undifferentiated state in the absence of feeders. This effect also seems to be 
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synergistic with LIF (Sato et al. 2004). Transcript levels of GSK3 itself increase upon 
differentiation (Adjaye et al. 2005). The mechanism for this may be to increase 
expression of pluripotency transcription factors in addition to STAT3. Oct4 and Nanog 
both have TCF binding sites in their promoters. Mutation of TCF3 in ESCs causes 
delayed differentiation upon LIF withdrawal (Pereira et al. 2006; Tam et al. 2008). 
Additionally, inhibition of Wnt signalling is necessary to allow neural differentiation of 
ESCs. Addition of the Wnt inhibitor SFRP2 increases this while the GSK3 inhibitor 
lithium chloride inhibits differentiation to neural precursors (Aubert et al. 2002). Other 
downstream components of the Wnt pathway have been implicated in ESC regulation. 
TCF/CBP mediated transcription appears to contribute to self-renewal while TCF/p300 
activates differentiation related genes. Altering the balance towards TCF/CBP 
dependant transcription by inhibiting p300 phosphorylation with the small molecule 
inhibitor IQ-1 helps inhibit differentiation of mouse ESCs (Miyabayashi et al. 2007). 
This information has led to the development of a new culture system for ESCs, 2i 
culture. It uses two small molecule inhibitors instead of inductive signalling to maintain 
self-renewal (Ying et al. 2008). PD0325901 inhibits the Mek/ERK signalling cascade, 
which as discussed earlier, leads to inability of the cells to commit to differentiation in 
the mesoderm and neural lineage. CHIRON99021 is another GSK3 inhibitor that has 
been shown to help maintain self-renewal. CHIRON is more specific than BIO and 
provides more evidence that GSK3 inhibition is the important mechanism rather than 
any off target pharmacological effects (Murray et al. 2004). However, it is still unclear 
whether the canonical Wnt/TCF pathway is downstream of GSK3, or whether GSK3 is 
acting through another downstream pathway. Both inhibitors act together to maintain 
ESCs in an undifferentiated state. LIF is unnecessary although it still provides a 
beneficial effect to the system. 2i has also been used to grow naïve human ESCs that 
appear to represent a similar developmental stage as the mouse and to derive rat ES 
cells, suggesting that the mechanism of action is not species specific, unlike LIF 




1.6 TLEs in ES cells 
As will be discussed later, TLE proteins are expressed in mouse ES cells. However the 
roles they play in these cells are so far unclear. The importance of the Wnt pathway in 
regulating ES cell self-renewal might be expected to involve TLEs as TCF corepressors. 
Indeed, the effects of altering TCF-TLE binding motifs on pluripotency described above 
seem to confirm this. TLE5 is also expressed in ESCs and its expression decreases upon 
differentiation, directly controlled by reducing STAT3 (Sekkai et al. 2005). FOXD3 
inhibits differentiation in ES cells and has been shown to use TLE3 as a corepressor 
(Liu and Labosky. 2008). TLE/TCF can recruit HDACs and bind pluripotency 
associated genes; acetylation of these is associated with pluripotency (Spivakov and 
Fisher. 2007; Huangfu et al. 2008). Of course, this is all circumstantial evidence and the 
role of TLEs in ESC self-renewal has not been directly investigated before. In addition, 
the roles of TLEs in embryonic development would implicate TLEs in control of ESC 
differentiation as well.  
In this thesis, I attempt to identify roles of TLE proteins in ES self-renewal. 
Consequences of loss of function and forced expression are examined to this end. I have 
also used ES cell differentiation as a model for embryonic development to investigate 











Introduction to experimental strategies and results 
The Drosophila Groucho gene was initially identified through genetic studies as a 
corepressor of Notch mediated transcription. Groucho and its homologues in other 
species have been shown to be involved in the regulation of diverse states of 
development and differentiation including neurogenesis, somitogenesis and 
haematopoiesis. They have also been shown to be involved in early lineage 
specification in vertebrates but a direct role in this has not been identified to date in the 
mouse. TLEs have no sequence specific DNA binding ability. They act as corepressors 
for other DNA binding proteins. Many transcription factors use TLEs as corepressors 
and the known motifs WRPW or eh1 are often found in TLE binding proteins. Through 
out development, TLE proteins are also expressed in cells alongside the factors with 
which they interact such as HES1, RUNX1 and HEX. Therefore any effect seen may be 
due to affecting more than one TLE-corepressor interaction.  
In this thesis I use an ES cell model to try to isolate specific lineage decisions regulated 
by TLE family proteins.  
A role for TLE proteins in early development has been described in Xenopus, sea urchin 
and other organisms. Our laboratory recently implicated the transcriptional regulation of 
TLE3 and TLE4 by the homeobox transcription factor HEX as essential for early 
anterior axis specification. HEX acts to promote anterior identity by amplifying Wnt 
signalling, in part, by suppressing the expression of TLE proteins.  This high level 
stimulation of the Wnt pathway leads to the induction and expansion of the anterior 
endodermal domain know to promote the establishment of the anterior neural axis. We 
wanted to investigate this in more detail by asking whether altering TLE activity also 
has an affect on anterior identity specification.  
At the present time, relatively little is known about the role TLE proteins play in the 
earliest stages of mammalian embryonic development. While TLE knockout mouse 
lines have been made, no phenotype before peri-natal stages has been observed. This is 
likely due to redundancy as the family contains four members, of which three appeared 
expressed in early development. Previous studies have characterized the expression 
pattern of members of this family from 7.5dpc, which are expressed in all germ layer 
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derivatives and multiple developing organs. However, based on in silico analysis they 
appear to be expressed as far back as the zygote.  
TLE1, TLE3 and TLE4 are also expressed at high levels in ES cells and have been 
implicated in the regulation of pluripotency.  TCF is believed to regulate Nanog via a 
TLE mediated repression mechanisms and they could also act on Oct4. They have been 
indirectly implicated in the control of self-renewal and differentiation as corepressors 
for other proteins. TLEs also have direct roles in lineage specification in the neural and 
possibly mesendodermal lineage.  As factors that promote differentiation will be 
inhibitors of ES cell self-renewal and vice versa, the role of the TLEs in early lineage 
specification may provide clues as to their function in ES cells.  
In this thesis I have taken two complementary approaches to delineating specific roles 
for TLE family members in ES cells and early developmental decisions. I describe these 
approaches and the reagents generated for them in Chapter 3. The first was to use 
overexpression of a wild type full length TLE1 and TLE1 point mutations with defined 
loss or gain of activity with respect to specific interactors or signalling pathways. This 
approach allowed me to analyse the molecular basis for TLE phenotypes. One mutation 
had loss of WRPW and eh1 motif binding and an enhanced ability to suppress wnt 
signalling. The other had loss of WRPW binding specifically but the mutation did not 
affect other interactions. The second strategy was to assess whether the lack of an early 
phenotype in development is due to redundancy by generating compound TLE3 and 
TLE4 mutations in ES cells.  Analysis of in-silico expression data and mRNA levels in 
ES cells showed that these were the most expressed TLEs in this context. In Chapter 4, I 
show that TLE family members act in early differentiation. In ES cells, they repressed 
self-renewal associated genes and enabled initial differentiation to proceed. 
Complementary evidence from the gain and loss of function approaches also showed 
both positive and negative effects of TLEs on later lineage specific differentiation. 
TLEs both promote differentiation towards neural progenitors while restricting neural 
differentiation through the Notch pathway. In addition, in an in vitro mesendodermal 
differentiation assay, PS/mesoderm markers are increased by loss of TLE. Reduction 
though not complete loss of TLE activity allows more efficient anterior endoderm 
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differentiation suggesting a later role for TLE mediated corepression by homeobox 
proteins in anterior patterning.  
Summary of thesis main aims 
• Construction of a range of tools to analyse the role of TLEs in ES cell self 
renewal and differentiation, namely ES cell lines both overexpressing and 
mutant for TLE proteins 
• Analysis of the role of TLE proteins in ES cell self renewal; to identify TLE 
proteins effects and the mechanism for these 










































2.1.1 Restriction Digests 
1µg of DNA was put in a 20µl digest mix containing 2µl of reaction buffer and 10 units 
of the appropriate enzyme. All restriction enzymes were from New England Biolabs or 
Roche Diagnostics. 
 
2.1.2 Modification of DNA ends 
Vector backbones for cloning were sometimes dephosphorylated to prevent 
recircularization with cohesive ends. This was done using Antarctic Phosphatase (NEB) 
in the supplied buffer for 15m at r.t. The enzyme was then inactivated by heating at 
65ºC for 10m. Synthetic oligonucliotide linker was phosphorylated with T4 
polynucleotide kinase (NEB) in T4 buffer with 100mM dATP. The reaction was carried 
out at 37ºC for 30m and enzyme then inactivated at 65ºC for 20m.  
 
2.1.3 Ligation of DNA fragments 
Ligations were normally performed with a 3:1 ratio of insert to vector DNA. For 
synthetic linkers, 2pmol of linker was ligated with 0.2pmol vector. DNA was mixed in a 
20µl total reaction with 2µl Quick ligase buffer and 1µl Quick ligase (NEB). Reactions 
were performed for 5m at r.t. before being chilled on ice for transformation. 
 
2.1.4 DNA transformation 
DNA for subcloning (1ng) or from ligations (2µl of the reaction) was added to 
chemically competent Escherichia coli (E.Coli) and transformed according to the 
suppliers instructions. DH5alpha cells were used for subcloning and MAX Efficiency 
TOP10 for subcloning (Invitrogen). Bacteria were plated after recovery onto LB agar 
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plates containing ampicillin (100mg/ml) or kanamycin (50mg/ml). X-gal was also 
spread onto plates if necessary for indicating recircularized vector in TOPO cloning.  
Plates were incubated at 37ºC overnight to allow growth of colonies.  
 
2.1.5 Preparation of Plasmid DNA 
 For small-scale minipreps, single bacterial colonies were picked and inoculated into 
5ml LB media with ampicillin (100mg/ml) or Kanamycin (50mg/ml).  Cultures were 
incubated with shaking overnight at 37ºC. 1.5ml of this culture was centrifuged and 
DNA prepared from the cells with the Quiagen Miniprep Kit (Quiagen) according to the 
manufacturers instructions. Large-scale plasmid preparations were performed in the 
same way using 250ml of LB and the Quiagen Maxiprep Kit (Quiagen). 
 
2.2 General Molecular Biology 
2.2.1 Preparation of genomic DNA 
Cells or mouse tissue samples were lysed in TE-SDS with 5mg ProteinaseK (Sigma) at 
50ªC for 4hrs. KAc was added to 1.5M and DNA was separated from cell debris by the 
addition of 1volume of chloroform followed by centrifugation. The aquacious phase 
was extracted and precipitated by adding 2 volumes cold EtOH and incubation at -20ºC 
for 20m. DNA was pelleted by centrifugation at 13000rpm for 20m followed by a wash 
with 70% EtOH. DNA was dried and resuspended in RNAse free water (Ambion) 
 
2.2.2 Agarose gel electrophoresis of DNA 
DNA was generally separated in 1% agarose gels containing 0.5mg/ml Ethidium 
bromide in TAE buffer. DNA was loaded with 1X loading buffer into the wells and 1kb 
ladder (Invitrogen) was also added to a well to mark fragment size. Electrophoresis was 
performed in TAE at 100V until loading buffer dye had migrated an appropriate 
distance. DNA was visualised on a UV lightbox.  
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2.2.3 Preparation of DNA from agarose gels 
DNA fragments of interest were cut from agarose gels with a scalpel under UV light. 
The DNA was extracted and purified using the Quiagen gel extraction kit (Quiagen) 
following the manufacturers instructions. 
 
2.2.4 Preparation of RNA 
RNA was extracted from cells using the RNAEasy kit (Quiagen) following the 
manufacturers instructions. During the protocol, RNA was subjected to a 15m on-
column digestion by RNAse free DNAse1 (Quiagen) to remove any contaminating 
genomic DNA. 
 
2.2.5 cDNA synthesis  
cDNA was synthesized using SuperscriptIII reverse transcriptase (Invitrogen) according 
to the manufacturers instructions. Briefly, 500ng RNA was incubated with 1µl of 1µM 
random primers (Promega) and 1µl of 10mM dNTPs at 65ªC for 5m in a total volume of 
14µl. 6µl of transcription mix containing 4µl First Strand buffer, 1µl 0.1M DTT and 1µl 
of SuperscriptIII enzyme was then added. This was incubated at 50ºC for 1h and 
inactivated at 75ºC for 15m. The total reaction was diluted with nuclease free water 1:6 
and aliquoted for future PCR analysis.  
 
2.2.6 Quantitation of nucleic acids 
DNA or RNA was quantitated using a Nanodrop spectrophotometer (Fisher Scientific) 




2.2.7 Polymerase Chain Reaction 
General PCR was carried out using Taq DNA polymerase (Quiagen) according to the 
manufacturers instructions. Briefly, DNA (1ng of plasmid, 100ng genomic or 3µl 
diluted cDNA) was added to a reaction containing 1X CL and Q PCR buffers, 200µM 
dNTPs, 0.5µM each of forward and reverse primers and 0.01µl Taq per 1µl reaction 
volume. Amplification was carried out in a thermal cycler according to the 
manufacturers recommended conditions. Annealing temperature was according to the 
Tm of primers (generally 58ºC) and amplification time was 30s per Kb. For long range 
genomic PCR the amplification time was extended by 20s per cycle for the final 20 
cycles.  
For the amplification of construct components for cloning, Phusion High fidelity DNA 
polymerase (Finnzymes) was used to minimize sequence errors introduced during 
amplification. The reaction conditions used were similar to those for Taq. Two step 
fusion PCR was used to generate fused amplicons from two separate templates, A and 
B. This used standard PCR to generate A and B products with a short overlapping 
extension at the 3’ end of A and the 5’end of B. The second step uses both products in a 
single reaction as first strand primers for each other, annealing using the overlapping 
sequence at the intended AB sequence junction. Second strand synthesis is from 
oligonucliotide primers annealing at the 5’ end of A and the 3’ end of B to give the 
product AB. 
 
2.2.8 TOPO cloning of PCR products 
TOPO cloning of PCR fragments was used for some construct building steps of for 
making DNA standard templates of rtPCR primer amplicons. TOPO TA (for taq) or 
ZeroBlunt (for Phusion) vectors were used (Invitrogen). 5µl of gel purified DNA was 




2.2.9 Quantitative real time PCR  
Quantitative PCR was performed on reverse transcriptase synthesised cDNA to analyse 
gene expression. The SybrGreen (Roche Diagnostics) system, which uses fluorescence 
integration into the product, was used in most cases except for Nanog. This was 
quantified with the Roche UPL system due to problematic amplification with 
SybrGreen. UPL probe 25 was used. For each gene, 3µL of cDNA synthesized and 
diluted as above was used. This was added to a mastermix containing 5µL SybrGreen 
Mix1 and 1µL  of each primer (0.5mM). For UPL system, 5µL of Probe Mix was used 
with 0.95µL each primer and 0.1µL probe. All samples were analysed in either 
duplicate or triplicate in 364-well plates using a Light Cycler 480 real time PCR 
machine (Roche Diagnostics). To normalize for the amount of mRNA in each sample, 
the housekeeping gene TBP was used as a reference. The relative expression levels for 
each gene were expressed as a ratio between those of a single reference point (plotted as 
1) and the experimental condition of interest in each dataset. This ratio was calculated 
from measured raw Ct threshold values by the delta Ct (Pfaffl) method using the 
equation shown: 
Ratio=(EfficiencyG ) Ct G(reference point) – Ct G (experimental condition) 
    (EfficiencyTBP)Ct TBP(reference point) – Ct TBP (experimental condition) 
Where G=gene of interest. Amplification efficiency was assumed to be 100% (i.e. 2) 
where this was unable to be determined experimentally. 
An average value was calculated from the triplicate wells, discarding any single value 
that severely deviated from the mean. Primers used for qPCR in this thesis are listed in 
the table below: 
 
Gene Forward primer Reverse primer 
Klf4 CGGGAAGGGAGAAGACACT GAGTTCCTCACGCCAACG 
Dppa3 GATGCACAACGATCCAGATTT TGGAAATTAGAACGTACATACTCCA 
Nr0b1 ACCGTGCTCTTTAACCCAGA CCGGATGTGCTCAGTAAGG 
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Rex1 TCTTCTCTCAATAGAGTGAGTGTGC CCAGGACAGCTCAGGATACAG 
Gata4 GCCTGCGGCCTCTACATGAA CAGGACCTGCTGGCGTCTTA 
Gata6 GGTCTCTACAGCAAGATGAATGG TGGCACAGGACAGTCCAAG 
Oct4 GTTGGAGAAGGTGGAACCAA CTCCTTCTGCAGGGCTTTC 
Nanog CCTCCAGCAGATGCAAGAA GCTTGCACTTCATCCTTTGG 
Sox2 GTGTTTGCAAAAAGGGAAAAGT TCTTTCTCCCAGCCCTAGTCT 
Ecadherin AGACTTTGGTGTGGGTCAGG CATGCTCAGCGTCTTCTCTG 
Fgf5 GTTTCCAGTGGAGCCCTTC GAGACACAGCAAATATTTCCAAAA 
Brachyury GTGACTGCCTACCAGAATGA ATTGTCCGCATAGGTTGGAG 
Wnt3a CGCTCAGCTATGAACAAGCA GGTGTTTCTCCACCACCATC 
Nestin CTGCAGGCCACTGAAAAGT TTCCAGGATCTGAGCGATCT 
Sox1 GTGACATCTGCCCCCATC GAGGCCAGTCTGGTGTCAG 
Six3 CCTTCCCCTCCTCTTCGTAA CGGTTTGTTCTAGGGATGGA 
BLBP AACCAGCATAGATGACAGAAACTG ACTTCTGCACATGAATGAGCTT 
NeuroD1 CGCAGAAGGCAAGGTGTC TTTGGTCATGTTTCCACTTCC 
Tuj1 GCGCATCAGCGTATACTACAA TTCCAAGTCCACCAGAATGG 
Cerberus GACTGTGCCCTTCAACCAG AGXAGTGGGAGCAGAACC 
FoxA2 CATCCGACTGGAGCAGCTA GCGCCCACATAGGATGAC 
Hex CTACACGCACGCCCTACTC CAGAGGTCGCTGGAGGAA 
Cxcr4 TTTCAGCCAGCAGTTTXTTT TCAGTGGCTGACCTCCTCTT 
Sox17 CTCGGGGATTAAAGGTGAA CTTAGCTCTGCGTTGTGCAG 
Mixl1 AGTTGCTGGAGCTCGTCTTC AGGGCAATGGAGGAAAACTC 
Frzd5 CAGCACTCAGTTCCACACCA CAGCAGGATCCTCCGAGA 
Goosecoid   GAGACGAAGTACCCAGACGTG GGCGGTTCTTAAACCAGACC 
h/mTLE1  ACGGAGCCAGCTGTATTGAC TCGAGCTGGTACTTGTCAGG 
mTLE1 AGAGGCACAGATAAGCG TCTTGTCCCCATCACTGTCA 
TLE3 AGACAGCCTCAGCAGATACG TTTGTCCAGCCCATTTTCAG 




2.2.10 Sequencing of DNA 
The functionally important segments of the targeting vector were sequenced before use 
to confirm their integrity. This was performed using appropriate sequencing primers by 
the University of Edinburgh sequencing service (The Gene Pool, Ashworth, University 
of Edinburgh).   
 
 
2.2.11 Southern Blotting 
DNA was extracted from targetted cell lines identified by PCR screening and from 
control cells. After purification, 5µg was digested with BclI restriction enzyme. Digests 
were separated by agarose gel electrophoresis as above. A 1% agarose gel was used and 
electophoresed at 4V/cm overnight. Migration distance of digested DNA and reference 
ladder was recorded. The separated DNA strands in the gel were nicked by exposure to 
UV light and denatured with 0.5M NaOH, 1M NaCL which was afterwards neutralised 
with 0.5M Tris, 3M NaCl (pH 7.4). Transfer of the DNA onto a Hybond N+ 
nitrocellulose membrane (GE Healthcare) was performed as standard using the upward 
transfer blotting technique in 20XSSC (0.3M tri sodium citrate, 3M NaCl). The 
membrane was baked at 80ºC for 2hrs to crosslink the DNA and stored for analysis.  
Analysis of digestion patterns produced from the lines was with a 3’ external probe 
downstream of the TLE4 targeting vector 3’ arm. The template was amplified from 
genomic DNA by PCR and gel purified. A radioactive probe was made from it using the 
Megaprime DNA labelling kit (GE Healthcare) according to the manufacturers 
instructions. The blot was blocked in QuikHyb (Stratagene) and the purified probe 
added and incubated at 65ºC overnight. Washes in 0.5XSSC 0.1%SDS were performed 
until no increased background levels of radiation were detectable on the blot using a 
Geiger counter. The blot was then exposed to X-ray film to produce a hybridisation 
pattern for analysis.  
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The following primers were used to generate a 3’ probe: 
TLE3 3' BclI probe F  CCTTGGTGTTTTGCCCTTTA 
TLE3 3' BclI probe R  GCCCTCTGAAGTCTCACCAG 
 
2.2.12 Western Blotting 
Western blotting was used to measure the protein expression from TLE1 expression 
constructs in HEK293 cells. Protein was extracted from the cells by harvesting cells 
from plates at equal plating densities and boiling in Lameli Sample Buffer (BioRad) for 
10 minutes followed by vortexing to denature. Samples were then centrifuged to remove 
insoluble debris and loaded onto precast Novex 10% BisTris acrylamide gel 
(Invitrogen), which was electrophoresed at 200V for 40m. Separated protein was 
transferred onto nitrocellulose membrane by Western transfer at 360mA for 1hr. The 
membrane was blocked in TBST (25mM Tris, pH 7.4, 3mM KCl, 140mM NaCl, 0.1 % 
TWEEN 20) with 5% dried milk powder (Marvel). The blot was stained overnight with 
rabbit anti-FLAG antibody (1:1000)(Cambridge Biosciences). It was then washed in 
TBST and stained with HRP conjugated anti-rabbit secondary (Sigma). After further 
washing, the blot was developed using Pierce Reagent (Pierce) and visualised by 
exposure to X-ray film.  
2.2.13 Constructs 
The following constructs were used in this thesis for experiments and as cloning 
components: 
pFLAG CMV2 containing TLE1wt, TLE1 S239A/S253A, TLE1 S239E/S253E, TLE1 
V488S, TLE1 C488R, TLE1 R534A, TLE1 E550K and TLE1 L743F; pVP16-TLE1; 
pEGFP-Grg6 (gifted by Stefano Stifani, McGill University); pMIR QD (a gift from 
Amanda Fisher, Imperial College London); pYX AES (Geneservice); pCS2 xTCF3; 
pCS2 TCF3∆ßcatBD VP2; pTOPflash (Upstate Biotechnology); pKO901 (NEB);  
pRSET-B mORANGE and mCHERRY (gifts from Roger Tsein’s lab); 
pCAGIPfloxGFP (by Adam Yates); pBSK Flox CMV-HygroTK; pBSK C2MAZSPA 
(Andrew Smith’s lab); pTTO TLE3 (gift from Susan McConnell). 
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2.3 Cell culture and experiments 
2.3.1 Cell lines 
All ES cell lines used for overexpression were based on E14tg2a (Austin Smith lab). 
TLE4+/LacZ and TLE4LacZ/LacZ ES cells were derived from the ICM of 3.5dpc 
blastocysts from timed matings between TLE4+/LacZ mice. Derivations were performed 
by Jan Ure (Transgenics Facility, ISCR, University of Edinburgh). Blastocyst 
outgrowths were genotyped and expanded. Before use, cells were screened for 
mycoplasma and checked for normal karyotype (Jonathan Rans, ISCR, University of 
Edinburgh). HEK293 cells were also provided by Austin Smith’s lab. 
 
2.3.2 Maintenance of Cells 
For routine culture, ES cells were maintained on 0.1% gelatin coated TC plasticware 
(IWAKI) in Glasgow Modified Eagle’s Medium (Gibco) containing 10% fetal calf 
serum, non-essential amino acids,  L-Glutamine, Sodium Pyruvate, 0.1mM ß 
mercaptoethanol and 1000U/ml LIF. Cells were incubated at 37ºC in a humidified 6% 
atmosphere. HEK 293 cells were cultured in the same way but without LIF. 
Cells were passaged when judged nearly confluent (generally every 2-3 days). They 
were dissociated from the substrate using brief incubation with 0.1% trypsin before the 
trypsin was neutralized with an excess of serum containing media. Cell were 
centrifuged at 1300rpm, resuspended in fresh medium and around 1/7 replated.  
For freezing, cells were trypsinised and neutralized as before and resuspended in media 
containing 20% FCS and 10% DMSO. They were frozen in cryovials at -80ºC and 
transferred to liquid nitrogen for long term storage 
 
2.3.3 Transient transfection of HEK293 cells and TOPflash assays 
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For testing of overexpression vector fluorescence reporters, DNA was transiently 
transfected into HEK293 cells using Lipofectamine2000 (Invitrogen) according to the 
manufacturers instructions. Cells were examined 48hrs later by fluorescence 
microscopy.  
For TOPflash luciferase assays, HEK293 cells were plated in 24 well plates at an initial 
density of 105 per well. When cells had reached 80% confluency they were transfected 
in triplicate using Lipofectamine2000 with DNA mixtures containing 10ng TOPflash 
luciferase reporter plasmid, 10ng pRL-SV40 renilla luciferase and 100ng of each 
expression vector required per condition. All expression vectors used the CMV 
promoter and levels of CMV were kept constant across conditions using empty 
pCDNA3 vector to make up any differences. Total DNA transfected into each well was 
800ng and pBSK was used to make up any remaining differences between amounts 
used in each condition. Cells were collected and analysed with the Dual Luciferase 
assay reporter system (Promega) using the manufacturers instructions. Samples were 
analysed on a Mediators	  PHL luminometer (Mediators Diagnostika) and firefly 
luciferase values normalised to the constitutively active SV40 renilla luciferase for each 
well. All transfections were carried out in triplicate and the average luciferase value for 
each set calculated. 
 
2.3.4 Stable transfection of ES cells 
DNA for electroporations (50µg as standard) was prepared by restriction digest 
overnight followed by ethanol precipitation as described before and resuspension in 
100µl of sterile pH8 Tris buffer. For non-integrative Cre vector transfections, plasmid 
DNA was used uncut.  
For overexpression lines and gene targeting, ES cultures were grown to approximately 
2-10X107 cells per electroporation. Cells were dissociated from the substrate by 
trypsinisation and neutralization as standard. They were washed twice with PBS and the 
concentration counted using a haemocytometer. 107 cells in PBS were placed in a 
disposable electroporation cuvette with the DNA. Electroporation was carried out on a 
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Gene Pulser at 800V and 3µFarad capacitance (BioRad). Electroporated cells were then 
diluted in media and plated at 5X105 and 1X106 cells per 10cm dish. Selective agents 
were added after 24hrs as required. Concentrations were as follows: 2µg/ml puromycin, 
150µg/ml hygromycin, 10µM gancyclovir. Surviving colonies were selected and 
expanded by picking from the plate by pipette followed by dissociation and replating in 




2.3.5 Antibody staining of cells 
Cells were washed with PBS and fixed in PBS 4%paraformaldahyde for 20m. They 
were then washed and permeablized with PBS 0.1% TritonX-100 (PBST). Non-specific 
antibody binding was blocked with 1%BSA, 3% secondary antibody species serum in 
PBST. Primary antibody staining was performed overnight at 4ºC with the antibody 
diluted in the above blocking solution. Cells were then washed with PBST and stained 
with an appropriate secondary antibody conjugated to an Alexa fluorophore in the dark 
for 2hrs at r.t. The plates were washed again and DAPI was used as a counterstain to 
mark total cells. Staining patterns were visualised using fluorescence microscopy. 
Antibodies used in this thesis were as follows: 
Rabbit anti Nanog (R&D systems), mouse anti Oct3/4 (Santa Cruz), goat anti Sox2 
(Santa Cruz) mouse anti nestin (gift from Sally Lowell), mouse anti ßIII-tubulin 
(Covance) 
 
2.3.6 2i culture of ES cells 
Cells were grown in 2i media according to the conditions developed by Qi-Long Ying 
and coworkers (Ying, Wray et al. 2008). This is a mixture of N2B27 media (Stem Cell 
Sciences), 3µM CHIRON99021, 1µM PD0325901 (Stemgent) and LIF. CHIRON 
concentrations were reduced for some experiments as described. Cells were plated at 
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approximately 2x104 /cm2 and passaged 1:10 after 3 days. TrypLE Express cell 
dissociation buffer (Invitrogen) was used for this and cells were washed with PBS to 
remove dissociation buffer.   
 
2.3.7 Neural Differentiation 
Monolayer neural differentiation was performed according to the protocol developed by 
Qi-Long Ying and co-workers (Ying, Stavridis et al. 2003).ES cells were plated at a 
density of 104 /cm2 in N2B27 neurobasal media (Stem Cell Sciences) with LIF on 
gelatin coated plastic. Cells were left to attach overnight and the media was replaced 
with N2B27 minus LIF. Cultures were left to differentiate and grow and the media 
changed as necessary with fresh N2B27 when the pH indicator in the media started to 
indicate increased acidity (between 1-3 days).  Full neural differentiation, with cultures 
containing significant numbers of neurons with elongated TujI positive axons, took 7d 
of culture. 
 
2.3.8 Mesendoderm differentiation 
ES cells were differentiated towards the mesendoderm lineage using the protocol 
developed by Gillian Morrison and co-workers (Morrison, Oikonomopoulou et al. 
2008). Cells were plated at a density of 6X103/cm2 in gelatinized 6 well plates in 
N2B27 media containing 20ng/ml Activin A and 10ng/ml BMP4 (R&D systems). They 
were left incubated to undergo the initial stage of differentiation for 48hrs. The media 
was then changed to SF03 (Iwai Chemicals Company) supplemented with 0.1%BSA 
and 20ng/ml Activin A, 20ng/ml EGF and 10ng/ml FGF4 (R&D systems). Cells were 
left to differentiate for a further 5d with the supplemented SF03 being refreshed after 
2d.  
 
2.3.9 Flow cytometry 
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Cells were dissociated form the substrate using trypsin as standard and pipetted to singe 
cell suspension. They were then centrifuged and resuspended in FACS buffer (PBS, 
10%FCS, DAPI to mark dead cells) and chilled on ice. Flow cytometry was performed 
with a Fortessa flow cytometer (BD Biosciences) using laser and filter combinations 
optimized for the 487nm excitation and 410nm emission maximums of mCHERRY and 




2.3.10 Colony forming assays 
Cells were plated in normal media in the presence or absence of LIF in 6 well plates at a 
density of 50/cm2.  They were left to grow into colonies for 5d to allow potential 
differentiation. Alkaline phosphatase staining was performed using the Alkaline 
Phosphatase Kit (Sigma) according to the manufacturers instructions. Briefly, plates 
were washed with PBS to remove residual media and debris and fixed with AP fixative 
(25% Citrate solution, 65% acetone, 8% of 37% Formaldehyde). Plates were then 
washed with water and stained with freshly made AP stain containing Fast Red Violet 
in the dark for 15m at r.t. Stained plates were washed with water again and dried before 
colonies were counted, scored and photographed under a dissecting microscope. Colony 
type percentages in the figures are an average of four biological replicates. 
 
2.4 Mouse experiments 
2.4.1 TLE4+/LacZ mice 
TLE4+/LacZ mice were obtained by kind donation from Susan McConnell (Stanford 
University, USA). Mice were shipped following Home Office approval and the line was 
transferred to the ISCR animal facility from a local intermediary quarantine facility by 
embryo transfer into Bl6 females followed by successive inbreeding. For ES cell 
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derivation, mice were outcrossed onto a 129/SV background to increase the processes 
efficiency. Routine genotyping was performed using the following primers: 
PLAP	  F	  (mutant)	   GTGCAGGAGCAGACCTTCAT	  
Grg4	  5'	  intron	  F	  (wt)	   CCTTGCCTCCCTGTCTTTC	  
Grg4	  3'	  intron	  R	   CCCATCAGGTGAGACCACTT	  
 
All animal husbandry was carried out by Carol Manson (Animal unit, ISCR, University 
of Edinburgh). 
 
2.4.2 ß galactosidase staining of embryos 
Embryos were dissected in M2 media using a dissecting microscope. For 3.5-4.5dpc 
stages, preimplantation stage embryos were flushed from the uterus at 2.5dpc and 
cultured for a further 1-2 days in K2 embryo culture media at 37ºC. Dissected embryos 
were washed in PBS and fixed with X-gal Fix (PBS, 0.1M phosphate, 5mM EGTA, 
2mM MgCl2, 0.2% gluteraldehyde) for 20m. Fixed embryos were washed in rinse 
buffer (100mM sodium phosphate, 2mM MgCl2, 0.01% sodium deoxycholate, 0.2% 
NP-40) and stained (5mM potassium ferricyanide, 5mM potassium ferrocyanide, 
1mg/ml X-gal (Promega) in rinse buffer) at r.t. overnight. Embryos were then refixed 
with 4% PFA and transferred to PBS for visualisation by brightfield microscopy.  
ß galactosidase staining of ES cells was carried out using the same reagents and same 











TLE family expression in ES cells and early development and the generation of 













3.1   Expression of TLEs in ES cells 
To determine which TLE family members to focus on I examined the expression of 
different TLE transcripts as they appear in public domain databases. In silico expression 
information on TLE family members was collated from available databases. EST 
profiles from the NCBI Unigene database are summarized in Fig 3.1a. The TLE family 
contains four full-length functional proteins and a number of shorter peptides (see 
Figure 1.3). Of the four full length TLEs (TLE1-4), only TLE3 and TLE4 are expressed 
at the blastocyst stage from which ES cells are derived and only TLE4 appears 
expressed around the onset of gastrulation (egg cylinder stage, 6.5dpc)(Fig 3.1a). Gene 
trapping is a technique for the simultaneous identification and mutation of genes 
(Gossler et al. 1989).  The majority of gene trap insertions have been generated with 
promoterless vectors and therefore the likelihood of gene trap insertions occurring is 
directly proportional to their expression level (Nord et al. 2007). As a result the number 
of gene trap insertions in a particular loci can be seen as proportional to its expression 
level in ES cells. Figure 3.1b shows the number of traps observed and documented in 
the database for the in the International Gene Trap Consortium (IGTC). Three full-
length TLE family members, TLE1, TLE3 and TLE4 have all been trapped in ES cells. 
However, based on both in silico blastocyst expression and the numbers of gene trap 
events, TLE3 and particularly TLE4, appear the most significant family members. 
Although TLE1 was not observed as expressed in blastocysts, in the EST databases it 
does appear expressed in ES cells based on the gene trap database. Of the truncated 
TLEs, TLE6 appears expressed throughout early development and produced a 
significant number of gene trap insertions.  TLE5, like TLE1, appears in the gene trap 
database, but appears relatively rarely in ESTs derived from pre and peri implantation 
stages of development.  
As I was interested in the activity of full-length TLE proteins, I sought to quantitate the 
expression of these four transcripts in E14tg2a ES cells. Quantitative RT PCR was used 
to analyse TLE1, TLE3 and TLE4 in these cells as maintained under standard culture 
conditions and during differentiation in response to LIF withdrawal and in neural 
differentiation (Fig 3.1c). While, TLE2 was undetectable despite multiple PCR primer 
pairs tried, all three TLEs were expressed at broadly similar levels in normal culture 
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Zygote Morula Blastocyst Egg cylinder
TLE1 0 0 0 0
TLE2 0 0 0 0
TLE3 0 262 14 0
TLE4 35 180 78 157
TLE5 0 0 14 0
TLE6 140 36 104 14





Fig 3.1 Expression of the TLE gene family in embryonic stem cells
(a) EST expression profiles in mouse early embryonic stages. Data shown is taken
from the Unigene EST database (http://www.ncbi.nlm.nih.gov/UniGene). (b)
Trapping of TLE family loci by the International Gene Trapping Consortium.
Genome tracks showing vector insertion sites are from the USC genome browser
(http://genome.ucsc.edu) TLE1,  TLE3 and TLE4 have been trapped multiple times by
promoterless traps showing significant expression in ES cells. (c) Expression of TLE
genes in E14 ES cells. Samples were taken for RNA extraction in normal growth
conditions with serum and LIF, after LIF withdrawal for 1 and 3 days and at days 2,6
and 8 of a monolayer neural differentiation protocol.  cDNA was synthesized and
used for qPCR analysis of TLE1,  TLE3 and TLE4.  PCR was performed in technical
triplicate and levels are shown normalized to TBP and relative to TLE4 level in E14
cells. TLE2 was undetectable by multiple primer pairs.
c
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conditions in the presence of LIF. Upon LIF withdrawal, the expression level of all 
three TLEs was increased, although with differing kinetics. Interestingly, TLE4 was 
expressed at dramatically higher levels following LIF withdrawal in these cultures and 
TLE3 was most significant upregulated in the early stages of neural differentiation. As 
ES cells are known to contain a heterogeneous mix of partially differentiated and 
undifferentiated cells, these levels might explain the frequency with which these 
transcripts comes out in in silico datasets. However, all three genes are expressed at 
quite high levels in all these cultures and in the absence of data on additional cell lines it 
is difficult to make any definitive statements about their relative levels.  
While the RT-PCR suggests three TLE transcripts are expressed in ES cells, TLE1, 
TLE3 and TLE4, only TLE3 and TLE4 were identified as Hex targets (Zamparini et al. 
2006) Moreover, TLE3 and TLE4 both appear to be more ubiquitously expressed based 
on in silico analysis therefore my loss of function studies began with these two genes. 
However there is a clear possibility that redundancy with TLE1 may still be an issue. 
 
3.2 Expression of TLE4 in early stage mouse embryos 
Based on the in silico analysis in Figure 3.1, TLE4 appears the most likely transcript to 
be expressed at peri implantation stages.  I also was able to exploit a previously 
generated gene trap line for TLE4. TLE3 and TLE4 mutant mouse lines had been 
generated by the McConnell laboratory, but they have only been able to maintain the 
TLE4 line, based on a behavioural phenotype in the TLE3 heterozygotes (S. McConnell 
personal communication). The TLE3 and TLE4 mutants were generated from targeted 
insertions of the pTTO gene trap into intron 4 of the TLE4 locus (Friedel et al. 2005). 
This vector inserts a ß-geo neomycin resistance/LacZ reporter and polyadenylation 
sequence into the TLE4 transcript after exon 4 of 20 exons. It leaves only the first 
section of the Q domain so is predicted to be an effective null mutation (Fig 3.2a). We 
obtained these mice (Kind gift of Susan McConnell). Mice were genotyped and found 
to be heterozygous for TLE4. Despite extensive inbreeding, we were unable to obtain 
live pups homozygous for the TLE4 mutation. Observed frequencies of heterozygotes 
and homozygotes were close to the expected Mendelian ratios assuming homozygous 
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IRES PLAP pAExon	  4 Exon	  5 Exon	  6Exon	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wild type 25% 33% 39% (n=81)
heterozygous 50% 66% 61% (n=127)
homozygous 25% 0% 0% (n=0)
H
20 TLE4	  LacZ	  intercrosses
InserOon	  site	  region
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Fig 3.2 Expression pattern  of TLE4 in early development
(a) Schematic of targeting in the TLE4 locus (As performed by Friedel et al, 2005).
The targeted trap contained ßgeo to mark TLE4 expressing cells, a placental alkaline
phosphatase (PLAP) gene used to stain neuronal axons in the original reference and
a polyadenylation sequence to terminate transcription. The vector was targeted to
intron 4/20 and leaves only an N-terminal fragment of TLE4 fused to ßgeo
translated. (b) TLE4+/LacZ  mice were interbred and genotyped by PCR for the
presence of wt and mutant alleles (representative litter shown). (c) Table shows
expected Mendelian ratios and the observed results.  ß galactosidase staining was
carried out on early stage TLE4+/LacZ  embryos. Day 3.5 (d,e), 4.5 (f), 5.5 (g) and
7.5 (h) embryos were dissected and stained. Arrows indicate expression mentioned
in the main text. n represents the number of embryos examined for each stage. (i)
The observed LacZ staining at 7.5dpc conforms quite well with previous in situ data
published by Koop et al, 1996.
3.5dpc (n=12) 3.5dpc (n=7)
4.5dpc 	  (n=4) 5.5dpc (n=2) 7.5dpc (n=5)





lethality (Fig 3.2b,c). Genotyping of embryos up to 16dpc showed that homozygous null 
embryos were still developing. It was concluded that there must be a lethal phenotype 
that affects the pups before or shortly after birth. However there were no easily 
identifiable morphological differences between mutant and wild type embryos. This 
would be interesting to investigate at a later time, as there is no published phenotype for 
TLE4 null mice. However detailed analysis lies outside the scope of this thesis.  
Expression patterns for TLE3 and TLE4 in mouse embryos have previously been 
published from 7.5dpc onwards. It was therefore interesting to look at expression at 
earlier stages. To this end I used the TLE4 LacZ reporter gene trap mice. Pre and post 
implantation stage embryos from 3.5-7.5dpc were obtained from TLE4 LacZ mice. 
These were dissected, fixed and stained for ß galactosidase activity using X-gal. The 
TLE4 reporter was expressed as early as 3.5dpc (Fig 3.2a,b) and although most strongly 
in the inner cell mass (arrows), faint blue staining was also observed in the 
trophectoderm. The pattern was also observed at 4.5dpc, where expression is seen in 
both the epiblast and primitive endoderm (Fig 3.2c), although by 5.5dpc, the expression 
of LacZ was restricted to the epiblast (Fig 3.2d). By 7.5dpc TLE4 started to become 
restricted towards the early headfold region and most strongly in the primitive streak 
(Fig 3.2e, arrows). This expression pattern was consistent with published RNA in-situ 
hybridisation at the same stage (Fig 3.2f, Koop et al, 1996).  
 
3.3.1 The generation of TLE mutants with altered binding and corepression 
activity 
As TLE proteins are known to act as a co-repressor on diverse classes of transcription, 
over expression experiments are very difficult to interpret. To circumvent this problem 
we began a collaboration with Stefano Stifani’s laboratory (see appendix 1) to test the 
activity of point mutations predicted to alter TLE activity. These point mutations were 
introduced in the context of the human cDNA sequence to allow me to differentiate 
between the endogenous allele and any molecules over expressed.  
The TLE variants we generated in collaboration with the Stifani group were obtained 
from a variety of sources. Human TLE1 L743F, E550K, R534A, C488R and V486F are 
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point mutations affecting the central binding pore of the WD40 domain of TLE1. This 
site interacts with WRPW and eh1 motifs in TLE binding partners and so could affect 
binding to either or both these classes of sequence specific transcription factors. TLE1 
S239E/S253E and S239A/S253A affect residues implicated in phosphorylation and 
have been shown to regulate nuclear retention of TLE1 (Nuthall et al. 2004). Mutation 
of serine to glutamic acid mimics constitutively active phosphorylation and hence 
increased activity. Mutation to alanine makes the residue unphosphorylatable and hence 
less able to remain in the nucleus.  TLE1 VP16 is a fusion of TLE1 to an HSV protein 
transactivator domain, which has been shown to increase transcription factor activity as 
a fusion (Sadowski et al. 1988). Grg6 GFP is a truncated TLE that has been shown to 
have partial repression activity (Dang et al. 2001) fused to GFP. AES (TLE5) is a C-
terminal truncated TLE that lacks a WD40 cofactor-binding domain and has been 
implicated as a dominant negative TLE (Brantjes et al. 2001). QD is an even shorter C-
terminal truncation that has also been described as a dominant negative (Milili et al. 
2002). This lacks both cofactor binding and repression mediating domains. However it 
still contains an LzL motif that can bind other TLEs and may sequester them into 
inactive complexes.  
3.3.2 Activity of point mutants and fusion proteins with respect to Wnt signalling. 
As our interests in TLEs were initially based on their role in Wnt signalling, we tested 
these fusions for their activity on a Wnt reporter gene in transient transfections. The aim 
of this was to identify possible mutants with altered ability to affect the pathway, either 
positively or negatively. These could then be overexpressed in ES cells as dominant 
negative/positive proteins to modulate the normal effect of TLEs. The Wnt pathway is 
normally activated by the binding of Wnt ligands to the Frizzled receptor, which 
suppresses the activity of the APC-GSK3 complex and allows ß catenin to translocate to 
the nucleus and activate transcription of targets in conjunction with TCF/LEFs. In the 
absence of Wnt ligands, the APC-GSK3 complex causes degradation of ß catenin and 
Wnt targets are kept fully repressed, in large part by TLEs bound to TCF/LEFs.  
Plasmids expressing the different TLE variants and Wnt pathway components were co-
transfected alongside a Wnt reporter and assayed for their ability to stimulate or repress 
transcription of this reporter. This experiment used a reporter plasmid containing 
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reiterated TCF binding sites acting upstream of a basal TK promoter driving luciferase. 
Activation of the reporter was achieved by cotransfecting plasmids expressing ß catenin 
and TCF. When TCF binds TLE, it competes with the capacity of the TCF- ß catenin 
complex to bind these sites and activate transcription (Fig 3.3.2a). The assay was 
performed in HEK293 cells and TLE point mutations FLAG tagged so that their levels 
could be monitored by western blot. All proteins were expressed from the CMV 
promoter. The expression level of these proteins appeared broadly similar indicating 
that observed alterations in TLE activity were due to an intrinsic property of the 
mutation (Fig 3.3.2b). The TOPflash reporter assay was performed on all the point 
mutations (Fig3.3.2c) and fusion proteins (Fig 3.3.2e) described above.  All proteins 
were expressed from the original plasmids, which contained CMV promoters except for 
QD. This was subcloned from pMIR into the pCDNA expression vector using KpnI and 
XhoI restriction sites. All transfections were normalized to the level of luciferase 
activity obtained from TOPflash in the absence of exogenous factors.  The endogenous 
activity of these promoter elements is presumably due to both the basal level activity of 
the TK promoter and to endogenous TCF and β-catenin.  Thus TLE1 suppresses 
TOPflash activity in the absence of added exogenous β-catenin (Fig 3.3.2c, e) and 
interestingly TCF itself inhibits the activity of β-catenin, even in the absence of 
additional TLE. This observation has been reported by others who have shown that 
endogenous levels of TLEs and other co-repressors in HEK 293 cells can suppress 
TOPflash activity through an interaction with additional excess TCF (Brantjes et al. 
2001). However, in all instances, the level of transcription from these reporters was 
repressed by the exogenous TLEs co-transfected in these assays and the behaviour of 
the different TLE point mutants with respect to each other was always the same. 
While all TLE point mutations repressed transcription of this Wnt reporter, the 
behaviour of these mutations relative to each other was similar and observed in all 
contexts (presence or absence of ß catenin and TCF). This made the interpretation of 
differences between individual mutations repression ability difficult.  To circumvent 
this I employed a strong TOPflash activator, a fusion of TCF3 directly to a strong 
transcriptional activation domain, TCF3∆ßcatBD VP2 (Fig 3.3.2d). This fusion protein 
contains TCF3, but with the ß catenin binding domain deleted and replaced with two 
copies of the VP16 transactivator (Zamparini et al. 2006). Cotransfection of plasmids 
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Fig 3.3.2 Analysis of TLE variants and point mutations for wnt modulating activity
The effect of a panel of TLE point mutations and other variants on wnt signaling
activity in cells was investigated using the TOPflash luciferase reporter system.
HEK293 cells were transfected with the TOPflash plasmid and constructs
expressing these TLE proteins in biological triplicate.  All expression vectors used
the CMV promoter. Luciferase activity was measured on cell lysates after 24hrs
using a luminometer. (a) Schematic of the TOPflash luciferase reporter construct
used. (b) Western blot showing the expression of the FLAG-tagged proteins in
HE293 cells. (c) Cells were transfected with vectors expressing the following hTLE1
proteins: wtTLE1, TLE1 S239A/S253A, TLE1 S239E/S253E, V488S, C488R, R534A,
E550K and L743F.  The experiment was performed with different combinations of
cotransfected xTfc3 and ß catenin. (d) A TOPflash experiment was performed on
the TLE1 point mutations, cotransfected with TCF3∆ßcatBD VP2 which greatly
increases reporter activity. (e) The first experiment was repeated with TLE1wt and
other groucho variants; AES, Grg6GFP, TLE1-VP16 and QD. (f) QD-VP16 was
tested in the same assay in comparison with TLE1-VP16 and in competition with
wild type TLE1
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expressing this protein alongside the TOPflash reporter gene resulted in a ~50-fold 
stimulation in luciferase activity. In this context, wild type TLE1 has little repression 
activity and most of the point mutations have even less effect on TCF3∆ßcatBD VP2 
activity. And while S239E/S253E had a similar activity to wild type TLE1, TLE1 
R534A could repress the activity of TCF3∆ßcatBD VP2 some 4-fold. Thus TLE1 
R534A appeared particularly effective at suppressing Wnt induced transcription. 
The other TLE variants were also tested for their ability to modulate TOPflash 
activation  (Fig 3.3.2e). None of the proteins displayed in this figure were able to 
activate TOPflash, indicating that they were unable to function as dominant negatives. 
Thus while the TLE1 VP16 transactivator fusion is unable to repress TCF activity, it 
appeared unable to activate TCF activity either, suggesting that VP16 was unable to 
function in the presence of the endogenous TLE repression domain. In an attempt to 
circumvent this, a QD VP16 fusion was also constructed which lacked the full length 
TLE repression domain. This was constructed by cloning the QD sequence into pTLE1 
VP16 in place of the TLE1 sequence as a single ORF. QD VP16 behaved as a stronger 
transactivator than TLE1 VP16, but was still unable to compete with TLE1 (Fig 3.3.2f).  
 
3.3.3 Altered cofactor binding activities of TLE1 point mutations 
The ability of TLE1 point mutations to bind to common TLE interaction motifs was 
also studied. Biochemistry for this was performed by our collaborators, Stefano 
Stifani’s lab (Buscarlet et al. 2008, see appendix). Immunoprecipitations for the FLAG 
tagged point mutations were performed with tagged versions of HES1, ENGRAILED1 
(EN1) and TCF3. These proteins all typify classes of TLE interactions: HES1 with a 
WRPW interaction motif, En-1 containing the engrailed homology motif, and TCF3. 
We found that all these mutations, except TLE1 V486S, impaired the interaction of 
TLE1 with Hes1 and the WRPW motif (Fig 3.3.3a). Interestingly, while unable to bind 
WRPW, TLE1 V486S and TLE1 L743F, are able to bind both En-1 and TCF (Fig 
3.3.3b, c), suggesting that these mutations are specifically defective in their interactions 
with Hes proteins. Moreover, TLE1 C488R, TLE1 R534A and TLE1 E550K bound 























Fig 3.3.3 Interaction of different TLE1 point mutations with hes1, engrailed1 and
TCF3
(Panels a, b and c and legends taken from Buscarlet et al, 2008)
(a) HEK293 cells were co-transfected with plasmids encoding FLAG epitope-tagged
WT or mutated Gro/TLE1 and either a fusion protein of GST and full-length Hes1
(lanes 1-6) or truncated Hes1 lacking the WRPW motif required for Gro/TLE
binding (ΔWRPW) (lane 7). Each cell lysate (INPUT) was incubated with glutathione-
Sepharose beads and the precipitated material (PD, pull-down), together with 1:10
of each input lysate, was subjected to Western blotting (WB) analysis with anti-
FLAG or anti-GST antibodies. B and C, HEK293 cells were co-transfected with
plasmids encoding FLAG epitope-tagged wild-type or mutated Gro/TLE1 proteins,
as indicated, and either HA epitope-tagged En1 (b) or Myc epitope-tagged Xenopus-
Tcf3 (c). Each cell lysate (INPUT) was subjected to immunoprecipitation (IP) with
either anti-HA (B) or anti-Gro/TLE1 (C) antibodies. Immunoprecipitates, together
with 1:10 of each input lysate, were analyzed by Western blotting with the indicated
antibodies.
(d) Structure of the WRPW domain of human TLE1 interacting with a WRPW
peptide. The residues mutated in the point mutants used in this study are
highlighted. The structure was determined by Pickles et al (2002) and deposited in
the Protein Database under 2CE9 (http://www.ebi.ac.uk/pdbe/). (e) The
interactions exhibited by different point mutations are summarized here.
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bind the N terminus of TLEs. The lack of interaction of R534A with either eh1 or 
WRPW could also explain why this C terminal mutation is particularly effective at 
suppressing Tcf mediated transcription. Transfected TLE1 R534A would not be titrated 
by endogenous WRPW or En homology domain containing proteins and the effective 
concentration free to bind TCF would therefore be higher. Analysis of the crystal 
structure of the TLE1 WD40 domain bound to peptide motifs has shown that all these 
residues mutated are situated in the central binding pore (Fig3.3.3d). However mutating 
R534 was predicted to have a more serious structural effect than L743 for example, 
consistent with the biochemistry (Jennings et al. 2006). The different interactions 
exhibited by each mutation are summarized (Fig 3.3.3e). 
 
3.4 Generation of TLE1 overexpression constructs  
From the immunoprecipitations and from the previous luciferase assays, two of the most 
interesting TLE1 point mutations were chosen for further study in overexpression 
experiments alongside the wild type protein. TLE1 R534A was chosen for its loss of 
function of Eh1 and WRPW motif interactions and its increased ability to antagonise 
wnt signalling. L743F was chosen for its specific loss of WRPW binding.  
As ES cells in culture might be expected to adapt to the presence of high levels of a 
global co-repressor like TLE, I thought it important to be able to rescue phenotypes by 
removing TLE.  A strategy that allowed the rescue of individual clonal lines also would 
control for non-TLE induced phenotypes as a result of clonal variation. To achieve this 
end I used a variation on the pCAGIPC vector. This contains the strong CAG promoter, 
which consists of a chicken ß actin promoter, CMV enhancer, ß actin intron and the ß 
globin polyadenylation signal (Niwa et al. 1991). The specific vector engineered for this 
study allows for selection of cDNA expression by puromycin and monitoring of 
expression by a red fluorescent marker via a puromycin acetyl transferase (Pac)-
mCHERRY fusion. The expressed cDNA can then be removed by recombination using 
Cre recombinase. Loss of the insert is monitored by GFP expression. It was modified 
from the pCAGIP flox GFP vector (Fig 3.4a). A Pac-mCHERRY fusion ORF was made 
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Fig 3.4 Overexpression strategy and construct design for TLE1 and point mutations
(a) Map of the vector used a basis (pCAGires-puro flox GFP) showing sites used for
cloning.  An in-frame fusion of mCHERRY and the puromycin-acetyl-transferase gene
was synthesized by fusion PCR. This was cloned into the ClaI and BsmBI  sites. (b) A
synthetic oligonucliotide linker containing restriction sites useful for cloning was
inserted into the XhoI-NotI sites downstream of the CAG promoter. (c) Diagram of
the finished construct containing TLE1. All TLE1 inserts were cloned into the
overexpression vector BstBI and SalI polylinker sites. (d) The constructs were tested
for functionality by transient transfection into HEK293 cells alone or with a CAG-
Cre expression construct. The expression of PacCherry and GFP after vector
recombination was verified by fluorescence microscopy after 48h.
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cloned and sequenced to check for any errors introduced during PCR.  The C terminal 
portion of this was digested out and cloned into pCAGIP flox GFP in frame with the 
existing Pac ORF using the BsmBI site in Pac and Cla1. To facilitate the insertion of 
different TLE variants into this vector, a synthetic oligonucliotide polylinker containing 
useful restriction sites was cloned into the Xho1 and Not1 sites downstream of the CAG 
promoter (Fig 3.4b). TLE1wt, TLE1 R534A and TLE1 L743F were all introduced into 
this vector as depicted (Fig 3.4c).  
The constructs tested for functionality by transient transfection into HEK293 cells. The 
PacCHERRY fusion protein was expressed and functional based on the red fluorescence 
observed in the cells. When Cre is co-expressed in these cells, the CHERRY 
fluorescence disappeared and was replaced by GFP (Fig 3.4d).  
 
3.5 Generation and initial characterisation of TLE overexpressing ES cell lines 
Once the expression constructs had been verified, they were introduced into ES cells. 
The constructs were linearized by digestion with Fsp1 and purified DNA was 
electroporated into E14tg2a ES cells. They were subjected to selection in 2µg/ml 
puromycin for 10 days and surviving colonies were picked and expanded. It was hoped 
to use mCHERRY fluorescence as a reporter of TLE expression levels in different 
clones. However despite the fact the cells were able to survive relatively high 
concentrations of puromycin, demonstrating the expression of the PacCHERRY fusion, 
no visible fluorescence could be observed by microscopy. This could be due to 
differences in the levels of protein required to generate visible fluorescence as opposed 
to enzymatic inactivation of an antibiotic. Differences between the levels of expression 
required for antibiotic resistance and visible reporter activity in fusion proteins have 
previously been described (Tsakiridis et al. 2007). Verification of overexpression levels 
was therefore performed by quantitative PCR (Fig 3.5a). cDNA from selected clones 
was analysed using primers amplifying total TLE1 (endogenous mouse and 
overexpressed human). Levels were compared between two independent clones for each 
vector. In all cases TLE1 transcript levels were raised significantly above the 






Fig 3.5 TLE expression levels in ES cell lines stably expressing CAG TLE1
(a) Transfected ES cell clones resistant to puromycin were subjected to RNA
extraction and cDNA synthesis. Levels of total TLE1 expression in the samples
were analysed by real time qPCR. The data is plotted as fold increase over the
vector alone control cells. Lines expressing the highest amounts of TLE1 (TLE1wt 2,
R534A 2 and L743F 1) were chosen for further study. (b) The TLE1 cassette was
removed from these lines to generate –TLE1 subclones. Vector recombination was
confirmed by genomic PCR using a forward primer in the promoter and reverse
primers in TLE1 and GFP. (c) qPCR was performed as before to confirm the loss of
TLE overexpression in these subclones. (d) Expression levels of endogenous TLEs
was also analysed by qPCR in these lines.  Mouse specific TLE1, TLE3 and TLE4
primers were used. Transcript levels are relative to TBP and plotted as fold change
















































However, levels of TLE1 R534A were noticeably lower than TLE1wt or the other 
mutant. It is possible the stronger effects of this mutation described earlier cause ill 
effects in cells with high expression leading to negative selection. The strongest 
expressing clones were selected for further study (TLE1 2, TLE1 R534A 2 and TLE1 
L743F 1). 
To demonstrate that any phenotypic effects observed in the cells were not from 
mutation caused by insertion into endogenous genes or clonal variation, it was 
important to generate subclones with the TLE1 cassette removed. Overexpression lines 
were electroporated with an unlinearized CAG Cre recombinase vector and plated at 
colonial density to allow the growth of subclones with recombined expression vector. 
Colonies were picked and GFP positive subclones were expanded. GFP positive 
subclones selected for use were also replica plated in puromycin and were unable to 
survive demonstrating a loss of the floxed cassette. This was confirmed by PCR 
analysis of genomic DNA of the subclones (Fig 3.5b). Primers amplifying the region 
from the CAG promoter to GFP gave the expected band in recombined subclones. The 
band generated by amplification of CAG TLE1 was not observed. Loss of TLE1 mRNA 
overexpression was also demonstrated by quantitative rtPCR (Fig 3.5c). Levels of TLE1 
transcript in recombined subclones have returned to the same as those in empty vector 
control cells.  
As there is considerable redundancy in the TLE family, I thought it important to assess 
the overall levels of TLE in response to TLE1 over expression.  Quantitative PCR was 
performed using primers specific for mouse TLE1, TLE3 and TLE4 (Fig 3.5d). 
Endogenous TLE1 levels may be slightly decreased while TLE4 is not significantly 
affected. TLE3 appears downregulated in all overexpression lines compared to the 
empty vector control. However TLE3 levels also remain low in the recombined 
subclones of both TLE1wt and R534A. It is unclear whether this is due to a permanent 
downregulation of TLE in these cells or just due to natural variations in expression 
between clones. However, the high levels of overexpressed TLE1 mutations mean that 
these proteins are likely to contribute most to overall TLE activity in the cells. 
To check for CHERRY fluorescence by a more sensitive method and to examine on a 
population level the efficiency of over expression, I analyzed expression of mCHERRY 
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and GFP by flow cytometry (Fig 3.5.2). The TLE overexpression cell lines, those with 
the empty vector, and those transfected with Cre were analyzed alongside E14 control 
by flow cytometry. Cells were also grown for analysis in 2µg/ml puromycin in case 
selection for the PacCHERRY fusion increased fluorescence. Data is presented as dot 
plots with CHERRY (horizontal) and GFP (vertical) axes. Unfortunately, I was only 
able to detect a slight shift towards higher red fluorescence as a result of PacCHERRY 
expression. The highest percentage of cells lying within the mCHERRY+ gate is from 
the L743F line (10.2%). This is in agreement with this line having the highest level of 
TLE1 expression according to the previous rtPCR. In recombined lines (bottom three 
plots, right) GFP is expressed in all cells in agreement with their visible green 
fluorescence indicating that the excision of the TLE1 expression cassette was effective. 
 
3.6 Derivation of TLE4 mutant ES cells 
The generation of ES cells with increased TLE activity and the use of point mutations 
with defined interaction deficiencies provided a powerful and highly useful method of 
investigating TLE function in this context. However to investigate the role of TLEs in 
ES cell self-renewal and differentiation in more detail, we also decided to generate TLE 
mutant ES cells as a loss of function model. TLE3 and TLE4 were chosen for mutation 
as the primary members of the family in ES cells. We took advantage of the pre-existing 
TLE4 gene trap mouse line discussed in 3.2 for TLE4 null ES cells as the basis for this. 
To save time and unnecessary or potentially disruptive manipulations of wild type ES 
cells, we derived TLE4+/- and TLE4-/- ES cells from blastocyst stage embryos from 
crosses between TLE4+/LacZ mice. These were genotyped to identify heterozygous and 
homozygous null lines for TLE4 (Fig 3.6a). They were also karyotyped and found to be 
normal (data not shown). There was no apparent morphological difference between 
these cells and E14 ES cells in normal culture. To further investigate TLE4 expression 
in ES cells, TLE4+/LacZ cells in normal culture were stained for ß galactosidase activity. 
Interestingly, the expression was heterogeneous, possibly reflecting levels of partial 















Fig 3.5.2 FACS analysis of mCHERRY and GFP expression in TLE1 overexpressing
and recombined subclones. Cells were  also grown for analysis in the presence of
puromycin to ensure expression of the PuroCherry fusion and check whether
selection could increase mCHERRY fluorescence.
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Fig 3.6 Derivation of TLE4 heterozygous and homozygous mutant ES cells
(a) PCR Genotyping of ES cell clones derived from TLE4+/LacZ intercross
blastocysts. 500bp band indicates wild type alleles, 900bp band indicates targeted
alleles. (b) ß galactosidase staining of TLE4+/LacZ ES cells derived from this mouse
line.





3.7 Construction of the TLE3 targeting vector 
A targeting construct for TLE3 was generated and is depicted in Fig 3.7. The vector is 
promoterless and takes advantage of increased in targeting efficiency that result from 
the requirement for an endogenous genes expression.  The construct was targeted into 
the fourth intron in a gene containing 20 exons. Only the first section of the TLE3 Q 
domain was left which was predicted to be an effective null mutation. Targeting arms 
used were from pTTO TLE3 (Friedel et al. 2005).  
The construct used an Engrailed2 splice acceptor to drive expression and an excisable 
HygroTK cassette that allowed both positive and negative selection. To avoid 
translating a fusion of TLE3 and HygroTK, a t2a peptide coding sequence was included 
before the ATG codon of HygroTK and in frame with the ORF of the spliced TLE3 
transcript. This is a short peptide sequence (t2A, Gly-Asp-Val-Glu-Glu-Glu-Asn-  
Pro-Gly;2B-Pro) from the TaV virus (Szymczak et al. 2004) that causes the ribosome to 
skip between the glycine and proline without forming a peptide bond, thus generating 
two intact but separate polypeptides. After the selection cassette is removed, the 
mORANGE fluorescent marker will be expressed from the TLE3 locus, again using t2a 
to separate the protein. To reduce the chance of downstream exons of TLE3 splicing 
onto exon 4 without the gene trap, a C2MAZ sequence was added after the polyA of 
mORANGE. This sequence contains a binding site for the MAZ DNA binding protein. 
MAZ bends DNA which causes a severe obstacle to RNA PolII and efficiently 
terminates transcription (Ashfield et al. 1994). A version of the vector vas also 
constructed which replaced HygroTK with a Pac-TK fusion and mORANGE with 
mCHERRY (Fig 3.7j). This was given TLE4 targeting arms and was designed for use in 
an alternative targeting strategy to target one allele each of TLE3 and TLE4 at the same 
time in wild type ES cells. This involved using Hygromycin and Puromycin selection in 
conjunction and would allow monitoring of TLE3 and TLE4 expression using the 
different fluorescent markers. However the double selection method proved problematic 
and when the TLE4+/LacZ mice became available, I decided to use homozygous null ES 







































































Fig 3.7 Cloning of the TLE3 targeting vector
(a) The En2 splice acceptor (SA) was digested and cloned into the pKO901 MCS
vector using AscI and BglII. (b) CMV HygroTK was cloned downstream of the SA
into a BamHI site. (c) The SA and HTK were coupled by a sequence containing a
LoxP site and t2a sequence. This was done by PCR amplifying the adjoining end
sections of the SA and HTK using primers with overlapping extensions containing
t2a and LoxP.  These were then joined together using fusion PCR and TOPO
cloned.  An ORF was preserved between the SA exon and HTK. Part of this TOPO
cloned component was cloned into the targeting construct using SexA1 in the SA
and NruI in HygroTK. (d) mORANGE was PCR amplified from the parental vector
and cloned into pKO901 using EcoRI and SalI. (e) A fragment containing the
C2MAZ sequence with synthetic-polyA was cloned in downstream of mORANGE.
(f) The section of DNA containing mORANGE-C2MAZSPA was rotated in the
vector using digestion with XhoI and SalI and religated after backbone
dephosphorylation in the opposite orientation. This reoriented restriction sites to
make the next step possible. (g) A fragment from pKO901 containing the SA-LoxP-
selection cassette was digested using HpaI and XmaI. This was cloned into the HpaI
and AgeI sites of the pKO901 backbone containing mORANGE-C2MAZSPA. (h)
Sequences were amplified by PCR containing the ends of HygroTK-polyA and
mORANGE using primers containing overlapping sequence with a LoxP site and t2a
sequence. These were joined together using fusion PCR in a similar way to the first
t2a fusion and TOPO cloned. Part of this was cloned into the targeting vector using
SacI in TK and SbfI in mORANGE. (i) This construct was  inserted into the AscI site
of the pTTO TLE3 targeted gene trap between the targeting arms to complete the
new targeting vector. (j) A version of the vector was also constructed in a similar
way for targeting TLE4. Briefly, mCHERRY was PCR amplified and inserted in the
same way as mORANGE. PuroTK from pCMV PTK was inserted into pCMV HTK
using Nde1 and NruI site and this was cloned into the targeting vector as in step
(b). In step (i), the finished construct was inserted into the AscI site of pTTO TLE4
between the targeting arms to complete the TLE4 targeting vector.
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3.8.1 Generation of TLE3/TLE4 mutant ES cells 
TLE3 was then targeted in TLE4-/- cells to generate TLE3/TLE4 null ES cells. The 
targeting strategy is shown in schematic (Fig 3.8.1a). Targeting vector was linearized 
and electroporated into cells. These were incubated with selection in 150µg/ml 
hygromycin for 10 days. Surviving clones were picked and expanded and PCR 
genotyped. Fig 3.8.1b shows PCR in which genomic DNA was amplified using a 
forward primer in mORANGE and an external reverse primer in TLE3 exon 4, just 3’ of 
the vector 3’ targeting arm (primers AB). The expected band of ~3.5kb indicating a 
correctly targeted insertion was observed in 4/19 clones examined. This represents a 
targeting frequency of 21% and is lower than the published expected targeting 
frequency of 66% but still acceptable. The selection cassette was then removed from 
these clones by electroporating with a CAG Cre expression vector and selection in 
10mM gancyclovir for 10 days. Surviving clones were then picked and expanded. 
Replica plated clones died in 150µg/ml hygromycin confirming a pure population of 
cells without the selection cassette. Vector recombination was also confirmed by 
genomic PCR using primers flanking the LoxP sites (primers CD).  
A recombined subclone was expanded and electroporated once more with the TLE3 
targeting vector. Selection in hygromycin and picking of colonies was performed as 
before. Genotyping of surviving clones was again performed by long range genomic 
PCR using a 3’ external reverse primer and a forward primer in HygroTK that should 
only amplify in clones with new a new vector insertion in the correct place (primers 
BE). However, this time the expected 5kb band representing targeting was seen in 18/20 
clones (data not shown). This was unexpected as the previous targeting frequency was 
only 21%. Further diagnostic PCR tests were performed on retargeted clones to confirm 
this. In all clones tested a 500bp band representing the untargeted TLE3 vector insertion 
site (primers FG) was seen. However a further test using primers flanking the LoxP sites 
in the vector (primers CD) revealed the recombined vector from the first targeting was 
missing in all 18 clones with the apparent retargeting. It was therefore concluded that 
the vector was able to retarget the 1º targeted allele with extremely high frequency due 
78
SA
  t2a HygroTK
t2a
mORANGE
































1kb=targeting vector without selection cassette (1˚ targeting event
unaffected)
No band=1˚ targeted locus retargeted
FG
500bp=wild type TLE3 allele











Fig 3.8.1 Targeting of the TLE3 loci in the  TLE4lacZ/LacZ cells
Schematic of the targeting strategy used to trap both loci of TLE3 in TLE4 null ES
cells. (a) The targeting vector was directed into the middle of intron 4-5 of the
TLE3 locus in  TLE4lacZ/LacZ  ES cells. Following selection by hygromycin and
confirmation of correctly targeted clones, the selection cassette was removed by
Cre transfection and selection with gancyclovir. The second locus of TLE3 was
targeted in these cells using the same method. Genomic PCR was used to initially
screen  resistant clones for the primary (b)  and secondary (c) targeting stages.
Primers indicated in the schematic are explained in the table. (d) Southern
hybridization using a probe 3’ of the TLE3 targeting arms (indicated in (a)). DNA
was digested with BclI which cuts a 4.7kb fragment from the wild type locus and a
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to greater sequence homology. To circumvent this problem the electroporation was 
repeated and a higher number of clones were picked for screening. A rapid PCR 
genotyping strategy was once again used to look for double targeting events (Fig3.8.1c). 
128 clones were screened in total. All but two produced a band representing untargeted 
TLE3 (primers FG) and lacked a band representing the first targeted allele (indicated by 
red box). These two potential TLE3/TLE4 nulls, H11 and B12 were expanded for 
further analysis.  
Southern hybridisation was used to confirm the correct genotype of the mutant lines. 
This used a 0.8kb external probe, just 3’ of the targeting arm homology that hybridised 
with a 7.5kb fragment from BclI digestion of genomic DNA from a targeted allele. This 
compared to a 4.5kb fragment from digestion of the wild type locus (restriction and 
probe sites indicated in Fig 3.7a). The expected bands were observed in each sample 
including loss of the wild type band in 34n cells, further confirming the targeting of 
both alleles (Fig 3.8d). They were also checked for karyotypic integrity. While H11 had 
the expected chromosomal spread, B12 had abnormalities in the chromosomal numbers 
and had to be discarded (fig 3.8.1e). This TLE3/TLE4 null cell line is hence referred to 
as 34n. 
 
3.8.2 Generation of TLE1 rescued TLE3/TLE4 null cells 
To confirm any observed phenotype in the mutant cells was specific to loss of TLE 
activity, it would be useful to have a subclone of the 34n cells with TLE added back to 
rescue them. For this purpose, 34n cells were electroporated with the CAGIPC TLE1wt 
vector. Selection and expansion of clones was performed as before. Once again no 
mCHERRY fluorescence could be seen as a reporter for TLE1 expression. Transcript 
levels were therefore analysed by quantitative rtPCR (Fig 3.8.2). Amplification of 
cDNA with TLE1 primers showed increased TLE1 levels in all candidate clones 
compared to the parental line. However clone (5) was picked for further analysis 
because of its much higher expression levels.  
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Fig 3.8.2 TLE1 expression in 34n TLE1 rescued lines
34n null cells were electroporated with CAG TLE1 and subjected to puromycin
selection. Resultant clones were analysed by real time qPCR for TLE1 expression
levels. Levels are shown relative to E14 and normalized to TBP for each sample. The





3.9 Altered TLE activity across a range of generated cell lines  
A range of cell lines, both overexpressing and reduced in different TLE proteins, has 
been developed. Transcript levels of TLE1, TLE3 and TLE4 in the mutant cell lines 
were analysed by quantitative rtPCR. TLE levels in the overexpression lines are also 
included and are summarized here (Fig 3.9). CAGIPC TLE1 and point mutation lines 
and the 34n TLE rescued cells all had increased TLE1 levels. The mutant lines represent 
an allelic series of reducing TLE activity. There still appeared to be some residual TLE3 
and TLE4 transcript in 34n cells though transcript is greatly reduced. The primers used 
for rtPCR are in exons downstream of the vector insertion site. It is possible that mRNA 
is being spliced around the vectors although the use of the C2MAZ sequence should 
prevent this for TLE3 at least. TLE1 loss of function would be also required for a true 
TLE null ES cell. However these significantly reduced levels of the most expressed 
TLE family proteins in 34n cells would be expected to produce a relevant phenotype. It 
is also interesting that TLE4 levels in TLE4+/- cells are almost the same as wild type 
cells. TLE3 levels in TLE4-/-/TLE3+/- cells are also the same as those in TLE4-/- only 
cells. This raises the possibility of feedback regulation of TLE3 and TLE4 where 


















Fig 3.9 Expression of TLE genes in all experimental cell lines
The expression levels of TLE1, TLE3 and TLE4 was analysed in all cell lines
generated for this thesis for comparison: overexpression lines CAG TLE1, CAG
R534A, CAG L743F,  and their recombined subclones, the allelic series of TLE3 and
TLE4 mutants and the TLE1 rescued TLE3/4 null cells. cDNA  was synthesized from
all lines under normal maintenance and growth conditions. Real time qPCR was
performed in technical triplicate on the samples for total TLE1 (a), TLE3 (b) and
TLE4 (c) Levels for each gene are shown relative to those for E14 cells. Note the
different scale in (a) due to high TLE1 overexpressors;  TLE1 copy numbers in E14
are actually ~50% of TLE4.
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3.10 Discussion 
In this chapter I have identified the key members of the TLE family in ES cells and 
early mouse embryonic development. I have also described the generation and initial 
characterisation of a range of molecular tools and cell lines that can be used to study the 
activity of this family of proteins.  TLE3 and TLE4 are the highest expressed full length 
TLEs both in ES cells and early stage embryos as shown by EST data, gene trapping 
frequencies and quantitative PCR. Advantage was taken of a previously generated 
mouse line and ES cells derived from this to study the expression pattern of TLE4. In 
agreement with in silico data, TLE4 was expressed at latest from blastocyst stages 
through gastrulation and beyond. The expression pattern of the TLE4 reporter at mid 
gastrula was in agreement with previously published RNA in situ hybridisations. This 
data provides novel in vivo information about TLE4 expression patterns in 
pregastrulation mouse embryos. In addition, the TLE4 LacZ reporter was used to 
visualise the expression of this gene in ES cells. This confirmed its presence in these 
cells and showed heterogeneous expression, which is known in ESC cultures to often 
reflect different levels of undifferentiated and partially differentiated states. It would be 
interesting to combine this reporter with staining for a self-renewal marker such as 
Nanog, to see whether TLE expression coincides with a more or less ES like state.  
From this data and because of our previous interest in TLE3 and TLE4 as Hex targets, 
we decided to mutate these genes to create a loss of function model. Mutation of more 
than one TLE was necessary, as single mutants do not have an early phenotype. TLE2 
did not appear expressed in this context. Although TLE1 may provide some redundancy 
for loss of these, its absence in early embryos and reduced gene trapping frequency 
suggested it is not normally biologically relevant for regulation of pluripotency and 
early lineage specification. Also, the complete loss of 2 out of the 3 primary TLEs 
expressed in this context was expected to produce a strong phenotypic effect; this is 
confirmed in chapter 4. TLE4LacZ/LacZ cells derived from TLE4+/LacZ mice were used 
as a basis to generate this model. Vectors were designed and engineered to target TLEs 
and terminate their expression plus provide a fluorescent reporter of normal expression. 
The TLE3 vector was successfully targeted to both TLE3 alleles in ES cells. Including 
TLE4+/LacZ cells and intermediate targeted lines, this provides a complete allelic series 
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of TLE3 and TLE4 expression. Gradual loss of TLE expression along this series was 
confirmed. A further cell line was generated to allow partial rescue and confirmation of 
the specificity of any observed phenotype by TLE1 overexpression in the 34n cells.  
To complement this loss of function model, I developed gain of function tools to 
overexpress a TLE1 and variants of this with defined losses of activity. We generated a 
range of TLE1 point mutations and TLE variants in collaboration with the Stefani lab 
and screened these for interaction with typical classes of sequence specific transcription 
factor and ability to modulate specific signalling pathways. Of particular interest were 
two of these TLE1 point mutations – R534A and L743F. TLE1 R534A did not interact 
with either of two classes of typical TLE cofactors. However it was able to bind TCF by 
a different site and strongly repress Wnt signalling induced transcription. This was 
possibly a consequence of its reduced ability to bind other factors and therefore 
increased effective concentration. TLE1 L743F showed a specific deficiency in binding 
the WRPW class of cofactor. The comparison of these two point mutations plus the wild 
type protein provided a useful tool to identify particular TLE interactions correlating 
with certain biological effects. TLE1wt, TLE1 R534A and TLE1 L743F were all 
transgenically expressed at relatively high levels in ES cells. The overexpression system 
used also provided a method of monitoring expression and an ability to later remove 
TLE1 to confirm specificity of any effect.  
Both these strategies were used to investigate the roles of TLE proteins in ES cell 































4.1 TLE1 overexpression reduces the efficiency of self-renewal in ES cells 
Upon establishing the TLE overexpressing cell lines I began to characterize their 
phenotypes in ES cells. The cells could be grown in normal ES cell culture conditions. 
They had no readily apparent growth defect when compared to either parental or 
rescued cell lines. However, overexpression lines do have a slightly different 
morphology in culture compared to those with just an empty vector (Fig 4.1a). Cells 
have a less rounded appearance, seem less adherent to each other and have more 
cytoplasmic projections. This morphology has also been observed in Nanog null ESCs 
(Chambers et al. 2007). Based on these observations, I tested whether TLE 
overexpressing cells have a deficiency in self-renewal.  
To test the capacity of these cells to self-renew, I addressed the ability of single cells to 
form undifferentiated colonies at clonal density. Cells were plated at clonal density and 
grown for five or six days until colony morphology could readily be discerned. Plates 
were then fixed and stained for alkaline phosphatase (AP) activity. AP activity is 
present in undifferentiated ESCs and provides a rapid and easy way of identifying them. 
The plates were then examined under a microscope and colonies were counted and 
classed according to morphology and AP staining. Undifferentiated ES colonies have a 
tightly packed rounded appearance and stain strongly for AP. I also scored mixed and 
differentiated colonies based on the extent to which the colonies were composed of AP 
negative, morphologically differentiated cells (Fig 4.1b, insert). In this experiment, I 
found that cells overexpressing TLE1 had a higher percentage of differentiated and 
mixed colonies than empty vector control cells. When the TLE1 expression cassette is 
removed, percentages of undifferentiated cells increased (Fig 4.1b). The reduced self-
renewal ability is similar for both wild type TLE1 and point mutations. This suggests 
that neither eh1 nor WRPW motif containing proteins are required for TLE1 to induce 













Fig 4.1 Self renewal ability of TLE overexpressing cells at colonial density
(a) Brightfield microscopy of TLE overexpressing and empty vector control cells
showing representative fields. (b) TLE overexpressors and recombined subclones
were plated in normal media at a density of 50 cells /cm2 and were left to grow into
colonies for 5d. Plates were then fixed and stained for alkaline phosphatase activity
and examined under a microscope. Colonies were counted and classed according to
the apparent level of self renewal or differentiation as judged by AP staining and
morphology. The figure represents the average percentage of each class per plate
over 4 biological replicates. Differences shown between +TLE and –TLE samples
were statistically significant (p<0.001 using a Student’s t-test) Examples of
representative colonies for each class are shown below for reference.
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4.2 TLE mutant ES cells exhibit enhanced self-renewal ability 
Due to the self-renewal defects in TLE overexpressing ES cells, I then asked if cells 
with reduced TLE activity exhibited higher than normal levels of undifferentiated 
growth and clonal self-renewal. Typical AP stained colonies derived from clonal plating 
of the allelic series of TLE mutations alongside an E14 control are depicted in Fig (Fig 
4.2a). The results showed that in normal culture conditions with LIF, reduction in TLE 
levels correlates with an enhanced self-renewal. Less than 6% of colonies formed by 
34n cells showed significant signs of differentiation. Both control lines, TLE4 mutant 
cells and E14s behaved similarly, despite the differences in genetic background. Control 
lines exhibited approximately 40-50% wholly undifferentiated colonies. Morphology of 
34n colonies was rounded and tightly adherent and they demonstrate no evidence of 
differentiated cells at the periphery of the colony (Fig 4.2b). The experiment was also 
carried out in the absence of LIF (Fig 4.2a, lower panels; Fig 4.2b, lanes 6-10). As is 
expected, E14 and TLE4+/- cells differentiate in absence of LIF, however 34n cells still 
effectively generate undifferentiated colonies.  Greater than 60% of colonies appeared 
as normal undifferentiated ES cell colonies in the absence of LIF.  This is greater than 
the values obtained for wild type ES cells in normal culture conditions. TLE4-/- TLE3+/- 
cells were also able to self renew with almost the same efficiency as the 34n cells, 
suggesting that there may be a critical level of TLE in ES cells necessary for them to be 
able to differentiate.  
That this phenotype is due to a reduction in global TLE levels was indicated by the 
rescue of the 34n phenotype by the ectopic expression of TLE1. Thus Figure 4.2a and b 
also show that TLE1 over expression both reduces the ability of these cells to adopt a 
hyper undifferentiated phenotype and increases the capacity of this line to differentiate 
in the absence of LIF. 
E14 and TLE4-/- TLE3+/- cells were also grown in the absence of LIF for 3 days to 
cause loss of ES markers and enhance any observed differences between the lines. They 
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Fig 4.2 Self renewal ability of cells with reduced TLE activity at colonial density
TLE mutant cells were plated in normal media in the presence or absence of LIF at a
density of 50/cm2 and were left to grow into colonies for 5d. Plates were then fixed
and stained for alkaline phosphatase activity and examined under a microscope. (a)
Representative pictures of colonies in each condition. (b) Colonies were counted
and classed according to the apparent level of self renewal or differentiation as
judged by AP staining and morphology. The figure represents the average
percentage of each class per plate over 4 biological replicates. (c) Comparison of
Oct4 (red) and Nanog (green) expression between the E14tg2a line and generated




microscopy (Fig 4.2c). TLE4-/- TLE3+/- cells have noticeably higher levels of both 
markers even without LIF promoted self-renewal.  
 
4.3 TLE1 expression results in modest reductions in some pluripotency markers.  
Because of the self-renewal defect in TLE1 overexpressing ES cells, molecular markers 
of self-renewal and pluripotency were investigated in these lines. cDNA was prepared 
from these cells and recombined subclones without overexpressed TLE1 and analysed 
by quantitative rtPCR (Fig 4.3a). Oct4, Nanog, Sox2 and Dppa3 were all modestly 
reduced in TLE1 overexpressing lines. While these effects are modest to negligible at 
the RT-PCR level, they are consistently repeated in immunohistochemistry and 
appeared more dramatic at the protein level (see below).  In the absence of LIF ES cells 
readily make primitive endoderm and mesoderm. Interestingly, alongside the decrease 
in some pluripotency markers, I also observed an increase in the primitive endoderm 
markers Gata4 and Gata6 for some lines.  
The reduction in the expression of key ES transcription factors was also apparent at the 
protein level. Immunohistochemistry for cultures grown with and without TLE1 in the 
presence or absence of the cytokine LIF are shown in Figure 4.3b-d. Wild type TLE1 
and both point mutations reduced the expression of Oct4, Sox2, and Nanog, and TLE 
over expressing lines appeared to down regulate these markers to a greater extent in LIF 
withdrawal than did rescued clones.   
 
4.4 TLE3 and TLE4 compound mutants express high levels of pluripotency genes 
To complement the overexpression experiments and further investigate the increased 
ability of TLE mutant ES cells to self renew, a similar analysis of molecular markers 
was carried out. The different TLE mutants were tested in the following growth 
conditions: GMEM and 10%FCS with LIF, after LIF withdrawal for 3 and 6 days. 
cDNA was prepared from each sample and subjected to quantitative PCR  analysis for a 
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Fig 4.3 Pluripotency and primitive endoderm marker expression in TLE1
overexpressors
cDNA prepared from TLE1 overexpressors and recombined subclones was
analysed by real time qPCR (a). The pluripotency markers Oct4, Nanog, Klf4, Rex1,
Nr0b1, Sox2 and Dppa3 and the primitive endoderm markers Gata4 and Gata6
were looked at. Expression levels are normalized to TBP for each sample and
shown relative to TLE1wt cells with TLE overexpression removed. Protein
expression was also analysed for the pluripotency markers Oct4 (b), Sox2 (c) and
Nanog (d). Cells were grown for 3d in the presence or absence of LIF before being
fixed and stained with the appropriate primary antibodies and fluorophore




























Fig 4.4 Pluripotency and differentiation marker expression in TLE mutant cells
(a) TLE mutant cells were grown in the presence of LIF and the absence of LIF for 3
days and 6 days. RNA was prepared from these and used to synthesize cDNA for
analysis by real time qPCR. The ES markers Oct4, Sox2, Klf4, Nanog, Rex1,
Ecadherin and Fgf5 and the differentiation marker Brachyury were looked at.
Expression levels are normalized to TBP and shown relative to those for TLE4+/-
cells in LIF. Cells were also grown for analysis by immunofluorescence. After being
grown with or without LIF for 3d, cells were fixed and stained with primary
antibodies for Oct4 (b),  Sox2 (c), and Nanog (d). They were developed with
fluorophore conjugated secondary antibodies  and viewed by fluorescence
microscopy showing representative fields.  Arrows show areas of highest
expression.
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increase in many pluripotency and self-renewal associated markers, as TLE alleles are 
lost. Oct4, Nanog, Klf4, Sox2 and Rex1 all showed this general trend in LIF media. 
Addition of a TLE1 expression vector partially rescued the increased Nanog and Sox2 in 
34n cells, though a rescue was not observed for all markers. When LIF was withdrawn 
from the entire set of cell lines, the overall levels of pluripotency gene expression were 
reduced across the board, although the reduction in gene expression is less extreme in 
TLE3/TLE4 compound mutants. Even after 6 days of LIF withdrawal the TLE4-/- 
TLE3+/- and 34n cells expressed significant levels of key ES cell markers.  
Interestingly, levels of Fgf5 remained high in the TLE3/4 compound mutants. Fgf5 is 
normally expressed early in differentiation, and is usually associated with epiblast and 
EpiSCs. Fgf5 appeared to increase with normal kinetics in the TLE3/4 compound 
mutations, but remained highly expressed out to 6 days of LIF withdrawal.  While the 
Ecadherin can also be seen as an epiblast marker, reduced TLE levels did not effect its 
expression. The mesendoderm marker Brachyury was also reduced in mutant cells as 
TLE levels decline, suggesting a block to spontaneous differentiation to this lineage, 
even after LIF withdrawal. No consistent effect was seen on the PrEn marker Gata6, 
although interestingly, high levels were seen in one particular line TLE4-/- after LIF 
withdrawal. 
Expression of ES markers was also assayed at the protein level by 
immunohistochemistry. Cells were grown as before, for 3 days with or without LIF and 
were stained with antibodies to OCT4, SOX2 and NANOG. The effect on OCT4 (Fig 
4.4b) and SOX2 (Fig 4.4c) was less pronounced, although consistently upregulated. 
With respect to OCT4 staining specifically, TLE4-/- TLE3+/- mutants and particularly 
34n cells showed patches of extremely high OCT4 expression (arrow in Fig 4.4b).  This 
expression appeared rescued by ectopic TLE1. NANOG expression was more 
dramatically upregulated in response to reduced TLE levels and its expression was 




4.5 TLE overexpressing cells are prone to differentiation in multiple lineages. 
While TLE1 overexpressing ES cells appeared prone to spontaneous primitive 
endoderm differentiation, I wanted to test their capacity to differentiate toward 
additional lineages; neural and mesendodermal. To this end I exploited defined 
differentiation protocols to generate both lineages.  
Initially I tested the capacity of these cell lines to form neural progenitors at a fixed time 
points.  The effective generation of high levels of neural progenitors can readily be 
achieved by the culture of ES cells in minimal media (N2B27) in the absence of any 
cytokines (Ying et al. 2003). A schematic of this differentiation protocol is shown in Fig 
4.5.1d. After three days under these conditions, these cultures consisted largely of 
NESTIN positive early neural precursors (Fig 4.5.1a). If the cultures were left in N2B27 
for a further 4 days, they began to resemble terminally differentiated neurons, 
expressing neuronal marker ß-III TUBULIN (TUJ1) (4.5.1b). Overexpression lines 
were compared to recombined subclones and cells with vector alone. Cells expressing 
TLE1 and especially the point mutations R534A and L743F exhibited greater numbers 
of strongly nestin positive cells at day 3.  By day 7 the two point mutations and in 
particular R543A showed significant inductions of TUJ1.  This observation was born 
out by significant increases in the number and density of elongated neurons in culture. 
Interestingly, while TLE1 wild type overexpressing lines generated significant levels of 
NESTIN positive precursors, they did not exhibit enhanced numbers or staining for 
TUJ1. In fact, cells with TLE1wt have reduced levels of TUJ1. Reduction of terminally 
differentiated neurons by wild type TLE1 is expected, as it is a known repressor of 
neuronal differentiation. However the increase in neurons when TLE1 mutations are 
used is more interesting. It would imply that repression of neural differentiation by 
TLE1 is in conjunction with WRPW motif containing cofactors such as HES1, as 
L743F is specific for this binding deficiency. This has previously been shown by the 
expression of these mutations in primary cultures of cortical neurons (Buscarlet et al. 
2008).  
To determine whether the over expression of these mutant TLEs was effecting the 

























Fig 4.5.1 Neural differentiation of TLE overexpressing ES cells
TLE overexpressing cells  and those with the vector alone were subjected to the
monolayer neural differentiation protocol. Differentiation efficiency was first
analysed by immunofluorescence. Cells were fixed and stained with the appropriate
primary antibody and a fluorophore conjugated secondary at day 3 for nestin (a)
and day 7 for Tuj1 (b). Cells were also differentiated in the same way for neural
marker analysis by real time qPCR (c). Cells were harvested before (d0) and at days
2, 4, 6 and 8  of the protocol. RNA extraction and cDNA amplification was
performed on the samples. cDNA was used for real-time qPCR analysis of the
neural lineage marker genes Sox1, Nestin, NeuroD1, Six3, BLBP and Tuj1. This was
performed in technical triplicate.  Transcript levels are normalized to TBP and
shown relative to the levels in empty vector cells at d0. (d) Schematic of the neural
differentiation protocol showing equivalent developmental stages and pathways
acting on this process.
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assessed a time course for neural differentiation by quantitative RT-PCR. Cells were 
differentiated as before and cDNA was produced from cultures at 0, 2, 4, 6 and 8 days 
of differentiation (Fig 4.5.1c). Both neural precursor markers Nestin and Sox1 were 
expressed at higher levels in TLE1 overexpressors, however, as with the NESTIN 
staining this was particularly pronounced in the lines harbouring TLE1 point mutations. 
Interestingly, expression of these early markers was retained in CAG TLE1 R534A cells 
even at the latest time point. Six3 and NeuroD1 are both expressed in neural precursors. 
Expression of these is higher in both wild type and point mutant overexpression lines. 
However, this result contrasted with the expression of late neural markers such as Tuj1 
and BLBP, which are only upregulated in the cell lines expressing TLE mutations that 
fail to bind WRPW.  This observation is similar to that observed the 
immunohistochemistry and is interesting. As the wild type protein can both repress 
Notch and Wnt signalling this is not surprising.  However, the increase in neurons in 
response to two TLE1 mutations is interesting as it implies that this effect relies on 
interaction with TCF like proteins and therefore would be related to Wnt signalling.  
Previous work in our laboratory has shown that repression of wnt signalling mediated 
by TLE4 is involved in the control of anterior definitive endoderm (ADE) formation in 
both mice and Xenopus (Zamparini et al. 2006). The transcriptional repression of TLE4 
by Hex promotes ADE formation in embryos by derepressing wnt signalling and 
suppressing mesoderm induction. It was therefore interesting to ask if forced expression 
of a TLE protein would modulate mesoderm or endoderm induction. Advantage was 
taken of a protocol newly developed in this laboratory, which uses defined conditions to 
differentiate ES cells first to primitive streak derivatives, then to endoderm and anterior 
endoderm (Fig 4.5.2a) (Morrison et al. 2008).  
TLE1 overexpressing cells and the control line were subjected to this protocol and 
samples were taken at 0, 2, 5 and 7 days and used to generate RNA/cDNA for 
quantitative RT-PCR (Fig 4.5.2b).  Consistent with my previous observations, the TLE1 
overexpressing cell lines appeared more effective at generating early derivatives of 
differentiation. The early mesoderm/primitive streak markers Brachyury and Wnt3a 
were higher in all TLE1 overexpressors at day 5. Interestingly, overexpression of 



























Fig 4.5.2 Mesendoderm differentiation of TLE overexpressing ES cells
(a) Schematic of the ADE differentiation protocol showing equivalent developmental
stages. (b) Cell lines overexpressing TLE and cells with the vector alone were
differentiated towards endoderm. They were harvested before (d0) and at days 2, 5
and 7 of the protocol. Samples were used for RNA extraction followed by cDNA
synthesis. Expression of lineage marker genes was analysed by real-time qPCR for each
cell line and time point. Each data point represent the average of two biological
replicates with PCR performed in technical triplicate. Levels are normalized to TBP
and shown relative to empty vector cells at d0.
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marker FoxA2 and significantly higher levels of the two ADE genes, Hex and Cerberus. 
While the increase in ADE markers appears to be the opposite observation than 
originally predicted it is consistent with a number of observations about anterior 
endoderm. First, late specification of anterior endoderm is dependent on Wnt 
antagonism and second, HEX activity is dependent on TLE1 as a co-repressor.  
Therefore in the TLE1 overexpressors, HEX would be predicted to be more broadly 
active.  The increase in endodermal markers is not seen with the L743F mutation. The 
TLE1 L743F line also displays higher Wnt3a transcript levels compared to the wild type 
TLE1 or R534A. This suggests that a eh-1 containing protein may mediate a specific 
TLE1 dependent suppression of endodermal identity and this may also help to reconcile 
the observations here with those of Zamparini et al. A summary of gene expression 
changes is provided in Fig S.1.1 (neural differentiation) and Fig S.1.2 (mesendodermal 
differentiation). 
 
4.6 Differentiation of TLE mutants. 
TLE mutant ES cells have been shown to have enhanced self-renewal ability due to 
reduced spontaneous differentiation. However it was not known whether they could 
overcome this initial block and undergo differentiation if they were given the correct 
inductive signals. To investigate this, I used defined protocols for both neural and 
mesendodermal differentiation to determine how ubiquitous the block to differentiation 
was. 
 As TLE1 overexpressors were better able to differentiate towards the neural lineage, I 
hypothesized that the loss of function lines might exhibit the opposite phenotype. Cells 
were plated out in the monolayer neural differentiation protocol as previously described 
and allowed to differentiate for up to 7 days. They were then stained with antibodies for 
TUJ1 to mark neurons and OCT4 to mark undifferentiated ES cells. Even at late time 
points in this protocol, some cells in this protocol failed to downregulate OCT4 as has 
previously been shown (Lowell et al. 2006). However, these normally represent a 
minority of these cultures. Thus while TLE4 single mutants and E14 cells formed areas 
















Fig 4.6.1 Neural Differentiation of TLE mutant ES cells
TLE mutant ES cells were grown and subjected to the monolayer neural
differentiation protocol. (a) Marker expression was analysed by
immunofluorescence. Cells were differentiated in the same way and fixed and
stained at day 7 for Oct4 (green) and Tuj1 (red) with the appropriate primary
antibodies and fluorophore conjugated secondaries. They were visualized by
fluorescence microscopy with DAPI used as a counterstain. Cells were harvested
before (d0) and at days 3, 5 and 7  of the protocol. (a) RNA extraction and cDNA
amplification was performed on the samples. cDNA was used for real-time qPCR
analysis of the neural lineage  marker genes Sox1, Nestin , NeuroD1, BLBP and the
self renewal marker Oct4.  Data shown represents the average of two biological
replicates with PCR performed on each in technical triplicate.  Levels are
normalized to TBP and shown relative to TLE4+/- cells at d0.
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some OCT4 positive cells (arrowhead in Fig 4.6.1a). However, this staining does not 
colocalize with the cell bodies of TUJ1 positive neurons and thus represents a minority 
of undifferentiated cells. Cultures from the TLE3/4 compound lines on the other hand, 
did not generate neurons. Faint, diffuse staining with the TUJ1 antibody was observed 
but these cells did not have the obvious elongated morphology of neurons. This staining 
may represent another cytoskeletal or mitochondrial form of tubulin. In addition, the 
majority of these cells failed to down regulate OCT4, despite prolonged culture in 
N2B27 without cytokines. Forced expression of TLE1 failed to rescue this phenotype, 
although this lack of rescue may be due to an insufficient level of TLE or the unlikely 
possibility that there are functional differences with in the family of TLEs.  Further 
work will be required to resolve these possibilities. 
To investigate kinetics of differentiation at the transcriptional level, a time course of 
neural differentiation was subjected to a range of RT-PCR markers. Cells were 
differentiated as before and sampled at days 0, 3, 5 and 7 of the protocol. cDNA was 
synthesized and analysed by quantitative rtPCR (Fig 4.6.1b). The neurectoderm marker 
Sox1 was upregulated from day 3 in TLE4 single mutant cells, but TLE3/TLE4 double 
mutant cells failed to upregulate Sox1 at any time point. However, this block to 
differentiation does not appear complete, as Oct4 message did appear reduced by day 7. 
This suggests a level of post translation regulation as the effect on Oct4 at the protein 
level appeared much more dramatic.  Nestin followed a similar pattern and increased 
most in TLE4+/-. NeuroD1 expression was also upregulated in all the cell lines tested. 
Interestingly, NeuroD1 is not exclusive to neural precursors though, and could represent 
a different lineage. The mature neuronal/glial marker BLBP was high in TLE4 single 
mutants by the end of the protocol but was almost completely absent in TLE3/TLE4 
double mutants. 
As with the TLE overexpressors, I tested the capacity of the TLE allelic series to form 
mesoderm and endoderm under defined conditions.  TLE mutants and the rescued lines 
were plated out for the monolayer ADE protocol summarized in Fig 3.13a. They were 
left to differentiate and samples taken for cDNA synthesis at d0, d2, d5 and d7 of the 
protocol. Transcript levels for mesoderm and endoderm markers were analysed by 










Fig 4.6.2 Mesendoderm differentiation of TLE mutant ES cells
TLE3/4 mutant and 34n TLE1 rescued ES cells were differentiated towards anterior
definitive endoderm. They were harvested before (d0) and at days 2, 5 and 7 of the
protocol. Samples were used for RNA extraction followed by cDNA synthesis.
Expression of lineage marker genes was analysed by real-time qPCR for each cell line
and time point.  Data shown represents the average of two biological replicates with
PCR performed on each in technical triplicate
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protocol, differentiation by this protocol appeared to be enhanced in TLE mutant cells 
based on marker upregulation. The mesoderm markers Goosecoid, Mixl1, Cxcr4, 
Brachyury, FoxA2 and Wnt3a were all expressed at higher levels in response to reduced 
TLE activity. Interestingly, specific anterior mesendoderm makers, Goosecoid, Frzd5, 
Hex and Cerberus were all expressed at high levels in the TLE4-/- TLE3+/- than 34n 
cells. Also, the double nulls were particularly ineffective at making these lineages, 
while the 34n rescued cells are.  This suggest that while a reduction in TLE is required 
for optimal mesendoderm induction, a critical level of TLE maybe necessary for the 
activity of homeobox transcription factors such as HEX and GOOSECOID, which use 
TLEs as corepressors, to properly pattern the emerging endoderm and suppress 
mesoderm induction. In general however, TLE mutants seemed to be more efficient at 
forming mesoderm during the protocol. Primitive streak markers Brachyury, Mixl1 and 
Wnt3a were dramatically upregulated in mutants. The gene expression changes 
observed in the TLE mutant cell differentiation experiments are also summarised in 
Figs S.1.1 and S.1.2.  
 
4.7 ES marker expression of TLE mutant cells in the 2i culture system  
TLE proteins have previously been implicated in the regulation of ES self renewal, 
albeit indirectly via TCF3. TCF3 has been shown to bind the Nanog promoter in ES 
cells and repress its transcription (Pereira et al. 2006). Mutation of the TLE binding 
domain of the TCF3 protein negated this repression, suggesting a TLE protein was 
acting as a corepressor. TCF3 binding has also been shown by ChIP-on–chip to other 
pluripotency associated genes such as Oct4 and the bound TCF3 colocalizes with TLE2 
(Tam et al. 2008). Interestingly, TLE5, which has been purported to act as a dominant 
negative TLE in some circumstances, is also expressed in ES cells. Its expression is 
regulated by STAT3 and declines upon LIF withdrawal induced reduction of STAT3 
(Sekkai et al. 2005). These studies suggest a model where repression of ES associated 
genes by Tcf3 in conjunction with TLE corepressors, is necessary for ES cells to 
differentiate efficiently. TCF3 can act as a transcriptional activator or repressor and this 
depends on whether it is complexed with ß CATENIN or corepressors such as CtBP or 
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TLEs. The balance between these two types of complex is controlled by Wnt signalling. 
We formulated a hypothesis that the increase in TLE mutant cells self-renewal abilities 
is due to an amplification of the Wnt pathway by reduction of Tcf mediated repression. 
ES cells can be grown in defined conditions without serum using the 2i culture system. 
Cells are cultured in N2B27 media with two small molecule inhibitors to control 
signalling pathways and keep ES cells in a self-renewing state (Ying et al. 2008). 
PD032501 blocks commitment to differentiation by suppressing phospho-ERK. 
CHIR99021 is a GSK3 inhibitor and its addition appears to enhance cell growth and 
viability. Moreover, other GSK3ß inhibitors have been used to maintain ES cells in an 
undifferentiated state. However, the dependence of the defined 2i system on GSK3 
inhibition allowed me to test whether the enhanced capacity of TLE3/4 compound 
mutants enables the to self renew in the absence of CHIR99021. 
TLE mutant cells were plated in 2i media containing the recommended normal 
PD0325901 concentration (1µM) and CHIRON99021 at the normal concentration 
(3µM), 1µM or without CHIRON99021. They were grown and passaged in this for 5 
days to allow gene expression changes. cDNA was then prepared from them for 
analysis by quantitative PCR (Fig 4.7a) and samples were also antibody stained for 
OCT4 expression (Fig 4.7b). In low or absent CHIRON, some ES markers such as 
Oct4, Sox2 and Nanog were higher in the 34n line than lines with more TLE, but there 
was no clear trend across the allelic series. No consistent effect was seen on Gata6, 
however one interesting observation was high levels of this marker in the TLE4-/-cells 
in 1µM CHIRON. However, when the lines were grown in normal CHIRON (3µM), 
differences between normally exhibited between these cell lines were less apparent, 
suggesting that TLE repression might feed indirectly into activate MAP kinase 
signalling that is effectively inhibited by the 2i condition. OCT4 protein expression was 
also largely unaffected across the allelic series in normal or moderately reduced 
CHIRON (Fig 4.7b). Again, levels did appear higher in 34n cells than other lines in the 
absence of CHIRON.  However, cell survival in this condition also appeared greater as 
shown by increased DAPI fluorescence, thus OCT4 expression may be increased as a 
consequence of this. The data presented in this experiment is inconclusive. However it 
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does not appear to support the hypothesis that TLEs are working through the wnt 








































Fig 4.7  ES marker expression of TLE mutant cells in 2i with altered CHIRON
concentration
TLE mutant ES cells were grown and passaged in 2i media with different CHIRON
concentrations for 5 days. The concentrations of CHIRON99021 in different 2i
medias were 3µM, 1µM and 0µM. PD0325901 and LIF in the media were kept
constant.  (a) Cells were then harvested and used for RNA extraction and cDNA
synthesis. Real time qPCR analysis was performed for the markers Oct4, Sox2, Klf4,
Rex1, Nanog, Dppa3,  Ecadherin and Fgf5. Expression levels are normalized to TBP
values for each sample and shown relative to those for E14 –CHIRON.  Analysis
was performed in technical triplicate for each data point. (b) Oct4 levels were also
analysed in the same experiment using immunofluorescence. Cells were fixed and
stained after 5 days using Oct4 primary antibody and a fluorescent secondary. They




In this chapter I have identified several interconnected roles for TLE proteins in the 
regulation of early lineage specification and ES cell self-renewal. Growing TLE 
overexpressing and TLE mutant cells at clonal density revealed differences in the cells 
self-renewal abilities. While ES cells with less TLE activity were able to self renew 
with high efficiency, ES cells overexpressing TLE were more prone than wild type cells 
to differentiation. Furthermore, the effect of loss of both TLE3 and TLE4 is strong 
enough to allow LIF independent self-renewal. These opposing phenotypes suggest 
TLE in ES cells facilitates the passage from a self-renewing to a more differentiated 
state. Overexpression of both wild type and point mutants of TLE1 increase 
differentiation, demonstrating that the effect is not dependant on eh1 or WRPW classes 
of TLE cofactors and could involve TCF proteins for example. This would agree with 
previous studies showing a role for TLEs in TCF mediated repression of Nanog and 
Oct4 (Pereira et al. 2006; Tam et al. 2008). However the phenotype of TLE 
overexpression is milder than that of TLE loss. This is in agreement with TLEs function 
as a corepressor with no independent DNA binding. Although increased TLE may 
amplify the effects of any TLE dependant proteins, it cannot independently affect 
specific processes without a DNA binding partner. In contrast loss of TLE would be a 
limiting factor in itself, reducing the ability of differentiation promoting TLE dependant 
repressors to act, thereby exerting a greater effect. This is also reflected in a molecular 
analysis of self-renewal and differentiation related markers.  
TLE overexpressing ES cells had a moderate decrease in certain self-renewal markers 
such as Oct4, Sox2 and Nanog as assayed by both quantitative rtPCR and antibody 
staining. However in TLE mutant ES cells, an opposite and more pronounced effect was 
observed. Transcript levels of self-renewal markers such as Oct4, Nanog, Klf4, and 
Sox2 all showed a general trend of increased expression as TLE levels reduced. 
TLE3/TLE4 compound mutants had the highest levels of these factors. Even after 
extended periods of LIF withdrawal, these cells maintained high levels of these factors, 
especially Oct4. In contrast, the mesendoderm marker Brachyury was reduced, 
demonstrating reduced spontaneous differentiation. No consistent effect was observed 
on the primitive endoderm markers Gata4 or Gata6 that could be correlated to total 
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TLE levels although Gata6 was significantly higher in TLE4-/- cells. This is a similar 
result to the high Gata6 levels seen in the same cells in 2i with reduced CHIRON. The 
significance of this is unclear but may reflect differences between individual TLEs. 
Transition of ES cells to specific differentiated cell types is controlled by both 
downregulation of the self-renewal promoting network and by control of early lineage 
promoting factors to steer differentiation. A role for TLEs in the latter was also 
identified. TLEs have previously been implicated in the control of differentiation in 
embryonic development and interact with developmental regulators such as Fox and 
homeobox proteins, Hes1 and Goosecoid (Yao et al. 2000; Izzi et al. 2007; Yaklichkin 
et al. 2007). Here I show that TLE1 overexpression promotes early differentiation 
towards the neural lineage from ES cells. This is in agreement with the increased ability 
of these cells to differentiate as discussed above and the repression of Wnt signalling 
which has been shown to promote neural differentiation (Aubert et al. 2002). Notch 
signalling can promote neural progenitor specification (Lowell et al. 2006) therefore 
TLE antagonism of Notch ICD/RBPJ mediated transcription may suppress neural 
differentiation. Lack of Notch antagonism by the point mutants would give these Wnt-
suppressing proneural activities but no Notch-suppressing antineural activity, explaining 
their strong neural differentiation promoting effect. Previous studies describe TLEs as 
repressors of terminal neural differentiation and this agrees with the observation that 
TLE1wt ES cells produce less TUJ1 positive neurons in a differentiation protocol. 
However, the increased number of these neurons in cells overexpressing TLE1 point 
mutants with a specific deficiency in WRPW interactions suggests this neural 
suppression is dependant on WRPW containing proteins for example Hes1. These 
experiments supports similar observations from TLE1 overexpression in primary 
cultures of neural progenitors (Buscarlet et al. 2008) and extends the role of TLEs to an 
earlier stage of differentiation. In contrast, TLE3/TLE4 compound mutant ES cells were 
less able to differentiate to the early neural lineage as shown by reduced Sox1 and 
persistent Oct4 expression. They appear completely unable to produce terminally 
differentiated neural cell types. A model is suggested whereby TLE proteins promote 
early specification towards the neural lineage by repression of pluripotency genes and 
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Wnt repression, then provide a secondary function at later stages to regulate neural 
differentiation through the Notch pathway.  
As well as the neural lineage, a role in mesendoderm lineage specification was also 
highlighted. In a mesendoderm differentiation protocol, cells overexpressing TLE1 and 
point mutations had a greatly increased propensity to differentiate towards this lineage 
as shown by increased primitive streak markers such as Wnt3a and Brachyury. This is in 
agreement with the previous observations of TLE1 overexpressing cells more readily 
differentiating and a more marked downregulation of Oct4 at the end of the protocol. 
Although they might be expected to have the reciprocal phenotype, TLE3/TLE4 
mutants also express more PS markers as TLE levels decrease. This apparently 
contradictory observation can be explained by the reduction in Wnt antagonism by loss 
of TLE. Wnt signalling promotes early mesendodermal differentiation therefore if the 
initial obstacle to differentiation by reduced pluripotency network repression can be 
overcome, TLE3/TLE4 mutants can differentiate towards this lineage with greater 
efficiency. At later stages of this protocol, cells are directed towards anterior endoderm 
and cells with reduced levels of TLE express higher anterior endoderm markers such as 
Hex, Cerberus and Fzd5. This is in agreement with the previous study by Zamparini et 
al that showed reduced TLE4 causes derepression of Wnt signalling, leading to 
upregulation of anterior endodermal Wnt target genes such as Cerberus. TLE1 and 
TLE1 R534A overexpressing cells also have increased anterior endoderm markers Hex 
and Cerberus. This is in apparent conflict with the previous observations. However, 
TLEs also act as cofactors with endodermal homeobox transcription factors such as 
HEX and GOOSECOID. These observations suggest dual positive and negative roles 
for TLEs in anterior endoderm differentiation at different stages, depending on the 
context of expressed cofactors. In agreement with this, reduction in TLE levels in the 
TLE3/TLE4 mutants up to a point allows better mesendodermal differentiation, but 
complete loss of both genes inhibits it.  
The possible roles identified for TLE proteins in self-renewal and lineage specification 





























Fig 4.8 Speculative model for roles of TLEs in ES cell self renewal and lineage
specification
Model for some of the possible roles of TLE in ES cell self renewal, neural and
mesendodermal differentiation. Positive (green) and negative (red) roles for TLE
mediated repression are shown for each process. TLE reduces self renewal by
inhibiting self renewal genes. TLE increases neural differentiation through inhibiting
self renewal and antagonising Wnt signaling, but can also decrease it through Notch
and bHLH mediated repression. TLE inhibits mesendoderm/primitive streak and
later anterior endoderm through wnt antagonism, but can also promote this
differentiation initially through decreased self renewal ability, later interactions with




























In this thesis, I have provided some novel insights into the roles of TLE family 
corepressors in early lineage specification and regulation of ES cell differentiation. This 
was facilitated by the generation of a range of tools that allowed both gain and loss of 
TLE, and perturbation of specific TLE activities.  
TLE proteins have been observed in both ES cells and early mouse embryos. Although 
they appear to be expressed throughout the embryonic portion of the conceptus, their 
expression pattern at gastrulation and beyond is highly dynamic. Moreover, even at the 
blastocyst stage, TLE4 seemed to exhibit slight heterogeneity in the ICM compared to 
the more uniform expression in the epiblast. In addition, a heterogeneous expression 
pattern was observed for TLE4 in ES undifferentiated ES cell cultures. These 
observations suggest a level of control over TLE expression, although the role of these 
proteins in early development and differentiation has not previously been studied in 
depth. Later developmental roles for TLEs have been described and experiments in this 
work expand these roles to earlier stages. TLE proteins were first identified as a neural 
suppressor in Drosophila (Groucho) and this role was later extended to mammals. 
However, previous studies concentrated on later stages of neural specification. 
Experiments here show that TLE1 has a positive effect on the initial specification of 
neural progenitors, probably through Wnt antagonism, and an opposing negative effect 
through an eh1 containing cofactor, probably via the Notch pathway.   
Experiments in this thesis explore the role of TLE1, TLE3 and TLE4 in early lineage 
specification events. Consistent with their distinct and dynamic expression patterns, 
different TLE mutants appear to have diverse effects on differentiation, for example 
differences in neural and endoderm markers between TLE4 and TLE4/TLE4 compound 
mutants and increased Gata6 observed in TLE4-/- cells in some experiments. While 
these effects could simply reflect the gene dose, the possibility remains that there are 
differences between the activities of individual TLEs. While TLE1 is purported to have 
identical biochemical properties to other TLEs, it only partially rescues TLE3/TLE4 
mutants. This may be a result of failing to rescue the heterogeneous gene activity with a 
constitutively active TLE1 vector or cultural adaptation to forced TLE1 expression, but 
could also imply subtle differences between the proteins that have not previously been 
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identified. Clearly more extensive rescue experiments using inducible expression are 
required to distinguish between these possibilities.  
Previous work in our lab (Zamparini et al. 2006) identified TLE family members as 
repressed targets of the homeobox transcription factor Hex, in anterior endoderm 
specification. Although this work was carried out in Xenopus, the gene interaction 
networks involve appeared conserved in the mouse, and suggested a possible role for 
Wnt signal amplification by repression of TLEs in regulation of mammalian anterior 
endoderm specification too. Experiments in this work lend further evidence to this idea. 
Mutant cells with reduced TLE activity were better able to differentiate into anterior 
endoderm as marked by genes such as Hex and Fzd5. In addition, primitive streak 
markers were increased at earlier stages of differentiation, in agreement with the need 
for the Wnt pathway in establishing the primitive streak and subsequently mesoderm 
and endoderm, and this would also drive ES cells towards endoderm. Roles for Wnt 
signalling in establishing dorsoanterior identity are well known the frog. In mouse, Wnt 
is classically thought of as a posteriorizing influence due to its role in establishing the 
primitive streak, however disruption of the wnt pathway prevents the correct positional 
expression of anterior markers like Hex before the establishment of the PS (Huelsken et 
al. 2000). Additionally, Hex and Cerberus are not expressed anteriorly when ß catenin 
is deleted specifically in the AVE (Lickert et al. 2002). These findings imply a role for 
Wnt signalling in anterior endodermal specification in mammals too and even suggest a 
Nieuwkoop like role for AVE.  
In addition to Wnt antagonism, TLEs are also implicated in later patterning of anterior 
endoderm in a positive role. Cells with reduced TLE made ADE very efficiently, 
however complete lack of TLE3 and TLE4 prevented this. ES cells expressing high 
levels of TLE1 also expressed high levels of ADE markers. TLEs have been shown to 
act as corepressors with anterior endodermal markers Goosecoid and Hex (Jiménez et 
al. 1999; Swingler et al. 2004). Goosecoid represses the mesendoderm marker Mixl1 
and this has been linked to TLE activity (Izzi et al. 2007). A model is suggested where 
TLE becomes necessary as a corepressor for anterior endoderm inducing homeobox 
factors to correctly pattern this tissue. In my experiments, increased TLE would only act 
in this process in a subset of ES cells that have already become endoderm, but would 
here amplify the effects of endoderm inducing proteins that require TLEs. In an 
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analogous manner, a pituitary dysplasia phenotype caused by an imbalance between the 
factors PROP1 and HESX1 can be amplified by ectopic expression of TLE1 acting as a 
HESX1 corepressor (Dasen et al. 2001). Interestingly, TLE1 R534A increased 
endoderm markers in the same way as TLE1wt while the less severe point mutation 
(L743F) did not. Therefore, losing the WRPW interactions decreased endoderm 
specification, and then subsequently losing eh1 interactions too increased it again. This 
suggests a WRPW protein may be promoting mesendodermal differentiation while an 
eh1 containing protein inhibits it. Further investigation of this through an increased 
panel of markers and inducible TLE1 expression would help resolve this. 
TLEs were also observed to affect the balance between self-renewal and differentiation 
in ES cells. Reduced TLE increased self-renewal and inhibited differentiation while 
increased TLE had the opposite effects. This did not appear due to inhibition of specific 
lineages as no consistent effects were seen on early neurectoderm, mesendoderm or 
primitive endoderm differentiation markers in normal ES culture. However, loss of TLE 
strongly upregulated self-renewal/pluripotency associated genes, most strongly Oct4 
and Nanog, while the reciprocal phenotype was seen with TLE1 overexpression, 
suggesting this is the mechanism by which TLE affects self renewal.  
The transition from naïve, uncommitted cells in an early embryo or a culture of 
undifferentiated ES cells towards specialised somatic lineages can be seen as being 
regulated by opposing interlinked processes. The pluripotency/self-renewal gene 
network must be maintained to allow the growth and maintenance of pluripotent 
precursors but then downregulated at the appropriate time to allow commitment of cells. 
The fine balance between these opposing programs allows rapid switching from self-
renewal to differentiation of uncommitted cells in a developing embryo. In ES culture, 
random, stochastic fluctuations in gene networks may cause individual cells to 
transition towards a more differentiated lineage such as epiblast or primitive endoderm, 
but with no intrinsic or extrinsic cues to stabilize this transition, and the continued 
activity of the pluripotency network, these precursors cannot commit stably. The most 
uncommitted ICM-like cells in the non-excited state have been termed the “ground 
state” and would have to transition through an epiblast-like state to differentiate. The 
low NANOG set in a population of cells heterogeneously expressing this marker, could 
be seen as transitioning away from the ground state (Ying et al. 2008). An alternative 
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explanation recently supported by work in our lab, is that all ES cells with an active 
pluripotency network are equally uncommitted and can transition freely between 
precursors and ICM like state. In this model, there would exist metastable, self-
renewing populations of early precursors to both primitive endoderm and primitive 
ectoderm (Canham et al. 2010). As TLE4 is expressed heterogeneously in ES cells and 
represses NANOG, an interesting possibility is raised where TLE4 is marking one or 
more lineage specific groups of precursor cells. It seems unlikely this is a PrEn 
precursor as no consistent effect was seen on markers like Gata4 or Gata6. However, 
the positive effects of TLE on neural specification suggest it could be a primitive 
ectoderm like population. It would be interesting to further investigate this idea through 
marker expression and by analysing the how the TLE3 and TLE4 reporters correlate 
with NANOG in ES cells. In addition, TLE3 mORANGE would enable purification of 
high TLE3 expressing live cells by flow cytometry, which could be tested for their 
capacity to differentiate towards specific lineages such as neural.  
Other experiments suggested by the outcomes of this work include further analysis of 
the molecular basis of Nanog or Oct4 repression by TLEs. This could be investigated by 
ChIP analysis of promoter acetylation in these genes in mutants compared to wild type, 
as TLE would be expected to deacetylate promoters via HDAC recruitment if the effect 
is direct. To directly probe the role of wnt modulation by TLEs, it would be useful to 
have a point mutant that lacked HDAC interaction. A Drosophila Groucho mutant with 
a short Q domain deletion, MB5, was recently shown to have absent TCF binding 
without affecting tetramerization ability (Mieszczanek et al. 2008) and could be 
replicated in mammalian TLE1. The 34n cells provide a useful background for testing 
TLE activities. Combining this cell line with Tet regulatable overexpression of specific 
TLEs or point mutants with altered activities would have several advantages. It would 
avoid any cultural adaptations to high TLE levels caused by long-term overexpression, 
which may be the cause of the incomplete rescue seen by TLE1 overexpression in the 
34n cells seen here. It would also mean highly controllable TLE activity and allow the 
analysis of defined aspects of TLE activity at specific timepoints during differentiation, 
in order to answer the questions raised by experiments in this thesis.  
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Fig S.1.1 Summary table of gene expression changes in neural differentiation for
TLE1 overexpressing and TLE mutant cells
Genes are listed in the table depending on whether they are up or down in relation
to levels in the control cell line in each cell type an timepoint (CAG empty for
overexpression lines, TLE4+/- for mutant lines)
TLE1 wt R534A L743F
d0 up NeuroD1 NeuroD1 NeuroD1
down
d2 up Six3 Six3 Six3
down Nestin
















TLE3+/- 34n 34n TLE1










































TLE1 wt R534A L743F
d0 up
down




























































Fig S.1.2 Summary table of gene expression changes in endodermal differentiation
for TLE1 overexpressing and TLE mutant cells
Genes are listed in the table depending on whether they are up or down in relation
to levels in the control cell line in each cell type an timepoint (CAG empty for
overexpression lines, TLE4+/- for mutant lines)
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Common Abbreviations 
A  Amperes  
AVE  Anterior Visceral Endoderm 
ADE   Anterior Definitive Endoderm 
AP  Alkaline Phosphatase 
bp  base pair 
BSA  Bovine Serum Albumin 
°C  Degrees Centigrade 
CO2  Carbon Dioxide 
DMSO  Dimethyl Sulphoxide 
DNA  Deoxyribonucleic Acid 
dNTP  Deoxynucleotide Triphosphate 
DTT  Dithiothreitol 
DVE  Distal Visceral Endoderm 
EDTA  Ethylenediamine Tetra-acetate 
EGO  Early Gastrula Organizer 
ESC  Embryonic Stem Cell 
EtOH  Ethanol 
FCS  Fetal Calf Serum 
g  grams 
GFP  Green Fluorescent Plotein 
GMEM Glasgow’s Modified Eagle’s Medium 
H2O  Water 
hr  hour 
ICM  Inner Cell Mass 
KAc  Potassium Acetate 
kb  kilobase 
kD  Kilodaltons 
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l  litre 
LB  Luria Broth 
m  minute 
μ  micro 
M  Molar 
MgCl2  Magnesium Chloride 
N  nano 
nm  nanometres 
NaCl  Sodium Chloride 
NaOH  Sodium hydroxide 
PBS  Phosphate Buffered Saline 
PBST  Phosphate Buffered Saline with Tween20 
PCR  Polymerase Chain reaction 
PLAP  Placental Alkaline Phosphatase 
PFA  Paraformaldahyde 
PrE  Primitive Endoderm 
PS  Primitive Streak 
RNA  Ribonucleic Acid 
rpm  revolutions per minute 
RT  Room Temperature 
SDS  Sodium Dodecyl Sulfate 
TE  Tris-EDTA 
TE-SDS Tris-EDTA with SDS 
TAE  Tris Acetate EDTA 
UV  Ultra Violet 
V  Volts 
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Inhibition of Cortical Neuron Differentiation by
Groucho/TLE1 Requires Interaction with WRPW,
but Not Eh1, Repressor Peptides*
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In both invertebrates and vertebrates, transcriptional co-re-
pressors of theGroucho/transducin-like Enhancer of split (Gro/
TLE) family regulate a number of developmental mechanisms,
including neuronal differentiation. The pleiotropic activity of
Gro/TLEdependson context-specific interactionswith a variety
of DNA-binding proteins. Most of those factors engage Gro/
TLE through two different types of short peptide motifs, the
WRP(W/Y) tetrapeptide and the Engrailed homology 1 (Eh1)
sequence (FXIXXIL). The aim of this study was to elucidate the
contribution ofWRP(W/Y) and Eh1motifs to mammalian Gro/
TLE anti-neurogenic activity. Here we describe pointmutations
within the C-terminal WD40 repeat domain of Gro/TLE1 that
do not perturb protein folding but disrupt the ability of Gro/
TLE1 to inhibit the differentiation of cerebral cortex neural
progenitor cells into neurons. One of thosemutations, L743F,
selectively blocks binding to Hes1, an anti-neurogenic basic
helix-loop-helix protein that harbors aWRPWmotif. In con-
trast, the L743F mutation does not disrupt binding to
Engrailed1 and FoxG1, which both contain Eh1 motifs, nor to
Tcf3, which binds to the Gro/TLE N terminus. These results
demonstrate that the recruitment of transcription factors
harboring WRP(W/Y) tetrapeptides is essential to the anti-
neurogenic function of Gro/TLE1.
Transcriptional co-repressors of the Groucho/transducin-
like Enhancer of split (Gro/TLE)3 family play critical roles dur-
ing multiple developmental processes, including neuronal dif-
ferentiation in the developing mammalian forebrain (1). Gro/
TLEs act as co-repressors for a variety of DNA-binding
transcription factors. Some of those proteins are dedicated tran-
scriptional repressors while othersmediate repression or transac-
tivation depending on specific contexts (1–4). Through interac-
tions with a large number of transcriptional regulators, Gro/
TLEs are involved in the gene regulatory functions of a variety
of signaling pathways, including Notch, Wnt/Wingless, trans-
forming growth factor- superfamily, and epidermal growth
factor receptor signal transduction mechanisms (1–6). More-
over, growing evidence suggests important roles for Gro/TLEs
in integrating these different signaling cascades during several
developmental processes (1, 5).
The regulation of neuronal differentiationwas one of the first
functions ofGro/TLEproteins to be characterized.DuringDro-
sophila neural development, Gro participates in theNotch-me-
diated lateral inhibition mechanism that restricts the number
of committed neuroblasts within proneural clusters containing
initially equipotential presumptive neural progenitor cells (7,
8). Neuroblasts undergoing commitment activate the Notch
receptor in adjacent cells, resulting in the transcriptional induc-
tion of genes encoding basic helix loop helix (bHLH) proteins of
the Hairy/Enhancer of split (Hes) family. These DNA-binding
proteins recruit Gro to form complexes that repress the expres-
sion, as well as biochemical activity, of proteins that promote
neuronal differentiation, like the bHLH factors encoded by
achaete-scute complex and atonal genes (9–11). Loss-of-func-
tion mutations ofDrosophila gro result in the differentiation of
supernumerary neurons, similar to the phenotype caused by
disruption of Notch or Enhancer of split genes (7, 8).
MammalianGro/TLE proteins also perform anti-neurogenic
functions. Gro/TLE1 and Gro/TLE3 are expressed in undiffer-
entiated neural progenitor cells of the ventricular zone of the
telencephalic vesicles (12–14). Forced expression of Gro/TLE1
in the forebrain of transgenicmice causes an inhibition/delay of
neuronal development in vivo (15). Similarly, exogenous
expression ofGro/TLE1 in primary cultures of undifferentiated
neural progenitor cells from the dorsal telencephalon causes
decreased neuronal differentiation and an accumulation of pro-
liferating progenitor cells (14).
The molecular mechanisms underlying Gro/TLE-mediated
inhibition of neuronal differentiation in the mammalian fore-
brain remain to be defined. Gro/TLEs form complexes, and
repress transcription, with a number of DNA-binding proteins
expressed during forebrain neuronal differentiation. These
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tion 1734 solely to indicate this fact.
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include, but are not limited to, bHLHproteins of theHes family,
like Hes1 (10, 14, 16, 17), forkhead box proteins, such as FoxG1
(18–20), and homeodomain proteins of the Six (21, 22), Pax
(23), andOtx (24) families. Most transcription factors that bind
to Gro/TLE interact with the C-terminal WD40 repeat (WD)
domain of the latter and can be grouped into two main classes
based on the fact that they utilize two different types of short
peptide sequences to recruit Gro/TLE co-repressors. Those
“repressor peptides” belong to either the WRP(W/Y) (termed
WRPW hereafter) or Engrailed homology 1 (Eh1; FXIXXIL)
motif families (1). Although different in sequence, bothWRPW
and Eh1 peptides bind to an overlapping, but not completely
identical, site on the surface of the Gro/TLEWD domain (25).
Here we describe studies aimed at determining the contribu-
tion of different groups of transcription factors to the ability of
Gro/TLE1 to inhibit the differentiation of cerebral cortex (cor-
tical) neural progenitor cells into neurons. Our results show
that Gro/TLE1 recruitment via repressor peptides of the
WRPWfamily is essential forGro/TLE1-mediated inhibition of
neuronal differentiation. In contrast, the ability to interact with
proteins that either contain repressor peptides of the Eh1 type
or bind to the Gro/TLE N terminus is not sufficient to mediate
Gro/TLE1 anti-neurogenic function. These results character-
ize the mechanisms underlying Gro/TLE1 activity during cor-
tical neurogenesis.
EXPERIMENTAL PROCEDURES
Site-directed Mutagenesis and DNA Plasmids—DNAs
encoding mutated forms of Gro/TLE1 harboring the muta-
tions V486S, C488R, R534A, E550K, and L743F were gener-
ated by site-directed mutagenesis using the QuikChange II
site-directed mutagenesis kit (Stratagene, La Jolla, CA),
using pCMV2-FLAG-Gro/TLE1 (14) as substrate. Oligonu-
cleotide primers used for mutagenesis were as follows





TACTTTGTCC, and L743F-F: 5-GAGTCCTCGTCAGTGT-
TTAGCTGTGACATCTC. pcDNA3-GAL4dbd-Gro/TLE1
plasmids were generated by amplifying by PCR the entire cod-
ing sequence of each mutant using the appropriate pCMV2-
FLAG-Gro/TLE1 plasmids as template, followed by subcloning
into the EcoRV site of pcDNA3-GAL4dbd plasmid, which
encodes the DNA-binding domain of GAL4 (GAL4dbd).
Vectors pEBG-Hes1, pEBG-Hes1(WRPW), pEGFP, pCMV2-
FLAG-Gro/TLE1, pCMV2-HA-FoxG1, pMyc-Tcf3, pCMV2-
HA-En1, p5xGAL4UAS-SV40p-luciferase, and pRSV--ga-
lactosidase were described (14, 16, 18, 20).
Transcription Assays—For studies using a GAL4-responsive
promoter, HEK293 cells were transfected using the SuperFect
reagent (Qiagen) as described (14, 20). The total amount of
transfected DNA was adjusted in each case at 3 g per well
using pcDNA3. Transcription assays were performed using 1.5
g/well of reporter construct p5xGAL4UAS-SV40p-luciferase
in the presence or absence of plasmids pcDNA3-GAL4dbd or
pcDNA3-GAL4dbd-Gro/TLE1 (WT, V486S, C488R, R534A,
E550K, or L743F) (1.0 g/well). In each case, 0.5 g/well of
-galactosidase expression plasmid, pRSV--gal, was used to
normalize for transfection efficiency. Twenty-four hours after
transfection, cells were subjected to determination of luciferase
activity as described (14, 16, 19, 26). Results were expressed as
mean values  S.D. Expression of GAL4dbd-Gro/TLE1 fusion
proteins was detected using an anti-Gro/TLE1 antibody
(1:1,000) (14).
Interaction Assays in Transfected Cells and Western Blotting
Analysis—HEK293 cells were cultured and transfected using
SuperFect. In each experiment, cells were co-transfected with
1.0 g of pCMV2-FLAG-Gro/TLE1 (WT, V486S, C488R,
R534A, E550K, or L743F) and 1.0 g of either pEBG-HES1 (or
pEBG-HES1(WRPW) as control), pCMV2-HA-FoxG1, pMyc-
Tcf3, or pCMV2-HA-En1. Cell lysates were prepared and GST
co-precipitations or co-immunoprecipitations using either
anti-HA (Covance, Berkeley, CA) or anti-Gro/TLE1 (14) anti-
bodies were performed as described (14, 20, 27). This was fol-
lowed byWestern blotting analysis using anti-FLAG (1:10,000;
Sigma), anti-GST (1:500; Santa Cruz Biotechnology, Santa
Cruz, CA), anti-HA (1:5,000), or anti-Myc (1:200; BD Pharm-
ingen, San Diego, CA) antibodies.
Cortical Neural Progenitor Cell Cultures—Primary cultures
of neural progenitor cells were established from dorsal telence-
phalic cortices dissected from embryonic day (E) 12–14 mouse
embryos as described (27–31). Cells were seeded into four-well
chamber slides (Nalgene Nunc, Rochester, NY) coated with
0.1% poly-D-lysine and 0.2% laminin (BD Biosciences, Bedford
Park,MD), cultured inNeurobasalmedium supplementedwith
1% N2, 2% B27, 0.5 mM glutamine, 1% penicillin-streptomycin
(Invitrogen), and 40 ng/ml of FGF2 (Collaborative Research,
Bedford, MA). After 48 h in vitro, cells were transfected with
plasmids encoding either enhanced green fluorescent protein
(GFP) alone (0.2 g/well), or both GFP (0.2 g/well) and Gro/
TLE1 (pCMV2-FLAG-Gro/TLE1 (WT, V486S, C488R, R534A,
E550K, or L743F)) (0.8 g/well). When needed, the total
amount of DNA was adjusted to 1.0 g using pcDNA3. DNA
was mixed with 50 l of OptiMEM medium (Invitrogen), fol-
lowed by incubation for 5 min. An equal volume of OptiMEM
medium were mixed separately with Lipofectamine 2000 rea-
gent (Invitrogen; 2 l/g of DNA) and then combined with the
DNA mixture and incubated for 20 min at room temperature.
The DNA-Lipofectamine 2000 mixture was then added drop-
wise to each well. Three days later, cells were fixed and sub-
jected to immunocytochemistry using antibodies against the
proliferating cell marker Ki67 (1:200; BD Pharmingen), the
neural progenitor cell marker nestin (1:400; Chemicon,
Temecula, CA), the neuronal cell marker III-tubulin (1:300;
Promega), the neuronal cell marker neuron specific nuclear
protein (NeuN) (1:100; Chemicon), the astrocyte cell marker
glial fibrillary acidic protein (GFAP; 1:300; Sigma), or activated
caspase-3 (1:200; BD Pharmingen). Cells were counterstained
with Hoechst 33258 (Sigma) before examination by fluores-
cence microscopy (14, 27, 31). Grayscale images were digitally
assigned to the appropriate red or green channel using North-
ern Eclipse software (Empix, Ontario, Canada). Three to six
random fields of each condition (per experiment) were used for
quantitation of the percent of GFP-positive cells co-expressing
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specific markers (28–31) Results were expressed as the mean
values S.D. At least six separate experiments were conducted
in each case, and statistical analysis was performed using the
Student’s t-test.
RESULTS
Characterization of Point Mutations in the WD Domain of
Gro/TLE1 That Do Not Disrupt Protein Folding—Previous
mutation and structural studies ofWDdomain containing pro-
teins like -transducin repeat-containing protein 1 (32), the
-subunit ofGprotein-coupled receptors (33, 34), and the yeast
Gro/TLE analogueTup1 (35) have revealed that residues impli-
cated in protein-protein interactions are preferentially located
at similar positions on the external surface surrounding the
central channel of the-propeller.Multiple blades and residues
are implicated in those interactions. More specifically, surface
residues located at the start of the first -sheet or just after the
second one are often implicated in protein-protein interactions
(32).
In agreement with those findings, analysis of the crystal
structure of the Gro/TLE1WD domain demonstrated that one
side of the central pore of the -propeller harbors overlapping
binding sites for bothWRPWand Eh1 peptides (25). This com-
mon transcription factor-binding pocket contains key surface
residues located within separate blades of the -propeller.
Some of those residues are essential for interaction with both
WRPWand Eh1 peptides, while others are required for binding
to the former but not the latter (25).
The crystal structure of the WD domain of Gro/TLE1 (25,
36) was utilized in conjunction with naturally occurring muta-
tions at evolutionarily conserved residues in Gro/TLE-related
proteins such as Drosophila Gro (25), Caenorhabditis elegans
UNC-37 (37, 38), and yeast Tup1 (35, 39) to select five residues
within the WD domain of Gro/TLE1 as in vitro mutagenesis
targets (Fig. 1, A–C). More specifically, we generated the fol-
lowing mutations: V486S (similar to the Gro mutations V435A
and V435L), C488R (analogous to mutations C348R in Tup1
and C437M in Gro), R534A (analogous to mutation R483H in
Gro), E550K (analogous tomutations E463N inTup1, E394K in
UNC-37, and E499A in Gro), and L743F (analogous to muta-
tion L692F in Gro) (Fig. 1D).
Based on crystallographic data (25, 36), thesemutationswere
not expected to disrupt the overall structure of theWDdomain.
In agreement with this prediction, we observed that all mutated
proteins migrated on denaturing polyacrylamide gels like wild-
typeGro/TLE1 (Fig. 1E), were able to translocate to the nucleus
(Fig. 1F), and retained the ability to repress transcription from a
basally active promoter when expressed as fusion proteins with
the DNA-binding domain of the yeast protein GAL4 (Fig. 2).
Together, these results demonstrate that the pointmutations in
the WD domain of Gro/TLE1 selected for this study do not
significantly perturb the structure and biochemical activity of
Gro/TLE1.
Different Effects ofWDDomainMutations on theAbility ofGro/
TLE1 to Interact with WRPW or Eh1 Repressor Peptides—To
assess the possible effects of the WD domain mutations on the
anti-neurogenic activity of Gro/TLE1, we first determined
whether they would block Gro/TLE1 interaction with different
FIGURE 1. Characterization of Gro/TLE1 WD domain mutations. A, sche-
matic representation of the Gro/TLE1 C-terminal -propeller composed of
seven blades each consisting of a four-stranded -sheet (36). B, surface map-
ping and electrostatic potential representation of the -propeller (color cod-
ing: red for negative charges and blue for positive charges) showing charged
residues surrounding the predicted central hydrophilic channel where
WRW(P/Y) and Eh1 repressor peptides bind. C, mapping of the five point
mutations (V486S, C488R, R534A, E550K, and L743F) introduced in the Gro/
TLE1 WD domain, shown in red. D, list of mutations analyzed in this study and
equivalent mutations in Drosophila Gro, C. elegans UNC-37, and yeast Tup1.
E, Western blotting (WB) analysis using an anti-FLAG antibody of WT or
mutated forms of FLAG epitope-tagged Gro/TLE1 proteins expressed in
HEK293 cells. F, nuclear localization of wild-type or mutated Gro/TLE1 pro-
teins determined by immunofluorescence analysis of transfected HEK293
cells using an anti-FLAG antibody.
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transcription partners. Several Gro/TLE-binding factors that
contain either WRPW or Eh1 motifs are expressed during cor-
tical neuron development in cells where Gro/TLE1 is also
expressed (18, 21–24). We therefore selected specific Gro/
TLE1 transcription partners that would represent examples of
different categories of proteins. The bHLH factor Hes1 was
selected as a prototypicalWRPWmotif-bearing protein.More-
over, Hes1 is a critical regulator of cortical neurogenesis (40–
42). Engrailed1 (En1) was chosen as a typical example of a pro-
tein that uses an Eh1 motif to recruit Gro/TLE proteins (43).
We also examined Tcf3, as an example of a transcription part-
ner that interactswith theN terminus, andnot theWDdomain,
of Gro/TLE (44).
Co-transfections followed by pull-down (Fig. 3A) or co-im-
munoprecipitations (Fig. 3, B and C) assays showed that sepa-
rateWDmutations had different effects onGro/TLE1 ability to
interact with those proteins. All mutations completely blocked
or severely reduced the interaction with Hes1 (Fig. 3A), sug-
gesting that each of those residues is important for optimal
WRPW peptide recognition. In contrast, the interaction of
Gro/TLE1 with En1 was disrupted only by mutations C488R,
R534A, and E550K, but not by the V486S and L743Fmutations
(Fig. 3B). These findings show thatWRPW- and Eh1motif rec-
ognition by the WD domain of Gro/TLE1 is mediated by both
overlapping and separate residues. In particular, the contribu-
tion of Leu-743 is essential forWRPW peptide binding but not
for Eh1 motif recognition. In contrast to the results with Hes1
and En1, all Gro/TLE1 WD mutations retained the ability to
bind to Tcf3 (Fig. 3C). In agreement with this finding, each
mutated protein repressed trans-activation mediated by
-catenin/Tcf complexes in transfected cells (data not shown).
These results are consistent with the notion that Tcf/Lef pro-
teins interact with the N-terminal domain of Gro/TLE (44).
We next examined the ability of mutated Gro/TLE1 proteins
to bind to the forkhead transcription factor FoxG1, which is a
critical regulator of telencephalic neurogenesis (45). Previous in
vitro studies have suggested that Gro/TLE1 binds to FoxG1
FIGURE 2. Analysis of transcription repression activity of wild-type and
mutated Gro/TLE1 proteins. A, HEK293 cells were transfected with a
p5xGAL4UAS-SV40p-luciferase reporter construct (1.5 g/transfection) in the
absence (bar 1) or presence of WT (bar 2) or mutated (bars 3–7) forms of
GAL4dbd-Gro/TLE1 (1 g/transfection). Basal luciferase activity in the
absence of effector plasmids was considered 100%, and values in the pres-
ence of effector plasmids were expressed as the mean  S.D. of at least three
separate experiments performed in duplicate; *, p  0.001. B, Western blot-
ting (WB) analysis of Gro/TLE1 proteins used in the transcription assays using
anti-Gro/TLE1 antibody. GAL4dbd-Gro/TLE1 consistently migrated as a dou-
blet; the migration of this doublet was slower than endogenous Gro/TLE1
(see arrow). The level of expression of exogenous GALdbd-Gro/TLE1 proteins
was similar to that of endogenous Gro/TLE1.
FIGURE 3. Effect of different Gro/TLE1 WD domain mutations on interac-
tion with Hes1, En1, or Tcf3. A, HEK293 cells were co-transfected with plas-
mids encoding FLAG epitope-tagged WT or mutated Gro/TLE1 and either a
fusion protein of GST and full-length Hes1 (lanes 1– 6) or truncated Hes1 lack-
ing the WRPW motif required for Gro/TLE binding (WRPW) (lane 7). Each cell
lysate (INPUT) was incubated with glutathione-Sepharose beads and the pre-
cipitated material (PD, pull-down), together with 1:10 of each input lysate,
was subjected to Western blotting (WB) analysis with anti-FLAG or anti-GST
antibodies. B and C, HEK293 cells were co-transfected with plasmids encod-
ing FLAG epitope-tagged wild-type or mutated Gro/TLE1 proteins, as indi-
cated, and either HA epitope-tagged En1 (B) or Myc epitope-tagged Xenopus-
Tcf3 (C). Each cell lysate (INPUT) was subjected to immunoprecipitation (IP)
with either anti-HA (B) or anti-Gro/TLE1 (C) antibodies. Immunoprecipitates,
together with 1:10 of each input lysate, were analyzed by Western blotting
with the indicated antibodies.
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using both its C-terminal WD domain and N-terminal Q
domain (18). This possibility is consistent with the presence of
both a putative Eh1 motif (FSINSLV) at the N terminus of
FoxG1 and a separate Gro/TLE binding sequence at a more
C-terminal location (18, 19), suggesting that FoxG1 uses mul-
tiple sequences to engage Gro/TLE1. Co-immunoprecipitation
studies showed thatmutations E550K and L743F did not signif-
icantly affect the Gro/TLE1 ability to bind to FoxG1 (Fig. 4A).
The other mutations reduced but did not completely block this
interaction. These observations suggest that the mode of Gro/
TLE1 recruitment by FoxG1 is complex and involves separate
domains. Nevertheless, the observation that FoxG1 still inter-
acts with the L743F mutant suggests further that Leu-743 is
critical for binding to WRPW peptides but not other Gro/TLE
binding sequences.
Analysis of Gro/TLE1 proteins on low percentage polyacryl-
amide gels allowed the resolution of separateGro/TLE1 species
with different electrophoretic mobility (Fig. 4A, lanes 1–7, and
Fig. 4B). Reduced electrophoretic mobility of Gro/TLE1 has
been shown previously to result from increased phosphoryla-
tion, a process that is promoted by interaction with several
transcription partners, including FoxG1, and is referred to as
“cofactor-activated phosphorylation” (14, 16). We found that
mutations that reduced binding to FoxG1, such as V486S,
C488R, and R534A, also reduced the increased phosphoryla-
tion of Gro/TLE1 observed in the presence of FoxG1 (Fig. 4B,
see lanes 2–5). Importantly, mutation E550K, which does not
prevent binding to FoxG1, com-
pletely blocked the cofactor-acti-
vated phosphorylation of Gro/TLE1
(Fig. 4B, lane 6). These findings sug-
gest an essential role for Glu-550 in
the regulation of Gro/TLE1 phos-
phorylation, possibly by mediating
protein-protein interactions with
critical factors.
Taken together, these results sug-
gest that different WD domain
mutations provide a usefulmeans of
uncoupling transcription repres-
sion partner recognition, permit-
ting the examination of the specific
contributions of separate protein
classes to the biological functions of
Gro/TLE1.
Requirement for WRPW Motif
Recruitment for Gro/TLE1 Anti-neu-
rogenic Activity—Forced expression
of Gro/TLE1 inhibits/delays corti-
cal neuron differentiation in the
telencephalon of developing trans-
genic mouse embryos and cultures
of cortical neural progenitor cells
(14, 15). To clarify the contribution
of transcription factors containing
WRPW or Eh1 motifs to its anti-
neurogenic function, we exog-
enously expressed wild-type or
mutated Gro/TLE1 proteins in primary cultures of neural pro-
genitor cells obtained from dissected dorsal telencephalon
from E12-E14 mouse embryos (Fig. 5, A and B). This defined
primary culture system (“cortical progenitor cells”) has been
used on multiple occasions to investigate the functions of
extrinsic and intrinsic regulators of cortical neuron differenti-
ation (27–31, 46–49). Enhanced GFP was co-expressed with
Gro/TLE1 to visualize the transfected cells, which were ana-
lyzed for the expression of markers of proliferating cells, undif-
ferentiated neural progenitors, postmitotic neurons, or astro-
cytes after 5 days in vitro (Fig. 5B and data not shown). As
previously described (14), exogenous expression of wild-type
Gro/TLE1 resulted in an increase in the number of cells co-
expressing GFP and the mitotic cell marker Ki67, compared
with control (Fig. 5C). Wild-type Gro/TLE1 caused a similar
increase in the number of nestin-positive neural progenitor
cells (Fig. 5D). These effects were accompanied by a significant
reduction in the number of GFP-positive cells exhibiting a neu-
ronal morphology and expressing the neuronal cell markers,
NeuN and III-tubulin (Fig. 5, F and G). GFAP-positive astro-
cytes accounted for a small fraction of the cells in culture and
Gro/TLE1 expression had no detectable effect on their number
(Fig. 5E). The number of transfected cells showing signs of pro-
grammed cell death, like the expression of activated caspase-3,
was small under all conditions tested (Fig. 5H). These results
show a role for Gro/TLE1 in delaying/inhibiting the differenti-
ation of cortical progenitor cells into neurons.
FIGURE 4. Effect of different Gro/TLE1 WD domain mutations on interaction with FoxG1. A, HEK293 cells
were co-transfected with plasmids encoding FLAG epitope-tagged WT or mutated Gro/TLE1 proteins, as indi-
cated, and FLAG-tagged FoxG1. Each cell lysate (INPUT) was subjected to immunoprecipitation (IP) with an
anti-Gro/TLE1 antibody. Immunoprecipitates, together with 1:10 of each input lysate, were subjected to SDS-
polyacrylamide gel electrophoresis on either 6% (lanes 1– 8) or 10% (lanes 9 –14) gels, followed by Western
blotting (WB) with an anti-FLAG antibody. B, HEK293 cells were co-transfected with the indicated combinations
of proteins, followed by fractionation of cell lysates on a 6% SDS-polyacrylamide gel and Western blotting with
an anti-FLAG antibody. Asterisks are placed next to the slower form of Gro/TLE1 observed in selected cases in
the presence of FoxG1.
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The anti-neurogenic effect of
Gro/TLE1 was abolished by muta-
tions that selectively disrupt inter-
action with WRPW, but not Eh1,
repressor peptides, such as V486S
and L743F (Fig. 5,C andD, F andG).
The E550K mutation, which pre-
vents interactionwithHes1 and En1
but does not block binding to
FoxG1, also abrogated the anti-neu-
rogenic affect ofGro/TLE1 (Fig. 5,C
and F). The samewas true formuta-
tions, like C488R and R534A, which
disrupt the interaction of Gro/TLE1
with Hes1, En1, and Foxg1, but not
Tcf3 (Fig. 5,C andD, F andG). None
of the mutated Gro/TLE1 proteins
caused significant changes in the
number of cells expressing GFAP or
activated caspase-3 (Fig. 5, E andH).
Taken together, these results indi-
cate that the anti-neurogenic activ-
ity of Gro/TLE1 depends on the
recruitment of WRPWmotif family
proteins. They suggest further that
Hes family members are the pri-
mary anti-neurogenic partners of
Gro/TLE1 during cortical neuron
development.
DISCUSSION
In this report, we sought to deter-
mine whether the ability of Gro/
TLE1 to inhibit/delay the transition
of cortical progenitor cells into neu-
rons depends on interactions with
proteins containing the WRPW
or/and Eh1 repressor peptides, or
neither of those. By analyzing a
panel ofWDdomainmutations that
selectively impair the interaction of
Gro/TLE1 with different transcrip-
tional cofactors, we have shown that
WRPW motif recognition is essen-
tial for Gro/TLE1 anti-neurogenic
activity.
Essential Role of Specific WD
Domain Residues in Repressor Pep-
tide Recognition—Using informa-
tion derived from previous struc-
tural and genetic studies, we
generated a panel of point muta-
tions within the C-terminal WD
domain of Gro/TLE1 that do not
disrupt the overall structure of this
-propeller, as indicated by the abil-
ity of the mutated proteins to trans-
locate to the nucleus and repress
FIGURE 5. Effect of Gro/TLE1 proteins on cortical neuron differentiation. A, primary cultures of E13.0 mouse
embryonic cortical progenitor cells were transfected with plasmids encoding FLAG-tagged forms of Gro/TLE1
(lanes 2–7), followed by immunoprecipitation (IP) and Western blotting (WB) analysis of the transfected pro-
teins with anti-FLAG antibody; untransfected cells were analyzed in lane 1. B, cortical progenitor cells were
transfected with either GFP alone (Control, top row) or a combination of GFP and wild-type Gro/TLE1 (middle
row), Gro/TLE1L743F (bottom row), or other mutated forms of Gro/TLE1 (not shown). Approximately 48 h later,
cells were fixed and subjected to double-labeling analysis of the expression of GFP (green) and either the
progenitor cell markers Ki67 and nestin, the neuronal markers NeuN and III-tubulin (red), the astrocyte marker
GFAP or activated caspase-3 (not shown). Arrowheads point to examples of double-labeled cells. C–H, quanti-
tation of the percentage of GFP-positive cells that also expressed the indicated markers. Results are shown as
the mean  S.D. (500 cells were counted in each case; n  6; *, p  0.001 using the Student’s t test). F and G,
III-tubulin immunoreactivity marks both younger and older neuron populations, whereas NeuN immunore-
activity labels preferentially more mature neurons. As a result, larger numbers of neurons are detected using
the anti-III-tubulin antibody compared with the anti-NeuN antibody.
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both basal and activated transcription in transfected cells.
These mutations can be grouped into two categories based on
their effect on repressor peptide recognition. One group (cate-
gory-1 mutations) disrupts interactions with both WRPW and
Eh1 peptideswhereas the second (category-2) blocks binding to
the former but not the latter.
Mutations C488R, R534A, and E550K behaved as category-1
mutations in our study. Those three residues sit near themouth
of the central pore of the -propeller (25, 36) and participate in
key interactions with the C-terminal tryptophan, N-terminal
tryptophan, and arginine of the WRPW peptide, respectively
(25). In the case of the Eh1 motif (FXIXXIL), those residues
make key contacts with leucine 7, phenylalanine 1, and isoleu-
cine 3, respectively (25). The essential roles of those amino
acids are further highlighted by their evolutionary conservation
amongGro/TLE orthologs and analogs and the severe effects of
naturally occurring mutations at those sites. More specifically,
amino acid positions corresponding to Glu-550 in Gro/TLE1
are conserved inDrosophilaGro (Glu-499),C. elegansUNC-37
(Glu-394), and yeast Tup1 (Glu-463). Mutations targeting this
position were found for Tup1 (E463N) (39) and UNC-37
(E394K) (38). In both cases, these mutations significantly per-
turb the biological functions of these proteins. Similarly, the
position equivalent to Arg-534 of Gro/TLE1 is mutated
(R483H) in a Drosophila gro allele that causes widespread per-
turbation of the embryonic functions of this gene (25). Taken
together, these observations are consistent with the notion that
category-1 residues are critical for Gro/TLE protein ability to
engage a large number of transcription partners.
We have found that V486S and L743F behave as category-2
mutations. Those residues are part of a hydrophobic recess
located at the mouth of the central pore, and are involved in
interactionswith the side chain of theC-terminal tryptophan of
theWRPWpeptide (25). This hydrophobic depression appears
to be flexible enough to accommodate the equally flexible side
chains of isoleucine-3, isoleucine-6, and leucine-7 of the Eh1
motif even in the presence of Val-486 or Leu-743 mutations
(this study and Ref. 25). Analysis in Drosophila shows that
mutation of Leu-629 (equivalent to Leu-743 of Gro/TLE1)
causes embryonic phenotypes that are somewhat weaker than
those resulting from mutations of WD domain residues
required for interactions with both WRPW and Eh1 peptides
(25), consistent with only a partial perturbation of protein-pro-
tein interactions.
The effects of theWDdomainmutations on cofactor binding
do not seem to be due to a generalizedmisfolding of Gro/TLE1,
because all the mutated proteins were competent to interact
with, and repress trans-activation mediated by, Tcf proteins.
These observations suggest further that thosemutations should
not cause a generalized loss of themany functions ofGro/TLE1,
as they are not predicted to affect all of its protein-protein inter-
actions. It should be noted, however, that we cannot rule out
the possibility that at least some of those mutations might dis-
rupt interactions with global cofactors that bind to the WD
domain and are required by most, if not all, transcription part-
ners, including those that bind to the N terminus of Gro/TLE1.
Uncoupling of Repressor Peptide Recognition Reveals an
Essential Role for WRPWMotif Recognition in Gro/TLE1 Anti-
neurogenic Activity—The present studies show that category-1
mutations, which block Gro/TLE1 ability to interact with both
WRPW and Eh1 peptides, also disrupt its inhibitory effect on
cortical neuron differentiation. Category-2 mutations, which
do not prevent binding to proteins that harbor an Eh1 motif
(like En1 or FoxG1) or proteins that bind exclusively to the
Gro/TLE1 N-terminal Q domain (like Tcf3), also disrupt Gro/
TLE1 anti-neurogenic function. These results indicate that the
ability to become recruited by transcription factors that either
belong to the Eh1 peptide group or engage Gro/TLE via the
N-terminal region of the latter is not sufficient to mediate Gro/
TLE1 anti-neurogenic activity. Thus, even though members of
these protein groups are expressed in forebrain progenitor
cells, they do not appear to be involved in Gro/TLE1-mediated
inhibition of cortical neurogenesis. Instead, our findings show
that Gro/TLE1 depends on interactions with proteins contain-
ingWRPWmotifs to inhibit the cortical progenitor-to-neuron
transition.
This interpretation agrees with several previous findings.
Hes1 (a prototypical WRPW motif protein) and Gro/TLE are
co-expressed in cortical neural progenitor cells, form com-
plexes, and repress transcription together (14, 16, 18, 20).
Moreover, bothHes1 andGro/TLE1were shown to associate in
cultured neural stem cells with the promoter of pro-neuronal
genes, like Mash1 (17). Misexpression of Gro/TLE1 in the
developing forebrain causes reduced neuronal differentiation
in vivo, as does its exogenous expression in cultured cortical
neural progenitor cells (Refs. 14, 15 and this study). These
effects are similar to the inhibition of neuronal differentiation
and maintenance of neural stem/progenitor cells caused by
misexpression of Hes1, Hes3, or Hes5 in the embryonic brain
(41, 50, 51). Conversely, Hes1;Hes5 double knock-out mice
show a premature differentiation of neural stem/progenitor
cells into neurons (52). Together with our present findings,
these results strongly suggest that Gro/TLE1 works together
with Hes proteins to regulate the transition of cortical neural
progenitor cells into neurons.
The physiological significance of the ability of Gro/TLE1 to
form complexes with other factors expressed during cortical
neurogenesis remains to be defined. It is possible that through
such interactions Gro/TLE1 might participate in mechanisms
important for other cellular processes, like the regulation of the
rate of cell proliferation of neural progenitors, or the specifica-
tion of selected neuronal fates. In that regard, previous studies
have shown that different Gro/TLE family members continue
to be expressed in different populations of post-mitotic cortical
neurons, suggesting non-overlapping roles in the establishment
and/or maintenance of neuronal identity (47, 53).
Gro/TLE family members regulate a large number of devel-
opmental processes. The availability of mutations that selec-
tively perturb interactions with specific families of Gro/TLE
transcription partners is expected to facilitate the elucidation of
themolecularmechanisms underlying the pleiotropic activities
of this family of transcriptional co-repressors.
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